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Abstract 
 
Background: During ageing, there are changes in many physiological systems including the 
gastrointestinal tract which may result in decreased absorption of micronutrients such as zinc. Decreased 
dietary absorption efficiency and/or inadequate zinc intake are contributing factors to the decline in 
plasma zinc concentration that has been reported in older adults. This decline in plasma zinc 
concentration may have important implications for health, e.g. through reduced immune function. To 
date, there is limited information on the relationships between zinc intake and plasma zinc concentration 
during ageing among adults in Saudi Arabia or on the molecular mechanisms responsible for age-related 
effects. Thus, the aims of this study were to test the hypothesis that changes in expression of zinc 
transporters including ZnT1, ZnT5 and ZIP4 are associated with changes in zinc status in young and 
older Saudi adults.  
Methods: Two hundred and two young and older Saudi adults of both sexes were recruited from Jeddah 
city in the western region of Saudi Arabia. Intakes of zinc and of zinc absorption modifiers in diet were 
assessed using an FFQ (designed and validated for this purpose) while plasma zinc concentration was 
determined by ICP-OES. RNA was extracted from white blood cells and qPCR was used to quantitatively 
measure expression of the ZnT1, ZnT5 and ZIP4 genes at the mRNA level.  
Results: Intakes of zinc and of protein were significantly higher in males than in females (P<0.05). A 
substantial proportion of the participants appeared to have inadequate zinc intake with the risk of 
inadequacy being greatest for young males (15%) and young females (4%). Plasma zinc concentrations 
in older adults were significantly higher than in young adults (P<0.05). Older males had significantly 
higher ZIP4 expression compared with young adults (P<0.05). Although older adults had apparently 
higher ZnT1 and ZnT5 expression than young adults, these differences were statistically non-significant. 
Several age and sex-specific correlations between zinc intake, zinc status and expression of zinc 
transporters were observed. Young and older adults who had apple-shaped fat distribution pattern, had 
significantly higher expression of ZnT1, ZnT5 and ZIP4 and plasma zinc status compared with 
participants who had pear-shaped fat distribution pattern (P<0.05).  
Discussion: Despite the changes in food availability in Saudi Arabia over recent decades, the prevalence 
of low zinc intake remains substantial. Contrary to reports from elsewhere, the prevalence of low plasma 
II 
 
zinc concentrations was greater in younger than in older Saudi adults. This study also identified 
relationships between expression of zinc transporters and zinc intake, zinc status and abdominal fatness 
in Saudi adults.  
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Chapter 1. Introduction and Background 
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1.1- Definition of Ageing:   
“Ageing is a degenerative process that is associated with progressive accumulation of deleterious 
changes with time, reductions of physiological function and increase in the chance of disease and death” 
(Lee and Wei, 2012). 
Chronological age is the most popular method to define aged or elderly but this approach is contested 
(World Health Organization, 2001, Balcombe and Sinclair, 2001). The World Health Organization uses 
65 years as a numerical cut-off point to refer to older persons (elderly) whereas 80 and over refers to 
oldest-old. Nevertheless, definitive categorization of older people is difficult because “old” is an 
individual-, culture-, country- and sex-specific term. For instance, many people in developing countries 
are functionally “old” in their forties and fifties (World Health Organization, 2001). In Saudi Arabia, 60 
years and above refers to older adults as it is considered as retirement age (Almadani, 2005). In 2008, 
Sanderson and Scherbov proposed an alternative to having a fixed age at which people are categorized 
as old i.e. to define old age as beginning at some threshold level of remaining life expectancy. Thus, 
there are at least two ways of defining old age: old-age based on chronological age and one based on 
prospective age (Sanderson and Scherbov, 2008).  
 
1.2- Demography of Ageing: 
Around the world, the number of people aged 60 years and over is on the rise (World Health 
Organization, 2011). For instance, there were 784 million older people in 2011 which represents 11% of 
the total population. By 2050, this number is projected to increase by factor of 2.6 to reach around 2 
billion (i.e. 22% of the population), with most of the increase in the developing countries. This percentage 
is expected to reach 30 in 2100 (see Figure 1.1) (World Health Organization, 2011, United Nations, 
2011). In Saudi Arabia, the number of older people (>60 years) in 2009 was 907,529 which represents 
5.2 % of the Saudi population (Ministry of Economy and Planning, 2009a). 
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Figure 1.1 Worldwide proportion of people aged 60 and over from 1950 to 2100 
Source: United Nations department of economic and social affairs/ population division (2011)  
 
Although there have been notable setbacks in life expectancies in some countries (such as sub-Saharan 
Africa, the countries of the CEE, Russia and the Baltic States) , the continuously growing proportion of 
older people is due to increasing longevity (World Health Organization, 2011, Leon, 2011). Table 1.1 
shows that life expectancy at birth by years at the world level is on the rise for both sexes (United Nations, 
2011). The greatest increases have occurred in east Asia, where life expectancy at birth increased from 
less than 45 years in 1950 to more than 74 years nowadays (Ministry of Economy and Planning, 2009b, 
World Health Organization, 2011). Table 1.2 showed the increase in life expectancy in Saudi population 
over recent years (Ministry of Economy and Planning, 2009b).  
 
Table 1.1 Life expectancy by sex for the world, 2005-2010, 2045-2050 and 2095-2100 
Life expectancy at birth (years) 
2005-2010 2045-2050 2095-2100 
Male Female Male Female Male Female 
65.7 70.1 73.2 78 79 83.3 
Source: United Nations department of economic and social affairs/ population division (2011) 
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Table 1.2 Life expectancy by sex for Saudi population, 2006-2009 
Life expectancy at birth (years) 
2006 2007 2008 2009 
Male Female Male Female Male Female Male Female 
72.4 74.4 72.5 74.6 72.6 74.8 72.7 74.9 
Source: Saudi Ministry of economy and planning/ department of statistics and information (2009) 
As can be seen from Tables 1.1 and 1.2, there are sex differences in life expectancy and females have 
longer life expectancy than males. The reason for this difference is not known but may be because 
females are less likely to engage in behaviors known to cause chronic health problems and to contribute 
to premature mortality such as smoking, poor diet and excessive alcohol consumption (McKevith, 2009). 
Improvements in life expectancies are part of a major transition in human health around the world. This 
transition includes a shift in the main causes of death and illness from parasitic and infectious diseases 
to non-communicable disease and chronic conditions and sustained  increases in life expectancy at birth 
and at older ages (World Health Organization, 2011). Center for disease control and prevention reported 
ten global health achievements over the first ten years of the 21st century. These improvements include 
the control of malaria, HIV, Tuberculosis and neglected tropical diseases (Morbidity and Mortality 
Weekly Report, 2011). 
The growing proportion of older people is due not only increasing life expectancy but also to decreasing 
fertility rate. Globally, the total fertility (average number of children per woman) was 4.45 in 1970-1975. 
This number declined to 3.04 in 1990-1995 and reached 2.52 in 2005-2010 (United Nations, 2011). 
Among Saudi women, total fertility rate decreased gradually from 3.6 in 2004 to 3.24 in 2009 and to 
2.26 in 2012 (Central Intelligence Agency, 2012, Ministry of Economy and Planning, 2009c). 
 
 
 
5 
 
1.3-The Basic Biology of Ageing: 
Ageing is a complex process which involves several mechanisms operating at different levels (von 
Zglinicki et al., 2001) and is not genetically programmed (McKevith, 2009). In 1956, Harman proposed 
that reactive oxygen radicals (ROS) cause ageing by damaging membranes, proteins, and DNA. There 
is a growing body of evidence supporting the idea that the action of ROS is an important theme linking 
several different kinds of damage (Kirkwood and Mathers, 2009). Cellular DNA is damaged by ROS 
damage occurring in the nuclear DNA, telomeric DNA and mitochondrial DNA (von Zglinicki et al., 
2001, López-Otín et al., 2013). 
1.3.1- Nuclear DNA damage and repair: 
DNA is subject to damage by exogenous and endogenous damaging agents (Burkle et al., 2002). 
Oxidative damage is among the most important form of DNA damage as it can occur at any time 
(Kirkwood and Mathers, 2009). When ROS attacks DNA, a variety of DNA lesions are generated such 
as oxidized DNA bases, abasic sites and DNA strand breaks, which then lead to genomic instability 
(Maynard et al., 2009). Repair activities of DNA control the rate of ageing by keeping the DNA damage 
at low levels (Burkle et al., 2002). In mammals, there are several DNA repair pathways including base 
excision repair (BER), nucleotide excision repair (NER), double-strand break repair and mismatch repair 
(Cui et al., 2012). Poly (ADP-ribose) Polymerase-1 (PARP-1) plays a key role in immediate cellular 
response to free radicals-induced DNA damage by recognizing DNA lesions and flags them for repair 
(Muiras et al., 1998). In 1992, Grube and Burkle compared the activity of PARP in mammalian species 
of different maximal life span and found a strong positive relationship between PARP activity and life 
span (Grube and Burkle, 1992). Similarly, PARP activity was higher in centenarians of a French 
population than controls aged 20 to 70 years providing further evidence that longevity is correlated with 
a high poly (ADP-ribosyl)ation capacity (Muiras et al., 1998). 
There is considerable inter-individual variation in DNA repair capacity (DRC) even among healthy 
individuals (Tyson and Mathers, 2007). Tyson et al (2009) found an eleven-fold variation in NER 
between individuals whilst Caple et al (2010) found a larger variation (41-fold) in BER capacity (Tyson 
et al., 2009, Caple et al., 2010). This difference is partly due to variations in age as there is sufficient 
evidence that all DNA repair pathways capacity decreased with increasing age (Xu et al., 2008, Tyson et 
al., 2009, Gorbunova et al., 2007). DRC can also be influenced by genotype as the majority of genes 
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encoding proteins important in DNA repair are polymorphic (Mohrenweiser et al., 2002, Tyson and 
Mathers, 2007). For instance, DRC was modulated by the presence of the A allele of XPA G23A (NER 
gene) polymorphism (Slyskova et al., 2011). Zhu et al (2008) showed that individuals with the variant 
alleles (AC and CC) of Lys 939 Gln in XPC, another NER gene, had significantly higher DNA damage 
following exposure to benzo[a]pyrene diol epoxide (BPDE) and gamma-radiation. On the other hand, 
subjects with the variant alleles (CT and TT) of Ala 499 Val had lower DNA damage (Zhu et al., 2008). 
A significant variation in DNA damage level was also found between 3 genotypes for the Val 16 Ala 
polymorphism in manganese superoxide dismutase (rs 4880) (Caple et al., 2010). 
In addition to age and genotype, diet is also responsible for differences in DRC. Certain dietary factors 
may enhance DNA repair capacities besides their role in the prevention of oxidative damage. Some 
examples of these dietary factors are organic products, whole grains, fruits (such as golden kiwifruit) and 
vegetables (such as broccoli) which are associated with decreased levels of oxidation of DNA bases 
(purine and pyrimidine) (Riso et al., 2010, Prado et al., 2010, Brevik et al., 2011a). Reduction of DNA 
single strand breaks (SSB) was more rapid after consumption of mixed carotene capsules while repair 
activity was enhanced after consumption of cooked carrots (Astley et al., 2004). Similarly, Brevik et al 
(2011) found a positive effect of consuming anti-oxidant rich plant products on decreasing DNA SSB 
whereas BER was increased (Brevik et al., 2011b). Thus, dietary factors which limit damage or which 
enhance repair would be expected to modify the rate of biological aging (Kirkwood and Mathers, 2009).  
Not only DNA damage but also mutagenesis was reported to increase with age and these contribute to 
aging by causing cellular dysfunction (Xu et al., 2008). 
 
1.3.2- Telomeric DNA:  
Telomeres are repeats of a noncoding sequence of DNA complexed with proteins which protect the end 
of the chromosomes (Champe et al., 2005). In most human cells, telomeres shorten with each round of 
DNA replication due to lack of telomerase enzyme. Additionally, oxidative stress accelerates telomere 
loss and repair of telomeric DNA damage is less effective than elsewhere in the chromosome (von 
Zglinicki, 2002). Loss of telomeres eventually stops chromosomes replicating and they became 
senescent. Loss of chromosomal replication limits the capacity for formation of new cells during ageing 
(Bodnar et al., 1998). Valdes et al (2005) found that telomere length declined constantly with age at a 
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mean rate of 27 bp/year and was 240 bp shorter in obese than in lean females and smoking accelerates 
telomere shortening (Valdes et al., 2005). Cawthon et al (2003) suggested that telomere shortening is 
associated with mortality (Cawthon et al., 2003). In 2008, Starr et al reported that SNPs in MSRA and 
NDUFA8 genes (oxidative stress-related genes) were associated with variation in telomere length and 
that nine SNPs in five genes were strongly related to biomarkers of physical ageing (Starr et al., 2008). 
Von Zglincki and Martin-Ruiz (2005) proposed that telomere length is a biomarker of ageing and ageing-
related morbidity (von Zglinicki and Martin-Ruiz, 2005). However, Mather et al (2011) reexamined this 
evidence and suggested that this evidence is equivocal. Telomere length does not fully meet the American 
Federation of Ageing Research criteria that it should reflect life span rather than chronological age and 
it must monitors a basic process underlying normal ageing at the population level and not the effects of 
diseases. On the other hand, this biomarker fulfills the criteria that telomere length can be estimated 
repeatedly without harm and that it can be examined in other mammals (Mather et al., 2011). Recently, 
Simons (2015) reviewed telomerase knockout and overexpression studies conducted on several model 
species and find little support that telomeres cause ageing. In addition, the causality hypothesis assumes 
that there is a critical telomere length at which senescence is induced. This generates the prediction that 
variance in telomere length decreases with age. In contrast, using meta-analysis of human data, no such 
decline was found. Inferring the causal involvement of telomeres in ageing from current knowledge is 
therefore speculative (Simons, 2015). 
 
1.3.3- Mitochondrial DNA: 
In 1972, Harman specifically extended the free radical theory by the mitochondrial theory of aging 
(Harman, 1972). This is based on the concept that mitochondria are the major producers of ROS (as by-
product of respiration) in mammalian cells and that mitochondrial DNA (mtDNA) is prone to oxidative 
damage. mtDNA mutations generated by ROS accumulates in the cell, leading to damaged respiratory 
chain proteins, thereby generating more ROS, which in turn causes higher mutation rates (Maynard et 
al., 2009). Several studies showed that mtDNA deletions increased in elderly people compared to young 
people (Hattori et al., 1991, Yen et al., 1991). In aging human tissue, Nooteboom et al (2010) showed 
that respiratory chain (RC) deficiency, caused by mtDNA point mutations, attenuates cell proliferation 
and increase apoptosis in the progeny of RC deficient stem cell, leading to decreased crypt cell population 
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(Nooteboom et al., 2010). Moreover, high level of mutant DNA in cytochrome C oxidase-deficient fibres 
were reported in muscle tissues from normal elderly humans (Brierley et al., 1998). Increased 8-oxo-dG 
(one of the most abundant DNA lesions caused by ROS) in mtDNA is frequently detected in aged tissues 
(Cui et al., 2012). While mtDNA mutations and deletions increase with age, Welle et al (2003) showed 
that the amount of mtDNA in muscle of older subjects was 38% lower than in young subjects.  
In addition to generating ROS, mitochondria play a critical role in mediating apoptosis (Cui et al., 2012). 
In many instances, developmental homeostatic and pathological cell death involves a critical step in 
which mitochondria release proteins that trigger the self-destructive enzymatic cascade that causes 
apoptosis (Green et al., 2011). Moreover, activation of the permeability transition pore (PTP), which 
plays a critical role in cell necrosis and apoptosis, is enhanced in spleen, brain and liver of aged mice 
(Mather and Rottenberg, 2000). Autophagy (a lysosome-dependent cellular degradation process) can 
specifically target cellular structures such as mitochondria (mitophagy) and, with increasing age, loss of 
autophagy can lead to accumulation of damaged mitochondria, which promotes cell death and 
inflammation (Green et al., 2011). 
As a result of a wide spectrum of alterations in mitochondria and mtDNA during ageing, Lee and Wei 
proposed that elevated oxidative stress, subsequent accumulation of mtDNA mutations, altered 
expression of a few clusters of genes, decreased mitochondrial energy metabolism, mitochondrial 
dysfunction and apoptosis are important contributors to human ageing (Lee and Wei, 2007, Lee and Wei, 
2012b).  
1.4- Nutritional and Physical Activity Requirements of Older People: 
1.4.1- Energy: 
Energy is needed by the body to maintain its fundamental functions (often assessed as Basal Metabolic 
Rate (BMR)) and for physical activity. Together with the thermic effect of food (TEF), these are the 3 
components of energy expenditure (Thompson and Manore, 2009b). 
In most people, 60-65% of energy expenditure is used to maintain basic physiologic functions at rest 
(estimated as BMR) (Thompson and Manore, 2009b). BMR is influenced by body mass, sex (Lazzer et 
al.), protein turnover (Welle and Nair, 1990), fat free mass, fat mass and age (Johnstone et al., 2005). 
BMR declines with age, with estimates of 2% and 2.9% decline per decade for normal weight females 
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and males, respectively (FAO/WHO/UNU, 2004). Aging is associated with changes in body 
composition, with increases in body fat, while fat free mass decreases, leading to reduced BMR (Guo et 
al., 1999, McKevith, 2009). 
The second component of energy expenditure is the energy cost of physical activity (PA). Typically, this 
energy represents 15-35% of energy output and it expended on muscular work and movement above 
basal levels (Thompson and Manore, 2009b). As people age they often become more sedentary and thus 
energy expenditure is diminished (McKevith, 2009). In addition, the high prevalence of  diseases and 
disabilities affects the daily activities of 39% of persons aged 65-74 years old and 48% of those aged > 
75 years (Elia et al., 2000). However, such age-related declines in physical activity are not inevitable. 
For instance, Evenson et al (2002) observed that, in retirement, American subjects in their study increased 
their participation in sport and exercise (Evenson et al., 2002). This highlights the fact that PA energy 
expenditure is the most variable component of total energy expenditure and that it depends on the 
individual’s health, social and cultural features that enhance, or limit, their PA (Elia et al., 2000, 
FAO/WHO/UNU, 2004). 
The thermic effect of food (TEF) (also called diet-induced thermogenesis (DIT)) is the third component 
of energy expenditure and it represents 5-10% of total energy expenditure. This is energy used to digest, 
absorb, transport, metabolize and store the nutrients of food (Thompson and Manore, 2009b). The effect 
of aging on this component of energy expenditure is unclear as results of several studies are inconsistent. 
For instance, Golay et al (1983) and Thörne and Wahren (1990) found that thermogenesis diminished 
with age (Golay et al., 1983, Thorne and Wahren, 1990). On the other hand, Poehlman et at (1991) 
showed that thermic effect of a meal was not related to age (Poehlman et al., 1991). Elia et al (2000) 
examined the factors which may have been contributed to the different findings about DIT in the elderly. 
First, the previous studies have been used either protein or carbohydrates meals, or mixed liquid meals 
and none of which used a mixed meal containing both liquid and solid components. Second, several 
factors such as body composition, PA level and visceral fat accumulation in women may affect DIT and 
many studies did not control for these factors (Elia et al., 2000). 
Table 1.3 shows the estimated average requirements (EAR) for energy for older people is lower than for 
younger adults. These values are even lower in cases of immobility or chronic illness (Scientific Advisory 
Committe on Nutrition, 2011). 
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Table 1.3 Estimated average requirements for energy (Kcal/day) 
Age Males Females 
19-24 2772 2175 
25-34 2749 2175 
35-44 2629 2103 
45-54 2581 2103 
55-64 2581 2079 
65-74 2342 1912 
75+ 2294 1840 
Source: (Scientific Advisory Committe on Nutrition, 2011). 
1.4.2- Macronutrients: 
Dietary recommendations for carbohydrates, dietary fibre and fat for older people are the same for other 
adults (Department of Health, 1991). However, protein recommendations are slightly changed in older 
adults compared with young adults. Male requirements are decreased while female requirements 
increased (see Table 1.4) (Department of Health, 1991). Discussions about the validity of protein 
requirements based on the FAO/WHO/UNU report are ongoing. Various researchers concluding that 
these recommendations should be higher because of increased illness, infections, poor wound healing 
and surgery in this age group (McKevith, 2009). 
Table 1.4 Reference nutrient intakes for Protein (g/day) 
 Age Males Females 
19-50 
51+ 
55.5 
53.3 
45 
46.5 
Source: Department of Health (1991). 
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1.4.3- Micronutrients: 
 
The micronutrients needs of older people are generally similar to those of young adults (see Table 1.5) 
(Department of Health, 1991, Sentific Advisory Committee on Nutrition, 2015).  
Table 1.5 Reference nutrient intake (RNI) for vitamins and minerals for adults over 50 years  
Nutrient RNI Nutrient RNI 
Calcium (mg/d) 700 Copper (mg/d) 1.2 
Phosphorus (mg/d) 550 Iodine (µg/d) 140 
Magnesium (mg/d) 
270 female 
300 male 
Zinc (mg/d) 
7 female 
9.5 male 
Sodium (mg/d) 1600 Iron (mg/d) 8.7 
Potassium (mg/d) 3500 Vitamin B12 (µg/d) 1.5 
Chloride (mg/d) 2500 Folate (µg/d) 200 
Selenium (µg/d) 
60 female 
75 male 
Thiamin (mg/d) 
0.8 female 
0.9 male 
Riboflavin (mg/d) 
1.1 female 
1.3 male 
Niacin (mg/d) 
12 female 
16 male 
Vitamin B6 (mg/d) 
1.2 female 
1.4 male 
Vitamin D (µg/d) 10 
Source: Department of Health (1991) and Scientific Advisory Committee on Nutrition (2015) 
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1.4.4- Fluids: 
With aging, the water % of total body weight falls. As a result, the body’s water reservoir is reduced and 
the safety margin for staying hydrated become smaller (Brown et al., 2005). Drinking 30 ml/kg of water 
per day (i.e. 6-8 glasses) is required by adults to prevents dehydration persons, even those who are 
underweight, should drink at least 1500 ml of fluid per day unless there is renal failure or some other 
reason to restrict intake (World Health Organization, 2002). Older people should increase their intake if 
they have fever, diarrhea, living in high environmental temperature or if there is drug- or caffeine-
induced fluid losses (McKevith, 2009). 
1.4.5- Physical activity: 
Regardless of age, sex, stage of life or socioeconomic status, physical activity (PA) has been 
demonstrated to benefit health (McKevith, 2009). PA recommendations for younger adults are applicable 
for older adults. In general, adults should achieve at least 30 minutes moderate intensity PA per day on 
at least 5 days per week. This can be achieved by doing life style activities such as brisk walking or 
climbing stairs as well as structured exercise or sport. In addition, older people are encouraged to do 
specific activities that improve and promote coordination, strength and balance (Department of Health, 
2004).  
The WHO’s global strategy on diet, PA and health recommends that individuals should engage in 
different types and amounts of PA to benefit from different health outcomes. For example, at least half 
an hour of regular, moderate intensity PA on most days reduces the risk of colon cancer, breast cancer, 
diabetes and cardiovascular disease (World Health Organization, 2003). 
1.5- Dietary Pattern, Nutrient Intake, Nutrient Status and Physical Activity of Saudi Older 
Adults: 
1.5.1- Dietary pattern: 
Differences in food patterns have been observed among people of different ages, sexes and cultures. The 
food patterns of young and older Saudi adults have been investigated by several studies (see Table 1.6). 
Briefly, the proportion of free-living older adults who consume three meals per day was higher than those 
of young adults. Sadiq (2005) investigated the number of meals consumed by 50 elderly females in 
Jeddah city (western province) before and after institutionalization and found that the number who 
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consumed 3 main meals/day declined significantly after institutionalization (Sadiq, 2005). On the other 
hand, consumption of snack meals is more common in young than in older adults. Intake of vegetables 
and fruits (except dates) are less preferred among young than older adults and dates are reported as a 
favorite fruit for all ages.  
Table 1.6 Studies of dietary patterns of young and old Saudi adults 
City/ 
province 
Age 
Sample size 
and sex 
Observations Reference 
Northern 
province 
60-70 
years 
404 
male 
86.2% consume 3 main meals/day 
(Alenezy, 
2003b) 
Riyadh/ 
central  
≥60  
years 
115 female 
57.9% of participants consume 3 main 
meals/day while only 3% eat snacks more than 
3 times/day, 63.2 % drink milk daily, 60% and 
44.2 % daily eat vegetables and fruits, 
respectively. 
(Hosa, 2004) 
Alqassim
/ central  
All 
age 
groups 
1804 male 
980 female 
More than 70% of elderly (≥60) reported 
preferences for fish, vegetables, fresh fruits 
and grilled meats while more than 40% of 
adults (<33) showed the same preferences, 
more than 40% of all ages groups preferred 
eating dates 
(Midhet et al., 
2010) 
Abha/ 
southwes
tern  
17- 
>25 
456 male 
75% had a snack 1-3 times/day, 42% drinks 
soft drinks more than 4 times/week 
(Al-Gelban, 
2008) 
Alqassim
/ central 
18-24 
years 
357 male 
31.4% consume 3 meals/day, 11.2% eat daily 
green, red or yellow vegetables, 4.5% eat daily 
fruits except dates, 36.1 % consume dates daily 
(Al-Rethaiaa et 
al., 2010) 
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1.5.2- Nutrient intake: 
Studies investigating nutrient intakes in older Saudi adults are rare and have been undertaken mainly in 
institutionalized rather than among free-living elderly. Average daily energy intake of older Saudi adults 
are varied according to difference in living situations and sex. For example, mean intake of free-living 
men (≥50 years) was 1834 kcal (below RNI) (Alissa, 2005), while for men in institutions it was reported 
to be 2795 kcal (above RDA) (Alnumair, 1998). The latter value seems high and may be affected by 
measurement errors. However, institutionalized women (55-70 years) had energy intake of 1232 kcal 
which is below the RDA (Sadiq, 2005a). Figure 1.2 shows the slight differences in the percentage energy 
in the form of total fat, total protein and carbohydrates between males and females according to different 
studies results.  
A
lis
s a
 (
2 0
0 5
)  
(m
a l
e )
*
A
ln
u
m
a i
r  
(1
9 9
8 )
 (
m
a l
e )
* *
s a
d
iq
 (
2 0
0 5
)  
( f
em
a l
e )
* *
*
0
2 0
4 0
6 0
%
c a rb o h y d ra te s
to ta l fa t
to ta l p ro te in
 
Figure 1.2 Percentages energy from fat, protein and carbohydrates in 3 separate studies of the diets of 
Saudi elderly. Ages: * (≥ 50 years), ** (50-85 years), *** (55- >75 years) 
Mean daily intake of fat, protein and carbohydrates in men were 78 g, 70 g and 213 g respectively (Alissa, 
2005). Lower intakes were reported in women, where fat, protein and carbohydrates intake were 47 gm, 
47 g and 160 g respectively (Sadiq, 2005). Dietary fibre intakes of male and females living in institutions 
were below recommendations (RDA) as the intake was 15 g and 4 g, respectively (Sadiq, 2005a, 
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Alnumair, 1998). Similarly, free-living male showed low fiber intakes (18 g) (Alissa, 2005). Low intakes 
of a range of micronutrients where highlighted in table 1.7 according to differences in Saudi regions. 
Table 1.7  Low intakes of micronutrients by Saudi older adults 
City/ 
province 
Age 
Sample 
size 
and 
sex 
Nutrients with low intake a 
(% of participants with low intake) 
Reference 
Riyadh/ 
central 
- 
- 
male 
Vitamin B12 (34%)* 
Folate (88%) 
(Al-Shitwi, 2006) 
Jeddah/ 
western  
55-75 
200 
female 
Niacin                 Vitamin D**   
Folic acid            Calcium 
Vitamin C            Iron 
Vitamin A 
(Sadiq, 2005a) 
Jeddah/ 
western  
≥50 
303 
male 
Selenium (87%)*** 
Vitamin A (54%) 
Vitamin E (29%) 
Vitamin C (32%) 
(Alissa, 2005) 
Northern 
province 
60-70 
404 
male 
Vitamin A** 
Vitamin D  
Vitamin C 
Vitamin B6 
(Al-Gelban, 2008) 
a - low has been defined differently. * Nutrients intake below RDI, ** nutrients intake below RDA, 
***nutrients intake below EAR 
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1.5.3- Nutritional status: 
In the UK population, it is estimated that one in seven elderly has a medium or high risk of malnutrition 
when examined using the malnutrition universal screening tool (MUST) (Malnutition Advisory Group, 
2003). Morbidity and mortality are predicted by involuntary weight loss. Additionally, excess body 
weight is associated with increased risks for many age-related diseases (McKevith, 2009). In a number 
of studies, there were large variations in the proportion of underweight and obese Saudi elderly (Figure 
1.3). These studies showed that underweight is more prevalent among institutionalized elderly whereas 
obesity is high among free-living Saudis.  
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Figure 1.3 Proportions of underweight and obese among free living and institutionalized Saudi elderly. 
* Criteria of inclusion is not available in the abstract, ** underweight= BMI < 20 kg/m2, *** underweight= BMI 
< 18.5 kg/m2, obese= BMI > 30 kg/m2 
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Iron, iodine, zinc, vitamin A and D deficiencies are highly prevalent in the Arab region but the magnitude 
of the problems differs from country to country (Madani and Kumosani, 2001). In Saudi Arabia, iron 
and vitamin D are widely studied. 
When using WHO criteria for diagnosis of anemia [i.e. Hb < 13g/l in men and Hb < 12g/l in women], 
the prevalence of iron deficiency anemia in institutionalized men and women in Riyadh was 40% and 
32% respectively (Al-Orf, 2012, Alhamdan, 2004). Similarly, the prevalence of anemia among women 
living in institutions in Jeddah was 32.5% (Sadiq, 2005). In contrast, free-living males and females 
showed lower prevalence of anemia (12.9%) overall but a higher frequency in females (18%) compared 
with males (5%) (Alsaeed, 2011). 
Vitamin D nutritional status can be determined by plasma 25 hydroxyvitamin D (25OHD) concentration 
(Ardawi et al., 2011). Decreased vitamin D intake, decreased cutaneous synthesis and other factors 
contribute to risk of vitamin D deficiency (Holick and Chen, 2008). Although Saudi Arabia is a sunny 
country, direct exposure to sunlight is restricted for cultural reasons and/or due to excessive heat (Ardawi 
et al., 2012).  Serum 25 OHD concentration decreases significantly with age in both sexes. In men aged 
(<50 years) mean serum 25 OHD (nmol/l) was 31.25 and declined to 26.84 in older adults (>50 years) 
(Ardawi et al., 2012). Similarly, mean serum 25 OHD (nmol/l) fell from 42.97 nmol/l to 33.3 nmol/l in 
pre-menopausal and post-menopausal women, respectively (Ardawi et al., 2011). 
1.5.4- Physical activity: 
A national epidemiological health survey was carried out in Saudi Arabia between 1995 and 2000 in 
which 7395 Saudi males and females aged between 30 and 70 years participated. Participants were 
classified into active and inactive categories based on the intensity, duration and frequency of physical 
activity. Findings showed that levels of inactivity were high and that significantly more females were 
inactive (98.1%) than males (93.9%). Inactivity increased with age in males increasing from 89.5% in 
young men (30-39years) to 97.4% in older men (60-70 years). This highlights the sedentary nature of the 
Saudi adult population (Al-Nozha et al., 2007). 
1.6- Nutritional Role of Zinc: 
Zinc is a transition element in the series of the fourth period of the periodic table with the atomic number 
of 30 and an atomic weight of 65.4, which forms the redox-stable Zn2+ cation. In the human body, zinc 
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is present in all organs and tissues (Gropper et al., 2005) with total body content estimated at 2-3 gm. 
More than 80% of total body zinc is in muscle, bone, hair and skin. Additionally, the liver, pancreas, 
kidney and toenails contain high concentrations of zinc (Mahan and Escoot-Stump, 2004, Fairweather-
Tait, 1988). 
1.6.1- Functions of zinc: 
Zinc is an essential cofactor for more than seventy enzymes including DNA and RNA polymerases 
(Berdanier and Zempleni, 2009) and so it is therefore for nucleic acid synthesis. Equally important, 3-
10% of all human proteins bind zinc, including zinc finger proteins of which the majority are transcription 
factors (Cousins, 1998, Andreini et al., 2006). Recently, it has been discovered that zinc acts as an 
intracellular signaling molecule, able to communicate between cells, convert extracellular stimuli to 
intracellular signals and control intracellular events (Fukada et al., 2011). This trace element is also 
central to other biological functions including inflammation (Prasad, 2009), immunity (Haase and Rink, 
2009), bone metabolism (Yamaguchi, 1998), taste perception (Keast, 2003, Wright et al., 1981), 
spermatogenesis (Yamaguchi et al., 2009), skin health (Rostan et al., 2002) and defense against free-
radical attack (Powell, 2000). 
1.6.2- Dietary sources of zinc: 
Relatively little zinc is stored in the body and, thus, a constant adequate supply of dietary zinc is 
required. Table 1.8 shows selected zinc-rich foods.      
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Table 1.8 Zinc content (mg) per common measure of selected foods 
Food item and description Measure 
Zinc content 
(mg/measure) 
Oyster (cooked), breaded and fried 3 oz 74.06 
Alaska king crab (cooked), moist heat 3 oz 6.48 
Baked beans, canned 1 cup 5.79 
Duck meat (cooked), roasted 1/2 duck 5.75 
Ground beef (cooked) 3 oz 5.31 
Turkey meat (cooked), roasted 1 cup 4.34 
Sirloin beef steak 3 oz 4.14 
Ready- to-eat cereals, Kellogg's all bran 1/2 cup 3.72 
Lobster (cooked), moist heat 3 oz 3.44 
Ricotta cheese, whole milk 1 cup 2.85 
Chickpeas (cooked) 1 cup 2.51 
Oats cereal (cooked) 1 cup 2.34 
Low-fat plain yogurt  8-oz container 2.02 
Mixed  nuts with peanuts 1 0z 1.08 
Source: USDA National Nutrient Database for Standard Reference, Release 24 (2011) 
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1.6.3- Zinc in the GI tract: 
After consumption of a meal, zinc is liberated from food components as a result of digestive process 
most likely by proteases and nucleases in the stomach and small intestine. Hydrochloric acid also appears 
to play a key role in zinc release from the food matrix and/or its absorption (Gropper et al., 2005, Krebs, 
2000). Zinc may move across the brush border membrane either as the free ion or as part of a complex. 
Most evidence supports the latter idea- that free zinc form complexes with ligands such as amino acids, 
phosphates and other organic acids (Gropper et al., 2005, Krebs, 2000). In addition to dietary zinc 
(exogenous zinc), endogenous zinc from pancreatic and biliary secretions is released into the 
gastrointestinal tract (Gropper et al., 2005). 
1.7- Zinc Absorption: 
Absorption can be considered as the process of influx into the enterocyte, through the apical membrane, 
and efflux across the basolateral membrane, into the portal circulation (see Figure 1.4) (Krebs, 2000, 
Wang and Zhou, 2010). Absorption of dietary zinc in humans is in the proximal small bowel, either the 
distal duodenum or proximal jejunum (Lee et al., 1989, Krebs, 2000). Several studies on rat intestine and 
human intestinal Caco-2 cell monolayers showed that zinc uptake in the intestine is concentration-
dependent and that both carriers mediated (saturable) and non-mediated (non-saturable) pathways are 
involved (Yasuno et al., 2012, Steel and Cousins, 1985). 
Multiple zinc transporters are expressed  in the enterocyte including ZnT1, ZnT2, ZnT4, ZnT5, ZnT6, 
ZnT7, ZIP4 and ZIP5 (see Figure 1.4) (Wang and Zhou, 2010). These mammalian transporters belong 
to two families – the ZnT and Zip families. The ZnT (solute-linked carrier 30 (SLC30A)) proteins 
decrease intracellular zinc concentration by mediating zinc efflux from cells or influx into intracellular 
compartments (e.g. endosomes and Golgi apparatus). Conversely, the ZIP (Zrt- and Irt-like proteins 
(SLC39A)) proteins increase cytosolic zinc concentrations (Eide, 2004, Palmiter and Huang, 2004b).
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Figure 1.4 Zinc transport pathways in the enterocyte. The question mark indicates a pathway that is not 
yet well-characterized. Straight arrows indicate the direction of zinc transport. Curved arrows indicate 
exocytosis. Source: (Wang and Zhou, 2010) 
Ten members of the SLC30 family are recognized in mammals. All of them, except ZnT5, are predicted 
to have six transmembrane (TM) domains with both N- and C- termini on the cytoplasmic side of the 
membrane, and most have a long C-terminal tail as shown in Figure 1.5A (Palmiter and Huang, 2004b, 
Lichten and Cousins, 2009). ZnT5 is estimated to have six (in variant A) to twelve (in variant B) 
additional TM domains and a long N-terminal tail (Cragg et al., 2002). TM domains are connected with 
small loops with the exception of the loop between domains IV and V which is large (Palmiter and 
Huang, 2004b, Ford, 2004). This loop was reported to be rich in histidine residues and therefore 
represents a potential Zn-binding region (Ford, 2004, Paulsen and Saier, 1997). 
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Fourteen members of the SLC39 family are encoded by the human genome. Most Zip proteins have eight 
predicted TM domains with extra cytoplasmic N- and C-termini, as shown in Figure 1.5B. Some of the 
proteins, such as ZIP4, have a long N-terminal tail. Loops connecting TM domains are quite short while 
a longer histidine-rich loop generally occurs between TM domains III and IV (Ford, 2004, Eide, 2004). 
 
 
 
 
 
                            (A)                                                                                        (B) 
Figure 1.5 The Predicted Topology of (A) SLC30 Proteins (B) SLC39 Proteins. Source: (Palmiter and 
Huang, 2004b, Eide, 2004). 
 
1.7.1- Zinc transporters involved in zinc uptake into enterocytes: 
1.7.1.1- SLC39A4 (ZIP4): 
The human gene SLC39A4 was identified and characterized by two groups simultaneously (Wang et al., 
2002, Kury et al., 2002). This gene is located on chromosome 8 in a region previously identified as being 
linked to the rare autosomal recessive disorder acrodermatitis enteropathica (AE) (Kury et al., 2002, 
Wang et al., 2002). Affected individuals suffer from a severe zinc deficiency resulting from impaired 
absorption of zinc from intestine (Kury et al., 2002). All AE patients studied by (Kury et al., 2002) carry 
mutations in both alleles of SLC39A4 which probably affects the function of the protein. Further 
characterization showed that ZIP4 mRNA was abundantly expressed throughout the small intestine in 
both humans and mice (Kury et al., 2002, Wang et al., 2002, Dufner-Beattie et al., 2003). Mouse ZIP4 
was shown by immunohistochemistry to be localized at the apical membrane of the enterocytes (Dufner-
Beattie et al., 2003, Wang et al., 2002) and that the expression of the gene was affected by dietary zinc, 
exhibiting increased expression under zinc deficiency and rapidly decreased expression with increasing 
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zinc content in the diet (Dufner-Beattie et al., 2003). All of these findings strongly support a role for 
ZIP4 in zinc uptake across the apical membrane into the enterocyte (Wang and Zhou, 2010, Lichten and 
Cousins, 2009).  
1.7.1.2- SLC30A5 (ZnT5 variant B): 
SLC30A5 appears to exist as two major splice variants (A and B) (Ford, 2004). The higher-molecular 
weight transcript encodes ZnT5 variant A (ZnT5A) while the lower molecular weight transcript encodes 
ZnT5 variant B (ZnT5B), previously named the human zinc transporter like 1 (hZTL1) (Cragg et al., 
2002, Ford, 2004). ZnT5B consists of 523 amino acids and has homology with the mouse zinc transporter 
ZnT1, as shown in Figure 1.6 (Cragg et al., 2002). 
In 2002, Cragg et al detected ZnT5 mRNA in a range of mouse tissues (Cragg et al, 2002). At the same 
time, Kambe et al (2002) reported that ZnT5 Protein was expressed ubiquitously in several human tissues 
(Kambe et al., 2002). Transfection of a Myc-tagged ZnT5 protein into Caco-2 cells indicated that the 
protein is expressed on the apical membrane (Cragg et al., 2002). Subsequent confirmation of this 
location by immunohistochemistry was reported not only in Caco-2 cells but also in human intestine 
(Cragg et al., 2003, Cragg et al., 2005). In a recent study, localization of ZnT5B to the endoplasmic 
reticulum (ER) was also reported  (Thornton et al., 2011). 
Unlike other members of the SLC30 family, ZnT5B is a bidirectional zinc transporter which mediates 
zinc uptake, as well as zinc efflux. When the protein was expressed in Xenopus oocytes, zinc uptake 
across the plasma membrane increased (Cragg et al., 2002). In addition, the activity of the zinc-
responsive metallothionein 2a (MT2a) promoter increased when ZnT5B was co-expressed with an MT2a 
promoter-reporter construct in Caco-2 cells, indicating increased total intracellular zinc concentration 
(Valentine et al., 2007). Furthermore, the observed co-localization of ZnT5B with ZIP7 in the ER  may 
indicate a function in uptake of zinc into this compartment for subsequent release by ZIP7, possibly as a 
component of intracellular zinc signaling (Thornton et al., 2011). 
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Figure 1.6 The predicted topology of ZnT5B. The shaded area indicates the region of homology with 
ZnT1. Source: (Cragg et al., 2002) 
1.7.2- Zinc transporters involved in intracellular trafficking of zinc within enterocytes: 
Mechanisms for intracellular zinc trafficking from the apical cytoplasm to the basolateral cytoplasm of 
the enterocytes remain largely unknown (Wang and Zhou, 2010). Several intracellular zinc transporters 
are expressed in enterocytes and their suggested functions in intracellular zinc trafficking is shown in 
Table 1.9 and Figure 1.4.   
In addition to zinc transporters, metallothionein may contribute to zinc transport within the enterocyte. 
Briefly, this protein binds zinc in two separate clusters with different affinities and has been proposed to 
play a role in zinc detoxification and as a zinc reserve (Wang and Zhou, 2010, Mahan and Escoot-Stump, 
2004). 
25 
 
Table 1.9 Mammalian zinc transporters involved in intracellular trafficking of zinc  
Zinc 
transporter 
Sub cellular localization Function 
ZnT2 
Vesicles on the apical side of the enterocytes 
(Liuzzi et al., 2003) 
Transport zinc into endosomal/lysosomal-like vesicles and therefore protects 
cells from zinc toxicity (Palmiter et al., 1996) 
ZnT4 
Trans-Golgi network, vesicles at the basal 
cytoplasmic region and endosomes (Murgia et al., 
1999, Huang et al., 2002) 
When zinc concentration of the medium increased, ZnT4 trans located from 
Golgi to vesicles (Huang et al., 2002). In addition, a fraction of ZnT4 was 
detected on the plasma membrane, suggesting with a role in transporting zinc 
from vesicles to plasma membrane (Henshall et al., 2003). Thus, it is 
proposed that ZnT4 promotes zinc secretion from Golgi into the blood stream 
via exocytosis (see figure 4)(Wang and Zhou, 2010)  
ZnT5  
variant A 
Golgi apparatus (Kambe et al., 2002, Thornton et 
al., 2011, Jackson et al., 2007) 
 Increases uptake of zinc into Golgi vesicles and thus contribute to the          
activity of zinc requiring enzymes (Suzuki et al., 2005A, Kambe et al., 2002, 
Jackson et al., 2007) 
ZnT6 
Trans Golgi network and apical membrane (Huang 
et al., 2002, Yu et al., 2007) 
 Like ZnT2, ZnT6 was located from Golgi to peripheral vesicles 
(Huang et al., 2002) indicating that it transports cytoplasmic zinc into 
Golgi apparatus as well as into vesicular compartments for excretion 
into the lumen via exocytosis (see figure 4) (Wang and Zhou, 2010, 
Palmiter and Huang, 2004b) 
 ZnT6 forms a heteromeric complex with ZnT5A to activate zinc 
requiring enzymes (Suzuki et al., 2005B) 
26 
 
Zinc 
transporter 
Sub cellular localization 
Function 
ZnT7 Golgi apparatus (Kirschke and Huang, 2003A) 
 Transport zinc from the cytoplasm into the Golgi apparatus (Kirschke 
and Huang, 2003A, King, 2010) 
 Like ZnT5 and 6, ZnT7  is required for the activation of zinc requiring 
enzymes (Suzuki et al., 2005A, Suzuki et al., 2005B) 
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1.7.3- Zinc transporters involved in releasing zinc to blood circulation: 
Zinc must be released from the basolateral membrane of the enterocytes to reach the blood for systemic 
supply (Wang and Zhou, 2010) and  the molecular mediator of this process was suggested to be ZnT1 
(Wang and Zhou, 2010). This transporter was the first mammalian zinc transporter to be identified 
(Palmiter and Findley, 1995). It displays a ubiquitous tissue distribution and is highly expressed in tissues 
involved in zinc acquisition, recycling or transfer, such as the small intestine (McMahon and Cousins, 
1998a, Lichten and Cousins, 2009). Immunocytochemistry with an antibody to a myc epitope on the 
carboxy-terminus of ZnT1 revealed localization to the plasma membrane (Palmiter and Findley, 1995). 
McMahon and Cousins (1998) and Yu et al (2007) found that ZnT1 protein was most abundant at the 
basolateral membrane of enterocytes lining the villi of the rat duodenum and jejunum (Yu et al., 2007, 
McMahon and Cousins, 1998b). Cragg and Ford (unpublished results) confirmed this localization in the 
human intestinal Caco-2 cell line (Ford, 2004). ZnT1 location, along with functional evidence for zinc 
efflux in different cells, such as BHK cells and PC12 cells (Palmiter and Findley, 1995, Kim et al., 2000), 
support the suggestion that ZnT1 mediates efflux of absorbed dietary zinc from the enterocyte into the 
blood stream (Ford, 2004, Lichten and Cousins, 2009, King, 2010).  
1.8- Factors Influencing Zinc Absorption: 
1.8.1- Dietary factors: 
The efficiency of zinc absorption in humans responds to changes in dietary zinc intake (Krebs, 2000). 
Current zinc intake, rather than past zinc intake or status, was inversely related to fractional zinc 
absorption (Chung et al., 2008). As dietary zinc increases, the total amount of absorbed zinc increases 
but the percentage of absorption decreases and vice versa (King, 2010). For example, zinc absorption 
was up regulated to as high as 92% after consuming a low zinc (< 11 mg/d) and low-phytate diet for 4-8 
weeks (Hunt et al., 2008). 
 In addition to zinc intake, the presence of dietary inhibitors and enhancers affects the efficiency of zinc 
absorption. Phytic acid is the most potent known dietary repressor of zinc absorption as it can bind zinc 
and form insoluble complexes in the GI tract (Couzy et al., 1998, Kim et al., 2007, Hunt and Beiseigel, 
2009). Dietary protein also affects zinc absorption (Krebs, 2000). Generally, higher levels of protein 
were found to enhance zinc absorption (Sandstrom et al., 1980) but individual protein components can 
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have  different actions. For example casein may inhibit zinc absorption (Lonnerdal, 2000), while amino 
acids such as methionine and histidine  facilitated zinc absorption through a mechanism assumed to be 
related to zinc binding. Zinc-binding organic acids, such as citrate, had a similar effect (Lonnerdal, 2000).  
1.8.2- Age: 
Numerous studies have demonstrated that ageing influences intestinal zinc absorption in both humans 
and rats. Coudray et al (2006 A and B) found that zinc absorption in rat intestine declined significantly 
with age (Coudray et al., 2006a, Coudray et al., 2006b). Similarly, zinc absorption in human subjects 
decreased with increasing age (Aamodt and Rumble, 1983). When young men (22-30 years old) and 
older men (65-74 years old) consumed the same purified formula diet containing 15 mg of zinc per day, 
mean zinc absorbance was 31% in the young men and fell significantly to 17% in the older men 
(Turnlund et al., 1986). August et al (1989), reported that zinc absorption from a zinc adequate diet in 
elderly subjects was 21% compared with 39% in young subjects (August et al., 1989). Couzy et al (1993) 
reported a trend towards lower zinc absorbance in elderly subjects than in younger adult subjects, but 
this did not reach statistical significance, which the authors attributed to the small sample size of the 
study (Couzy et al., 1993a).  
1.9- Zinc Transport and Excretion: 
Zinc passing from the intestine into the portal blood is transported loosely bound to proteins, 
predominantly albumin (Mahan and Escoot-Stump, 2004). Up to 60% of zinc is transported by albumin 
while transferrin, α-macroglobulin and immunoglobulin G (IgG) may transport between 15 and 40% of 
zinc in the blood (Gropper et al., 2005). The major site of zinc uptake appears to be the liver (Berdanier 
and Zempleni, 2009). 
Zinc is excreted from the human body via three primary routes including the GI tract, kidney and the 
skin. Most zinc is lost from the body in the feces. Endogenous zinc that is not reabsorbed in the GI tract 
is also excreted in the feces. In contrast to intestinal zinc losses, renal and dermal losses of zinc, as well 
as loss in semen and menses, are relatively minor and also more constant (Gropper et al., 2005). 
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1.10- Zinc Homeostasis: 
It has been reported that experimental rats and humans can regulate whole body zinc content, while 
dietary zinc intakes vary over a 10-fold range (King et al., 2000). 
The GI tract is the major site of zinc homeostasis (King et al., 2000) and the mechanisms for zinc 
homeostasis include adjustments in zinc absorption and endogenous intestinal excretion of zinc (King et 
al., 2000, Hambidge et al., 2010).  With extremely low zinc intakes or with prolonged marginal intakes, 
changes in urinary zinc excretion, shifts in plasma zinc turnover rates and release of zinc from selected 
tissues such as bone can occur as secondary homeostatic adjustments (King et al., 2000). Altered 
regulation of expression of zinc transporters and metallothionein in the intestine is becoming increasingly 
accepted as critical players in cellular zinc homeostasis in the intestine (Sekler et al., 2007, Fukada et al., 
2011). Zinc transporter and metallothionein genes are regulated by increased or reduced zinc availability 
in both positive and negative manners and some genes show more complex responses to zinc (Jackson 
et al., 2008).  
1.10.1- Regulation of zinc transporters genes: 
Several studies report regulatory effects of zinc on ZIP4 expression in the intestine, and details of the 
underlying regulatory mechanisms are being uncovered. For example, ZIP4 expression in rat intestinal 
epithelium was up-regulated by excess zinc intake (Fujimura et al., 2012). Zinc supplementation reduced 
SLC39A4 protein in the ileal mucosa of humans (Cragg et al., 2005), and zinc addition to the medium 
of cultured cells increased endocytosis of the ZIP4 transporter resulting in reduced cellular zinc uptake 
(Kim et al., 2004). Similarly, Weaver et al (2007) found that administration of oral zinc caused 
degradation of ZIP4 in enterocytes while zinc deficiency increased the ZIP4 protein level (Weaver et al., 
2007). At the mechanistic level, ubiquitination and degradation of ZIP4 was observed in response to high 
zinc concentration (Mao et al., 2007) and Kruppel-like factor (KLF4) was found to bind to the mouse 
ZIP4 promoter under zinc-limiting conditions to increase expression of ZIP4 (Liuzzi et al., 2009). 
Unlike ZIP4, ZnT1 responds to zinc in a positive manner in rats and in cell lines but appears to respond 
differently in humans. McMahon and Cousins (1998) found that dietary zinc supplementation increased 
ZnT1 mRNA and protein in rat intestine by 50% and 10% respectively (McMahon and Cousins, 1998b). 
A similar result was reported by Jou et al (2009) (Jou et al., 2009). In cell lines (Mouse Hepa cells and 
Mouse embryo fibroblasts), treatment with zinc resulted in a rapid (3 hours) and dramatic (12-fold) 
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increase in ZnT1 mRNA levels. The zinc-responsive transcription factor MTF1 can bind to the ZnT1 
promoter and increase gene expression (Langmade et al., 2000). In contrast, ZnT1 mRNA and protein 
were reduced in ileal mucosa of humans following zinc supplementation, indicating that the response of 
ZnT1 to dietary zinc supplementation may differ between rats and humans (Cragg et al., 2005).  
Regulation of the SLC30 A5 gene appears to be complex (Jackson et al., 2008). In the human intestinal 
cell line Caco-2, increasing the zinc concentration of the medium reduced ZnT5 mRNA levels (Cragg et 
al, 2005) but in the presence of actinomycin D (to prevent transcription) ZnT5 mRNA was increased by 
zinc, demonstrating stabilization of ZnT5 mRNA (Jackson et al., 2007). Recently, Coneyworth et al 
(2012) identified a binding site in the SLC30A5 promoter region which is responsible for zinc-induced 
transcriptional repression, and which was named the Zinc Transcriptional Regulatory Element (ZTRE) 
(Coneyworth et al., 2012). Coneyworth et al (2012) also reported that a protein factor whose expression 
is increased under conditions of high zinc availability binds to the ZTRE and results in abrogated 
repression of a reporter gene in response to zinc (Coneyworth et al., 2012). This apparently complex 
mode of regulation may reflect the fact that two opposite pathways -transcriptional repression and 
increased mRNA stability - operate with increased zinc availability (Jackson et al., 2008).   
ZIP5 is another zinc transporter that may be involved in intestinal zinc homeostasis. This transporter was 
found to be located at the basolateral membrane of enterocytes and was internalized and degraded during 
zinc deficiency (Dufner-Beattie et al., 2004, Weaver et al., 2007). After zinc-gavage in mice, ZIP5 
rapidly resynthesized and targeted to the basolateral membrane (Weaver et al., 2007). Thus, ZIP5 may 
function in the removal of zinc from the blood stream into the enterocyte for ultimate excretion into 
intestinal lumen under zinc replete conditions (Dufner-Beattie et al., 2004, Wang and Zhou, 2010). 
1.10.2- Regulation of metallothionein gene expression: 
Zinc supplementation induces metallothionein (MT) mRNA in both cell lines and humans (Langmade et 
al., 2000, Cragg et al., 2005). In mice, increased MT1 and 2 gene transcription is mediated through the 
binding of the transcription factor (MFT1) to the metal response element (MRE) in the promoter region 
(Heuchel et al., 1994, Coneyworth et al., 2012). 
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1.11- Zinc Deficiency and Status:  
The first cases of dietary zinc deficiency in humans were described in the 1960s in male dwarfs from the 
Middle East (Sandstead et al., 1967). Clinical features of zinc deficiency included growth retardation, 
delayed sexual maturation, alopecia, delayed wound healing, impaired appetite and immune deficiencies 
(Mahan and Escoot-Stump, 2004). The major factor associated with the development of zinc deficiency 
at the population level is inadequate dietary zinc intake. High physiological requirements for zinc (such 
as during infancy, adolescence, pregnancy and lactation), decreased dietary zinc absorption efficiency 
and treatment with certain drugs (e.g. penicillamine, thiazide and glucagon) are additional influencing 
factors (Gibson et al., 2008). 
To assess zinc status and estimate the risk of zinc deficiency at the population level, three types of 
indicators are recommended by WHO/UNICEF/IAEA/IZiNCG i.e. serum zinc concentration, dietary 
intake and height-for –age in children aged<5 years (de Benoist et al., 2007). When the prevalence of 
low serum zinc concentration (less than the age/sex/time of day-specific cutoffs shown in Table 1.10) is 
more than 20%, interventions to improve zinc status are recommended. Additionally, when the 
prevalence of inadequate zinc intakes is greater than 25%, the risk of zinc deficiency is considered to be 
high (de Benoist et al., 2007). Other zinc biomarkers such concentration of zinc in hair, cells, zinc-
metalloenzymes, metallothionein (Grider et al., 1990), metallothionein mRNA, ZIP1 transporter  levels 
(Andree et al., 2004) and the size of the exchangeable zinc pool may also be valid, sensitive markers of 
zinc status (Gibson et al., 2008). 
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Table 1.10 Suggested lower cutoffs for the assessment of serum zinc concentration in population studies 
 Low cutoffs of serum zinc concentration µg/dl (µmol/L) 
 Children aged <10 years Females ≥ 10 years Males≥10 years 
Morning fasting -- 70 (10.7) 74 (11.3) 
Morning non-fasting 65 (9.9) 66 (10.1) 70 (10.7) 
Afternoon 57 (8.7) 59 (9.0) 61 (9.3) 
Pregnancy 
     1st trimester 
     2nd trimester 
 
 
 
56 (8.6) 
50 (7.6) 
 
Source: (Hotz et al., 2003b, Gibson et al., 2008) 
 
Table 1.11 provides an overview of zinc status in all age groups in Saudi Arabia. Briefly, low zinc intakes 
were found in adolescents (Washi and Ageib, 2010) and elderly females (Sadiq, 2005b) but not in males 
(Alenezy, 2003a). In 1997 in a study of all ages, Kumosani et al found that serum zinc concentration 
ranged from 0.5 - 13.90 µmol/L, which is lower than the international established standard. More recent 
studies have shown that low serum zinc concentrations persist in infants and preschool children (Bahijri, 
2001, Alshatwi, 2006) but not adults (20-54 years) (Al-Numair, 2006). Pregnant females have also been 
reported to have lower serum zinc concentrations than non-pregnant women, and that serum zinc 
concentration decreases as pregnancy progresses (Abdul-Jabbar and Kumosani, 1998). Older adults 
appeared to have low zinc status compared with young adults. This age-related decrease was also found 
in other countries (Table1.12). 
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Table 1.11 Measures relevant to zinc status in different age groups of the Saudi population 
Age group 
Sample size 
and sex 
Zinc index Results (mean) Reference 
All age groups  276 
 males and 
 females 
Serum zinc 
 
0-1 year (10.8 µmol/L) 
1-3 years (4.6 µmol/L) 
3-6 years (4.2 µmol/L) 
6-10 years (3.6 µmol/L) 
10-14 years (3.5 µmol/L) 
14-18 years (9.3 µmol/L) 
18-22 years (10.2 µmol/L) 
22-50 years (8.6 µmol/L) 
>50 years (6.1 µmol/L) 
(Kumosani et al., 
1997b) 
Infants and 
young 
preschool 
children 
728 Boys 
 And girls 
Serum zinc 4-72 months (8.91 µmol/L) (Bahijri, 2001) 
Preschool 
children 
178 boys and 
girls 
Serum zinc 
Zinc intake 
2-6 years (12.1 µmol/L) 
2-3 years (5.6 mg/day) 
4-6 years (5.8 mg/day) 
(Alshatwi, 2006) 
Adolescents 239 males and 
females 
Zinc intake 13-18 years (8.68 mg/day) (Washi and Ageib, 
2010) 
Pregnant 
women 
123 healthy 
pregnant and 
non-pregnant  
Serum zinc Pregnant (3.78 µmol/L) 
Non-pregnant (8.86 µmol/L) 
(Abdul-Jabbar and 
Kumosani, 1998) 
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Age group 
Sample size 
and sex 
Zinc index Results (mean) Reference 
Adults 100 females 
and males 
Serum zinc 
Zinc intake 
20-54 years (79.12 µg/dL) 
20-54 years (9.40 mg/day) 
(Al-Numair, 2006) 
Young and 
older adults 
303 males Zinc intake <33 years (9.26 mg/day) 
34-49 years (8.94 mg/day) 
≥50 years (8.75 mg/day) 
(Alissa, 2005) 
Elderly 404 males Zinc intake 60-70 (mean zinc intake 
above RDA (119%)) 
(Alenezy, 2003a) 
Elderly 200 females Zinc intake 55- >75 years (5.66 mg/day) (Sadiq, 2005b) 
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Table 1.12 Age-related decline in serum zinc concentration in different countries 
Country 
Sample size and 
sex 
Results (mean) Reference 
Tunisia  200 males and 
females 
30-60 years (11.61 µmol/L) 
>65 years (10.5 µmol/L) 
(Sfar et al., 2011 
) 
Thailand 1113 males and 
females 
20-35 years (19.12 µmol/L) 
51-75 years (18.05 µmol/L) 
(Boonsiri et al., 2006) 
Italy 152 males and 
females 
60-90 years (14.51 µmol/L) 
91-110 years (11.9 µmol/L) 
(Savarino et al., 2001) 
Five European 
countries 
(Italy, Greece, 
France, Poland 
and Germany) 
853 males and 
females 
60-69 years (12.99 µmol/L) 
70-74 years (12.3 µmol/L) 
75-79 years (12.12 µmol/L) 
80-84 years (11.91 µmol/L) 
(Marcellini et al., 2006) 
 
1.12- Zinc Toxicity: 
A tolerable upper level (UL) for zinc intake by adults, including pregnant and lactating women of over 
19 years, was set by the US Food and Nutrition Board at 40 mg per day (Institute of medicine, 2001). 
High intakes (50 to 450 mg) may cause diarrhea, vomiting, headache and other symptoms (Whitney and 
Rolfes, 2005). 
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1.13- Project Hypotheses, Aims and Objectives: 
My project hypotheses are: 
1) Zinc intake and plasma zinc concentrations in Saudi elderly are lower than in young Saudi adults. 
2) Ageing changes the expression of zinc transporter genes including SLC30A1, SLC30A5, 
SLC39A4. 
3) Age-related changes in expression of these zinc transporter genes may be associated with changes 
in zinc intake and plasma zinc concentration in young and older Saudi adults. 
 
My aims are to test these hypotheses by addressing the following objectives: 
1)  To design and test the relative validity and repeatability of a zinc-specific food frequency 
questionnaire suitable for use by Saudi adults in order to measure zinc intake. 
2)  To measure the dietary zinc intake and plasma zinc concentrations of a sample of young and 
older adults in Jeddah, Saudi Arabia. 
3)  To examine the effects of ageing on the expression of the zinc transporters SLC30A1, SLC30A5 
and SLC39A4. 
4) To assess whether differences in zinc status between young and older adults are associated with 
altered expression of the zinc transporter genes. 
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Chapter 2. Materials and Methods 
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2.1- Development of the Questionnaire: 
The interviewer-administered questionnaire has been designed to collect general demographic 
information, medical history, smoking habits and socioeconomic status (Appendix A). Questions were 
derived from previous studies and/or newly developed after consultation with experts in appropriate 
fields including economics, social sciences, public health and nutrition. In addition, dietary zinc intake 
was estimated using a specially modified food frequency questionnaire (FFQ). A convenience sample of 
adults was used to pilot the questionnaire and feedback from this group was used to produce the final 
version of the questionnaire. 
2.1.1- Demographic features: 
Demographic features including: sex, age, weight, BMI, waist circumference, hip circumference and 
waist-to-hip ratio were assessed for participants. 
Body weight was assessed by weighing the subject without shoes by using electronic scale (Seca). Height 
was also measured without shoes using a Seca Portable stadiometer. Measurements of weight and height 
were made to the nearest 0.1 kg and 0.1 cm, respectively. BMI was calculated by dividing the body 
weight in kg by the square of the height in m (Kg/m2). Participants were classified, according to WHO 
classification, into underweight (BMI= < 18.50), normal (BMI= 18.5-24.99), overweight (BMI= 25-
29.99) and obese (BMI ≥ 30). 
Waist and hips circumferences were measured using a Seca tape for a subgroup of participants only. The 
maximum circumference over the buttocks was measured as the hip circumference. Waist-to-hip ratio 
(WHR) was calculated by dividing the waist by the hip circumference. WHR is a simple method to 
differentiate between fatness in the lower part of the body (hip and buttocks) and fatness in the upper 
part of the body (waist and abdomen areas). Subjects were indicated as having abdominal fat 
accumulation if their WHR >0.9 for males and >0.8 for females (Thompson and Manore, 2009a).  
2.1.2- Medical history: 
Several health problems may affect zinc digestion, absorption, metabolism and excretion. Thus, 
participants were questioned about health problems including: cancer, high blood pressure, heart disease, 
liver disease, kidney disease, arthritis, osteoporosis, diabetes and lung disease. Other questions regarding 
the usage of dietary supplementation, consumption of herbs, dieting were also included. 
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2.1.3- Smoking habits: 
Four categories were used to describe the smoking habits of the participants i.e. smoker, former smoker, 
passive smoker and non-smoker. Further questions about number of cigarettes and/or happly bubbly (a 
device used for smoking fermented fruits, glycerin and tobacco in which the smoke passes through water 
before it is inhaled) usually smoked were also included in the questionnaire. 
2.1. 4- Socioeconomic status: 
Questions about the education status, occupation and household annual income were included in the 
questionnaire to describe the socioeconomic status of participants. 
2.1.5- Assessment of dietary zinc intake: 
A previously-validated semi-quantitative FFQ (Samman et al., 2010) developed in Australia was 
modified for use in assessing dietary zinc intake by Saudi adults. Modifications were based on a 
comprehensive list of foods and drinks consumed by 17892 Saudis obtained in a previous survey 
(Almuhaizie and Albehairy, 2003). This information was supplemented by data from a 24-h recall to 
collect new and recent data on food and drinks consumption. Saudi mixed dishes e.g. rice with milk and 
rice with tomato sauce that contain zinc in excess of 0.5 mg /100 g of the edible portion (Musaiger, 2006), 
according to the food composition tables for Arab gulf countries, were included in the FFQ developed 
for the present study. Foods with a high zinc content but prohibited or rarely consumed by Saudis e.g. 
pork, canned fish, raw oysters and quiche were excluded. Phytate-rich foods which inhibit the absorption 
of zinc and protein-rich foods which enhance absorption were included in the FFQ. Beef, lamb, liver and 
chicken are examples of high zinc and protein foods in the Saudi diet while chickpeas, broad beans, rice, 
potato and flafel (beans and vegetables patties) are high in phytic acid.  The FFQ collected information 
on foods eaten alone as well as the same foods when consumed in mixed dishes e.g. white rice alone and 
rice with milk (saleeq). 
Sixty four food items were classified into ten categories: meat (8 items), seafood (4 items), egg (1 item), 
dairy products (7 items), vegetables (9 items), seeds and nuts (2 items), cereals (19 items), beverages (1 
item) and miscellaneous (12 items) (Table 2.1). Relatively simple and unambiguous food items such as 
egg were placed at the start of the questionnaire since this approach may help study participants to get 
used to the format of the questionnaire and so decrease reporting errors (Cade et al., 2002). Food items 
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relatively rich in zinc such as meats and seafood were placed in the FFQ shortly after egg because the 
accuracy of participants' responses may decline towards the end of the questionnaire due to fatigue or 
boredom (Cade et al., 2002). 
For each food item, a standard serving (medium serve) was expressed in commonly used portions such 
as grams, cups, table-spoons, slices or pieces (Alissa, 2005, Samman et al., 2010). Participants were 
asked to recall how often, on average, they had consumed each food over the past year and how their 
usual serving size differed from that of the standard serve (i.e. small or large). Pictures of food portion 
sizes were used to aid participant recall (Nelson et al.). The frequency of intake was assessed on an 
ascending eight-point scale: never, less than once/month, 1-3 times/month, once/week, 2-4 times/week, 
5-6 times/week, once/day and twice or more/day. This scale was used because it covers the usual range 
in frequency of consumption of foods by Saudis; a few foods such as meat or cheese pie are consumed 
2-4 times/week whereas others e.g. rice and breads are consumed more than once per day. Finally, 
participants were asked to record any food items that were usually eaten and which were not included in 
the list. Between 2 and 6 weeks (average of 4 weeks) after the first administration of the FFQ (FFQ1) all 
participants completed the FFQ for the second time (FFQ2) to test the repeatability of the FFQ. 
Zinc intake from the FFQ was calculated by multiplying the amount of zinc (mg) in a medium serve by 
serving size factor and frequency factor. Serving size factors were 0.5, 1, 1.5 for small, medium and large 
serving, respectively. The frequency of intake per day was calculated as follows: 0, 1/60, 2/30, 1/7, 3/7, 
5.5/7, 1 and 2 for the eight-point scale respectively. Total daily estimated zinc intake for each participant 
was calculated by summing the intakes from each food item. Phytic acid and protein intake were 
calculated in the same way (see appendix B).  
An open-ended record of food intake (Food Record; FR) on two sequential week days and one weekend 
day was used as a reference method for validating the FFQ and were done in the same week after the 
administration of FFQ1. All participants were given instruction about filling out the FR. In addition, each 
participant was provided with a booklet of serving size pictures to aid them in recording the quantity of 
the foods and drinks consumed. Zinc, phytic acid and protein intakes from food records and FFQ were 
analyzed using the Nutrition Data System for Research software version 2012, developed by the 
Nutrition Coordinating Center (NCC), University of Minnesota, Minneapolis, MN after entering the 
analysis of Saudi dishes (Musaiger, 2006). 
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Table 2.1  Food items (serving size) included in the food frequency questionnaire 
 
Eggs Vegetables white toast (1 slice; 25 g) 
eggs (1 egg) potato(1 medium; 150 g) white pasta (1 cup; 100 g) 
Meat broccoli (1 cup; 80 g) white rice (1 cup; 175 g) 
beef (120g) spinach, silver beet (1/3 cup; 
60 g) 
rice with milk (saleeq) (1 cup) 
lamb (2 chops; 100g) tabouli (1 cup; 200 g) rice with tomato sauce (kabsa) (1 
cup) 
veal (1 chop; 90g) okra with tomato sauce (1 cup) rice with lentil (1 cup) 
diced meat(kabab or hamburger) 
(150 g) 
vegetables, stuffed (1 piece) whole meal crisp bread (1; 5 g) 
meat shawerma (1 medium 
sandwich) 
chickpeas (1/2 cup; 200 g) rolled oats (boiled) (1 cup; 230 g) 
chicken shawerma (1 medium 
sandwich) 
broad bean (1/2 cup; 100 g) fruit cake/loaf (1 slice; 75 g) 
chicken (1 breast or thigh; 110 g) Fruits muffin (1; 55 g) 
liver (3/4 cup; 150 g) citrus fruits (1 piece) biscuits (bran, whole meal ) (1; 20 
g) 
Seafood Beverages: Cocoa Miscellaneous 
fish (whole; 1 fillet; 120 g) drinking chocolate (1tbsp; 9g) meat pie (sambosak) (1 piece) 
oysters (smoked; 1; 5 g) Seeds and nuts cheese pie (sambosak) (1 piece) 
crab/scallops (1/2 cup; 90g) sesame butter (1 teaspoon) meat pie (fatayer) (160 g) 
lobster/prawn/squid (1/2 cup; 90 
g) 
nuts (15 g) cheese pie (fatayer) (160 g) 
Dairy  Cereals pizza (150 g) 
cheese (1 slice; 20 g) whole grain corn flakes (1 cup; 
30 g) 
Beans and vegetables patty 
(tameya, flafel) (3 pieces) 
yogurt (1 cartoon; 200 g) corn flakes (1 cup; 30 g) popcorn (1 cup) 
cow's milk (1 glass; 200 ml) brown pita bread (1 slice; 25 
g) 
chips/ corn chips/ twisties (50 g) 
cow's milk (with cereal) (1/2 
cup; 125 ml) 
white pita bread (1 slice; 25 g) chocolate (1 bar) 
cow's milk (in tea/coffee) (2 
tbsp; 40 ml) 
brown loaf bread (1 medium 
size) 
custard (1/2 cup) 
fermented milk (laban) (1 glass; 
200 ml) 
white loaf bread (1 medium 
size) 
rice with milk and sugar 
(mohalabeya) (1/2 cup) 
ice cream (2 scoops; 60 g) brown toast (1 slice; 25 g) cream caramel (1/2 cup) 
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2.2 – Clinical Chemistry Tests: 
Complete blood count (CBC) and a range of clinical chemistry tests were undertaken to provide an 
overview of the participant’s general health. Numbers of white blood cells, red blood cells and the 
amount of hemoglobin in fresh blood samples collected in EDTA-tube were measured usinga Beckman 
coulter instrument. Serum samples, separated from plain tubes, were stored at -80°c for later clinical 
chemistry measurements including glucose, albumin, creatinine, Alanine aminotransferase (ALT) and 
C-Reactive protein (CRP) using an Elitech clinical system instrument. 
2.3- Analysis of Plasma Zinc and other Minerals: 
2.3.1- Reagents and glassware: 
Hydrochloric acid was ultra-pure (MERCK). All glassware was decontaminated by soaking it in ultra-
pure 20% HCL for 24 hours and rinsed 3-4 times with deionized water.  
 
2.3.2- Preparation of plasm samples and sample diluent: 
Three milliliters of blood were collected in trace-element free tubes according to the instruction provided 
by IZiNCG (IZiNCG, 2007a). Plasma samples were separated and stored at -80ºC for later use. A 1:10 
dilution of plasma samples were prepared by adding 0.5 ml of plasma to 4.5 ml of sample diluent. Sample 
diluent was prepared by adding 8.34 ml of ultra-pure HCl in 2 L volumetric flask and the volume was 
completed to the mark by adding MilliQ water. Sample diluent was used as blank. 
2.3.3- Preparation of standard curve: 
A three point standard curve was used for the determination of plasma zinc and other minerals including 
copper, selenium, magnesium, manganese, iron, calcium, nickel, arsenic and lead. First, a stock solution 
at a concentration of 50 ppm was prepared by adding 25ml from 100 ppm AccuTrace Reference Standard 
ICP Quality control standard#1 (Accustandard) to 50 ml volumetric flask and the volume was completed 
to the mark by milliQ water. Then, another stock solution at a concentration of 10ppm was prepared by 
adding 10 ml from the first stock to 50ml volumetric flask and the volume was completed to mark by 
milliQ water. The second solution was used to prepare the three standard solutions. Next, 2.5 ml of 
glycerol was added to three 25ml volumetric flasks in an attempt to match the matrix of the plasma. From 
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the 10ppm stock solution, three aliquots of 2.5, 1.25 and 0.625 ml were taken and added to each 
volumetric flask and the volume were completed by adding sample diluent to prepare the three standard 
solutions with 1, 0.5 and 0.25 ppm concentrations, respectively (IZiNCG, 2012b).  
2.3.4- Analytical method: 
Zinc and other minerals were measured in standards, plasma samples and blank (sample diluent) by using 
inductively coupled plasma- atomic emission spectroscopy. For each mineral, a specific wave length was 
used as shown in Table 2.2. Concentrations of minerals were calculated automatically by ICP-OES. 
Table 2.2 Inductively coupled plasma-atomic emission spectroscopy wavelengths 
Mineral Wavelength 
Zinc 213.857 
Copper 324.752 
Selenium 203.985 
Magnesium 279.077 
Manganese 259.372 
Iron 259.939 
Calcium 317.933 
Arsenic 188.979 
Lead 220.353 
Nickel 231.604 
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2.4- Determination of Plasma Metallothionein 1: 
An Enzyme-linked Immunosorbent Assay Kit for metallothionein 1 (MT1) (Uscn Life Science, USA) 
was used to determine plasma MT1 according to the manufacturer’s protocol. Briefly, 100 µl of blank, 
standards and samples were added to each well in duplicate and incubated for 2 hours at 37°c. Liquid of 
each well was then removed without washing. One hundred micro-liter of detection reagent A was added 
and the plate was incubated for 1 h at 37°c. After incubation, the solution was aspirated and the plate 
washed 3 times by auto washer (PW40, BIORAD) using washing solution. Detection reagent B (100µl) 
was added and the plate was incubated for 30 min followed by aspiration and washing for 5 times. After 
that, TMB substrate solution (90 µl) was added and incubated for 20 min. Finally, the enzyme-substrate 
reaction was terminated by adding 50 µl of stop solution. The yellow color was measured 
spectrophotometrically at a wavelength of 450nm by microplate reader (PR3100TSC,BIORAD). The 
concentration of MT1 in the sample was then determined by comparing the average optical density of 
the samples to the standard curve (Figure 2.1). 
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Figure 2.1 Typical standard curve of metallothionein 1 by ELISA kit 
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2.5- RNA Extraction from Blood: 
RNA was extracted from fresh whole blood sample by using QIA amp RNA blood mini kit (Qiagen). 
The manufacturer’s protocol was modified to give better yields of RNA. Three milliliters of  fresh blood 
samples was diluted with an equal volume of  normal saline and poured slowly on the wall of a centrifuge 
tube containing 5 ml of histopaque 1077 (SIGMA, life science). Then, the sample was centrifuged at 700 
g for 30 min to separate the buffy coat. The buffy coat was then washed with normal saline and 
centrifuged at 300 g for 10 min to form the cell pellet. Lysis buffer (600 µl RLT buffer + 6 µl β-mercapto 
ethanol) was added to the pelleted leukocytes and the sample stored at -80°C for later RNA extraction. 
Seven hundred microliters of this sample were added to the QIAshredder spin columns and centrifuged 
for 2 min. at 20000 g.  The homogenized lysate was then added to 600 µl of 70% ethanol and transferred 
to RNease binding spin column. Genomic RNA was bound to the spin column membrane and 
contaminants were removed by a series of washes using buffer RW1 and RPE. During the purification 
of RNA, DNA was digested by using RNAase-free DNAase set (Qiagen). Purified RNA was eluted from 
the spin column in a concentrated form in RNase-free water and stored at -80°c for later use. 
2.6- Determination of RNA Concentrations: 
Nano drop 2000 spectrophotometer (Thermo Scientific) was used to determine the concentration, 
absorbance at 260/280 and absorbance at 260/230 of the RNA samples.  A 2 to 3 ml sample of whole 
human blood yields average of 120 ng/µl with an A260/A280 ratio of  > 1.8 and an A260/A230 ratio >0.36 
(Lam et al., 2012, Fleige and Pfaffl, 2006). 
2.7- Determination of RNA Integrity: 
The integrity of the RNA was assessed by using RNA 6000 Nanodrop Bioanalyzer Kit, which resembles 
RNA agarose gel electrophoresis. The RNA ladder, gel and gel-dye mixture were prepared according to 
the manufacturer’s protocol. Gel-dye mixture, RNA 6000 Nano Marker, RNA ladder and the RNA 
samples were loaded in a RNA Nano Chip according to the manufacturer’s protocol and then inserted 
into an Agilent 2100 bioanalyzer machine. Good quality, undegraded RNA was indicated by the presence 
of 2 horizontal bands representing the 28S and 18S ribosomal RNA and RIN values above 8.  
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2.8- Conversion of RNA to cDNA:  
The RNA samples were diluted to approximately 500ng and converted to cDNA by using QuantiTect 
Reverse Transcription Kit (Qiagen) according to the manufacturer’s protocol. Briefly, twelve microliter of 
the RNA samples were added to 2 µl of gDNA wipeout buffer and incubated for 2 min at 42°C. Then, 
RNA samples were added to tube containing reverse transcription master mix composed of Quantiscript 
reverse transcriptase, Quantiscript buffer and RT primer mix. For negative samples, RNA was added to 
reverse transcription master mix containing no transcriptase. Positive and negative samples were then 
incubated for 15 min at 42°C. Finally, samples were incubated for 3 min at 95°C to inactivate reverse 
transcriptase. The cDNA produced from the reaction was stored at -20 ºC.  
2.9- Quantitative Measurement of Gene Expression:  
Reverse transcription RT/PCR is the most sensitive technique to determine the expression of specific 
transcripts in an mRNA population. QRT/PCR was performed on cDNA samples to test the quality of the 
cDNA produced by checking the expression of the housekeeping gene (GAPDH) and to determine, 
quantitatively, the expression of specific genes in the study. Each 10µL of cDNA sample was diluted with 
10µL of DNase/RNase free water. Two microliter of diluted samples were then loaded in fast optical 96 
well reaction plates (0.1ml) in duplicate. Five microliter of Taqman universal master mix (Applied Bio 
Systems), 0.5 µl of primer of interest (gene assay) and 2.5 µl of DNase/RNase free water were added to 
each sample. Quantitative RT/PCR was performed using a StepOne plus PCR instrument with hold stage 
at 50 ºC (for 2 min), initial denaturation stage at 95ºC (for 10 min), denaturation stage at  95ºC (for 15 sec) 
and annealing stage at 60ºC (for 1 min). The last two stages make one cycle which was repeated for 40 
times (40 cycles). Fluorescence was detected for each PCR cycle and the threshold crossing points (CT 
values) determined. For each sample, expression of targeted genes were normalized with housekeeping 
gene (GAPDH) by subtracting CT  values for GAPDH from CT values of the target gene (ΔCT). Then, 2 (Δct) 
was calculated to determine the relative expression of each targeted gene at the mRNA level.  
2.10- Analysis of T cells, B cells, natural killer and monocytes by Flow Cytometery: 
Three milliliters of fresh blood sample was used to separate the buffy coat (see section 2.6) which coat 
was then washed with normal saline and centrifuged at 300 g for 10 min to form the cell pellet. One 
milliliter of freezing media (50% RPI 1640 + 40% fetal calf serum + 10% DMSO) was added to the 
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pelleted leukocytes and the sample stored at -80°C for later immunophenotyping of leucocytes by flow 
cytometery.  
At time of analysis, buffy coat samples were thawed at 37°C, washed with 3ml of PBS and centrifuged 
at 1600 rpm for 10 min at 4°C. The cell pellet was then resuspended in 200µl PBS. From 30 to 40µl of 
each sample (~ 500,000 cells as counted by VI-CELL cell viability analyzer, Beckman Coulter) was 
added equally to 3 flow cytometery tubes. The first tube contained 20µl of cocktail monoclonal antibody 
(CD3/CD16/CD56 antibody, FITC,PE conjugate) (Thermo Scientific). The second tube contained 20µl 
of another cocktail monoclonal antibody (CD3/CD19/CD45 antibody, FITC,PE, Cy5-PE) (Thermo 
Scientific). The third tube contained 10µl of each of the following antibodies: CD14 PE, CD15 APC and 
CD45 FITC (Thermo Scientific). The mixture was incubated in a refrigerator for 30 min. and then washed 
and centrifuged at 1600 rpm for 7 min. and the pellet was resuspended in 1ml of PBS. Lastly, ten 
microliter of 7AAD dye (BioLegend) were added to tube 1 and 3 to exclude dead cells from analysis. 
The samples were analyzed using a Navios Flow Cytometer (Beckman Coulter). The instrument was 
calibrated before each run by Flowcheck Pro Fluorospheres (Beckman Coulter) to check the laser.  
Typical dot plot of each tube are shown in Figure 2.2. The percentage of each cell subtype was calculated 
by using Flowing 2 Software (http://www.flowingsoftware.com/).  
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Figure 2.2 Typical dot plot for analysis of (A) CD3+ cells (T cells) and CD56+ cells (natural killer cells 
(B) CD19+ cells (B cells) and (C) CD14+ cells (monocytes) 
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Chapter 3. The Relative Validity and Repeatability of a Food Frequency 
Questionnaire for Estimating Intake of Zinc and its Absorption 
Modifiers in Young and Older Saudi Adults 
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3.1- Introduction: 
In Saudi Arabia, there have been few studies of zinc intake and zinc status. However, the limited evidence 
available suggests that older adults have lower serum zinc status than young adults (Kumosani et al., 
1997a, Al-Numair, 2006) and the proportion of free-living elderly males with inadequate zinc intake 
(below the Estimated Average Requirement (EAR)) was higher than among young adults (Alissa, 2005). 
Additionally, low zinc intakes were found in institutionalized females (Sadiq, 2005a) but not males 
(Alenezy, 2003b). For free-living older females in Saudi Arabia, there are no data on intakes of zinc or 
of zinc absorption modifiers. One reason for this evidence gap is the lack of a suitable tool designed 
specifically for quantifying intakes of zinc and its absorption modifiers by adults of all ages and both 
sexs in this population group. Most previous studies used either food records (FR) or 24-h recalls 
(Alenezy, 2003b, Sadiq, 2005a, Al-Numair, 2006); an exception was Alissa (Alissa, 2005). However, 
these methods requires a high degree of cooperation from participants and analysis of data is labour 
intensive (Lee and Nieman, 2010). A food frequency questionnaire (FFQ) may provide an adequate 
assessment of usual intake and has the benefits that the demand on respondents and on researchers is 
more modest (Lee and Nieman, 2010). Thus, the aim of my study was to design and validate a FFQ 
suitable for young and older Saudi adults of both sexs. 
Objectives: 
1) To assess the relative validity and repeatability of a FFQ for estimating dietary intake of zinc and 
its absorption modifiers in Saudi adults. 
2) To use the FFQ to investigate the effect of age and sex on these intakes. 
3.2- Materials and Methods: 
3.2.1- Subjects: 
One hundred male and female participants aged 20 - 30 years (younger adults) and 60 - 70 years (older 
adults) were recruited from King AbdulAziz University (KAU) students, staff and their families, via 
personal contact, by email messages and by telephone. This sample size was chosen based on the 
statistical tests used to assess validity and repeatability. For example, one hundred is desirable for the 
Bland-Altman test to allow the limits of agreement to be estimated precisely. In addition, one hundred is 
sufficient for the correlation coefficient tests (Cade et al., 2002). The older age range was chosen from 
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60 to 70 years because 60 years and above refers to older adults as it is considered as retirement age in 
Saudi Arabia and 74 is the life expectancy of Saudi adults. Participants were divided equally into four 
groups according to sex and age (25 persons per group). The study was approved by the Ethical 
Committee, Faculty of Medicine, King AbdulAziz University and all participants gave written informed 
consent. 
3.2.2- Assessment of dietary intake: 
To assess validity, all participants completed the FFQ (FFQ1) and a 3 d food record. After 1 month, the 
FFQ was administered for a second time (FFQ2) to assess repeatability (see section 2.1.5). 
3.2.3- Statistical analysis: 
To assess the validity of the FFQ, differences in mean intake of dietary components between the FFQ 
and FR were examined by using Student’s paired t test. Analysis of Variance (ANOVA) was used to test 
the differences in dietary components intakes between age and sex groups. Correlations between values 
obtained from the FFQ and the FR were tested using Spearman’s correlations because the data were 
skewed. Bland-Altman analysis was undertaken to investigate the agreement between the two methods 
for estimating dietary components intakes. Moreover, cross classification was used to evaluate the ability 
of both methods to classify individuals similarly into equal thirds of the distribution of dietary 
components intake. The cut-off points were determined separately for the FFQ and the FR. 
To test the repeatability of the FFQ, the same statistical tests were performed between FFQ1 and FFQ2 
with the exception of the cross classification. Additionally, intra-class correlation coefficients were 
calculated for each of the dietary components for data from FFQ1 and from FFQ2.   
All statistical analyses were performed using IBM SPSS Statistics software version 19 with the exception 
of Bland-Altman analysis which was performed using MedCalc Statistical software version 12.6.1. 
Statistical significance was taken as P< 0.05. 
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3.3-Results: 
3.3.1- Study participants: 
One hundred volunteers participated in this study. All completed two FFQs and a 3-day FR. The majority 
of the younger participants were healthy while half and one third of the older adults had diabetes and 
high blood pressure, respectively. The mean body mass index (BMI) was 28.30 kg/m2.  More than 50% 
of the participants were non-smokers and 40% had a high education level (Table 3.1).   
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Table 3.1 Characteristics of study participants 
 Young 
Female 
(n=25) 
Young 
Male 
(n=25) 
Older 
Female 
(n=25) 
Older 
Male 
(n=25) 
All 
Participants 
(n=100) 
Mean age (years) 25.6 22.2 64.9 64.6  
Mean height (m) 1.59 1.71 1.57 1.69 1.64 
Mean body mass (Kg) 70.9 82.6 77.3 76.6 76. 9 
Mean BMI (Kg/m2)§ 27.9 28.0 30.8 26.6 28.3 
Health status N (%) 
 cancer 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 high blood pressure 0 (0) 0 (0) 9 (36) 8 (32) 17 (17) 
 heart diseases 0 (0) 0 (0) 4 (16) 3 (12) 7 (7) 
 liver diseases 0 (0) 0 (0) 0 (0) 1 (4) 1 (1) 
 kidney diseases 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 osteoporosis 0 (0) 0 (0) 5 (20) 3 (12) 8 (8) 
 arthritis 0 (0) 0 (0) 7 (28) 2 (8) 9 (9) 
 diabetes 0 (0) 0 (0) 12 (48) 13 (52) 25 (25) 
 lung diseases 1 (4) 0 (0) 1 (4) 1 (4) 3 (3) 
 allergy 2 (8) 0 (0) 4 (16) 0 (0) 6 (6) 
 gastrointestinal disorders 2 (8) 1 (4) 5 (20) 6 (24) 14 (14) 
Cigarettes smoking status N (%) 
 non smoker 16 (64) 14 (56) 16 (64) 11 (44) 57 (57) 
 former smoker 0 (0) 4 (16) 3 (12) 6 (24) 13 (13) 
 passive smoker 6 (24) 2 (8) 4 (16) 2 (8) 14 (14) 
 smoker 3 (12) 5 (20) 2 (8) 6 (24) 16 (16) 
Shisha/argela smokers $ N (%) 3 (12) 8 (32) 4 (16) 3 (12) 18 (18) 
Highest grade in school 
 Illiterate (didn’t attend school) 0 (0) 0 (0) 1 (4) 0 (0) 1 (1) 
 primary 0 (0) 0 (0) 6 (24) 1 (4) 7 (7) 
 intermediate 0 (0) 0 (0) 6 (24) 2 (8) 8 (8) 
 high school 9 (36) 22 (88) 5 (20) 4 (16) 40 (40) 
 diploma 0 (0) 0 (0) 1 (4) 3 (12) 4 (4) 
 college 8 (32) 2 (8) 3 (12) 5 (20) 18 (18) 
 post graduate 8 (32) 1 (4) 3 (12) 10 (40) 22 (22) 
Household annual income N (%) 
 less than 50,000 SR 5 (20) 6 (24) 2 (8) 1 (4) 14 (14) 
 50,000 - < 100,000 SR 0 (0) 2 (8) 5 (20) 4 (16) 11 (11) 
 100,000 - < 150,000 SR 4 (16) 9 (36) 4 (16) 2 (8) 19 (19) 
 150,000 - < 200,000 SR 2 (8) 4 (16) 4 (16) 5 (20) 15 (15) 
 200,000 - < 250,000 SR 3 (12) 2 (8) 4 (16) 1 (4) 10 (10) 
 more than 250,000 SR 11 (44) 2 (8) 6 (24) 12 (48) 31 (31) 
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 Young 
Female 
(n=25) 
Young 
Male 
(n=25) 
Older 
Female 
(n=25) 
Older 
Male 
(n=25) 
All 
Participants 
(n=100) 
Current Occupation N (%) 
 student 9 (36) 23 (92) 0 (0) 0 (0) 32 (32) 
 unemployed 2 (8) 0 (0) 16 (64) 2 (8) 20 (20) 
 employed 14 (56) 1 (4) 1 (4) 5 (20) 21 (21) 
 Self-employed 0 (0) 1 (4) 1 (4) 4 (16) 6 (6) 
 retired 0 (0) 0 (0) 7 (28) 14 (56) 21 (21) 
 
 §BMI, Body Mass Index, $ shisha/argela, consists of tobacco, molasses or honey and dried fruits.  
 
3.3.2- Relative validity: 
We assessed the validity of the FFQ by comparing data collected using the first administration of the 
FFQ (FFQ1) with data from the 3-day FR (raw data for intake of food components are summarized in 
Appendix C). Table 3.2 shows the mean daily intakes of zinc, phytic acid and protein estimated by the 
FFQ1 and the 3-day FR. Mean intakes of zinc and protein from FFQ1 were significantly higher than 
those from the FR (P< 0.001 and P=0.013, respectively). In contrast, there were no statistically 
significant differences between estimates obtained by FFQ1 and the FR for the mean intake of phytic 
acid (P= 0.792). Significant correlation coefficients were found between zinc and protein intakes 
obtained from FFQ1 and the FR (Table 3.3). 
 
Table 3.2 Mean daily intake of zinc, phytic acid and protein assessed by FFQ1, FR and FFQ2 (n=100) 
 
FFQ, Food Frequency Questionnaire, FR, Food Record, $ paired differences between FFQ1 and FR. ¥ 
paired differences between FFQ1 and FFQ2. Mean values are significantly different from those of 
FFQ1: * P<0.05, *** p<0.001 
 
 
FFQ1 FR 
95% confidence 
intervals of the 
difference $ 
FFQ2 
95% confidence 
intervals of the 
difference ¥ 
Intake(unit/day) mean mean lower upper mean lower upper 
Zinc (mg/day) 10.6 8.2 *** 1.52 3.18 10.0 * 0.08 1.08 
Phytic acid 
(mg/day) 
521 511 -61.93 80.94 495 -7.92 60.77 
Protein (g/day) 76.4 68.7* 1.66 13.77 72.9* 0.16 6.92 
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Table 3.3 Spearman correlation coefficients (r) between intakes estimated from FFQ1 and FR (Validity) 
and between FFQ1 and FFQ2 (Repeatability) (n=100) 
Item (unit/day) r between FFQ1 and FR r between FFQ1 and FFQ2 
zinc (mg/day) 0.410*** 0.758*** 
phytic acid (mg/day) 0.110 0.628*** 
protein (g/day) 0.429*** 0.799*** 
 
FFQ, Food Frequency Questionnaire, FR, Food Record, r, Spearman correlation coefficient, *** P<0.001 
 
 
Bland-Altman analysis was performed to reveal if use of FFQ1 compared with the 3 day FR resulted in 
any bias in measured intake values across the range of values and to obtain values for limits of agreement 
between the two methods.  For this purpose, the differences in the estimates of zinc, protein and phytic 
acid intake between the two methods (FR-FFQ1) were plotted as a function of the mean zinc, phytic acid 
and protein intakes estimated by the two methods ((FFQ1+FR)/2).  Limits of agreement and mean 
differences, respectively, were: for zinc -10.6 to +5.9, mean difference -2.3 mg/d (Figure 3.1A); for 
intake of phytic acid -715 to +696, mean difference -9.5 mg/d (Figure 3.1B); for protein -67.5 to +52.1, 
mean difference -7.7 g/d (Figure 3.1C). For zinc and phytic acid, the difference in intake estimated by 
the FFQ1 and the FR increased with increased mean intake (Figure 3.1 A and B, respectively). However, 
the difference in protein intake as measured by the two different methods was consistent across the full 
range of intakes (Figure 3.1C). From the Bland-Altman plot (for both zinc and protein) the number of 
outliers is only 4 or 5 which is not likely to affect the validation of the FFQ (Figure 3.1 A and C).
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Figure 3.1 Bland-Altman plots showing the relationship between difference in daily intake of (a) zinc, 
(b) phytic acid, (c) protein estimated by the FFQ1 and 3 days FR, and the corresponding mean daily 
intake estimated by the two methods. Lines are mean difference and dotted lines are the lower and upper 
95% limits of agreements 
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The extent of agreement between measurement methods in classifying individuals into the same or 
extreme tertiles of the intake distribution are shown in Table 3.4. The proportion of participants correctly 
categorized in the same tertile ranged from 55 % (phytic acid) to 62% (zinc). Zinc and protein intake 
showed the lowest proportion of misclassification (2%), whereas the highest degree of misclassification 
was observed for phytic acid intake (8%).  
 
Table 3.4 Cross-classification of daily intakes derived from the FFQ1 and the FR (n=100) 
Item (unit/day) 
Correctly 
classified 
Grossly 
misclassified 
 
(same tertile) 
(%) 
(extreme tertiles) 
(%) 
zinc (mg/day) 62 2 
phytic acid (mg/day) 55 8 
protein (g/day) 57 2 
 
FFQ, Food Frequency Questionnaire, FR, Food Record 
 
3.3.3- Repeatability: 
We assessed the repeatability of the FFQ by comparing data collected using FFQ1 and data collected 
using the second administration of the same FFQ (FFQ2) (Table 3.2) (raw data for intake of food 
components are summarized in Appendix C). Daily zinc and protein intakes from FFQ2 were slightly 
but significantly lower than from FFQ1 by ~0.5 mg and ~4 g (P=0.024 and P=0.040, respectively) 
whereas estimates of phytic acid intake were not significantly different (P= 0.130). Intakes of zinc, phytic 
acid and protein from FFQ1 and FFQ2 were highly correlated (Table 3.3).  
Figure 3.2 presents the limits of agreement and the mean difference in estimated dietary intake obtained 
from FFQ1 and FFQ2. For all dietary components, the limits of agreement were narrower than those 
obtained for the comparison between FFQ1 and FR. The mean differences, for zinc and protein, between 
the two FFQs were smaller and for phytic acid was larger than those obtained between FFQ1 and FR.  
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Figure 3.2 Bland-Altman plots showing the relationship between difference in daily intake of (a) zinc, 
(b) phytic acid, (c) protein estimated by the FFQ1 and FFQ2, and the corresponding mean daily intake 
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estimated by the two methods. Lines are mean difference and dotted lines are the lower and upper 95% 
limits of agreements 
3.3.4- Effects of age and sex on intakes of zinc and zinc absorption modifiers in Saudi adults   
The mean intakes by sex and age groups estimated using each of the two methods are displayed in Table 
3.5. Irrespective of whether measured using FFQ1, or the 3-day FR, we observed that young adults 
consumed more zinc and protein than older adults. There were no detectable effects of age on phytic acid 
intakes by either dietary assessment method. In contrast, for other dietary components, differences in 
intakes between groups were statistically significant only when measured by the FR. Intake of phytic 
acid was 100 mg higher in males than females (P=0.033). Females consumed ~ 2 mg/d less zinc than 
males (P=0.002). Similarly, female intake of protein was lower, by approximately ~ 22 g/d, than that for 
males (P < 0.001).  
Both FFQs indicated that older adults consumed less zinc and protein than young adults (P=0.002 and 
P=0.006, respectively) (Table 3.5). Other differences in intakes between groups were statistically 
significant only when measured by the second FFQ. We observed that males consumed more zinc and 
protein than females (P=0.021 and P=0.045, respectively).  
Table 3.5 Mean daily intake of zinc, phytic acid and protein estimated by FFQ1, FR , FFQ2 by age and 
sex groups (n=100) 
 
Male Female 
Pooled 
SE 
Probability of effect 
 Young Older Young Older  Age Sex Age*Sex 
FFQ1         
zinc (mg/day) 12.9 9.5 10.6 9.3 0.81 0.005 0.126 0.157 
phytic acid (mg/day) 566 464 567 488 48.54 0.065 0.80 0.813 
protein (g/day) 92.6 68.8 75.0 69.1 5.71 0.011 0.138 0.12 
Food Record         
zinc (mg/day) 10.2 8.2 7.6 6.9 0.63 0.037 0.002 0.271 
phytic acid (mg/day) 579 574 458 436 59.92 0.827 0.033 0.891 
protein (g/day) 88.4 71.4 59.4 55.5 5.04 0.041 0.00 0.195 
FFQ2         
zinc (mg/day) 12.6 9.3 10.0 8.0 0.82 0.002 0.021 0.375 
phytic acid (mg/day) 555 477 520 428 49.16 0.085 0.395 0.886 
protein (g/day) 89.8 67.9 72.6 61.1 5.9 0.006 0.045 0.376 
FFQ, Food Frequency Questionnaire, FR, Food Record 
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3.4- Discussion: 
The 64-item FFQ developed for this study was used successfully to obtain estimates of intakes of zinc, 
protein and phytic acid by all 100 young and older Saudi adults recruited for this study. 
3.4.1- Relative validity: 
The FFQ yielded higher estimates of zinc intake than were obtained from the FR. A similar difference 
in estimates of zinc intake between a 74-item FFQ and a 7-day weighed record  was also reported by 
Samman et al (Samman et al., 2010). Although FFQs can both under- and overestimate nutrient intake, 
many validation studies have reported that FFQ overestimate nutrient intakes when compared with FR 
or 24 h recalls (Segovia-Siapco et al., 2007, Sebring et al., 2007, Schaefer et al., 2000). Of course, 
whether estimates of intake obtained using a FR is reliable cannot be known with certainty but it is 
evident that our FFQ yielded consistently higher estimates of zinc intake than did the FR (as confirmed 
by Bland-Altman analysis). Potential reason for this difference is the inclusion of large number of food 
items focusing on specific dietary components of interest which may lead to overestimates of intakes. 
Other factors include measurement errors caused by over-reporting of frequency of food consumption 
and serving sizes (Segovia-Siapco et al., 2007)  and the decrease of participants accuracy toward the end 
of the questionnaire.   
The observed correlations coefficients between the FFQ and FR  for estimates of zinc, phytic acid and 
protein intakes compare favorably with those reported in other studies using the same reference method 
(multiple days of FR) (Barrat et al., 2012, Barrett and Gibson, 2010, Na and Lee, 2012, Lee et al., 2006). 
The higher correlations between methods reported by Samman et al (Samman et al., 2010) and Heath et 
al (Heath et al., 2000) may result from the use of a different reference instrument i.e. weighed diet records 
rather than estimated FR.  
In the present study, the limits of agreement between the FFQ and the FR and the mean difference 
between them were not unreasonable for any dietary components measured. When compared with the 
results obtained by Samman et al (Samman et al., 2010), the limits of agreement between the two methods 
in estimating zinc intake were wider and the mean difference was slightly higher. Conversely, our 
estimate of the limits of agreement for protein intake was narrower than that reported by Pakseresht and 
Sharma (Pakseresht and Sharma, 2010) and the mean difference was lower. The authors of the latter 
study chose 24-h recalls as a reference method which shares with FFQs some of the same sources of 
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potential measurement error including recall bias, conceptualization of portion sizes and distortion of 
reported diet (Barrat et al., 2012). Bland-Altman plots of phytic acid intake showed that the agreement 
between the two methods was better for participants with lower phytic acid intake. This indicates that 
participants with higher intakes may be over-reporting their intake in the FFQ (Pakseresht and Sharma, 
2010) or that the FR method does not capture accurately the intakes of high consumers. To our 
knowledge, this is the first study to use Bland-Altman analysis to evaluate phytic acid intake. The cross-
classification analysis revealed that more than 50% of participants were correctly classified into the same 
third, and less than 10% were misclassified into opposite thirds, of dietary components intake. These 
results are in line with recommendations (Masson et al., 2003) and consistent with other studies assessing 
the ability of FFQs and FRs to classify nutrient intakes into tertiles (Lee et al., 2006, Barrett and Gibson, 
2010). The favorable tertile classifications that were obtained suggest that our FFQ is suitable for ranking 
individuals correctly according to their nutrient intake. 
3.4.2- Repeatability: 
Several studies have reported lower estimates of nutrient intake when a FFQ was used a second time 
with the same participants (Barrat et al., 2012, Lee et al., 2006). In our study, intake estimates with FFQ2 
were consistently lower than with FFQ1 but the differences were small for zinc and for the zinc 
absorption modifiers investigated (1.0 - 5.5% only) (Table 3). Barrat et al (2012) suggested that such 
decreases may be due, in part, to a learning effect (i.e. participants responded more accurately in the 
second FFQ and thus real dietary habits were reflected) (Barrat et al., 2012). Alternatively, the chore of 
completing the FFQ on a second or subsequent occasion may lead to less careful completion of the 
questionnaire. Nonetheless, Lee et al (2006) found that correlations between the first FFQ and the best 
estimate from dietary records (DRs) were slightly lower than those between a third application of the 
FFQ and the DRs, confirming the possibility of a learning effect (Lee et al., 2006). This trend is 
confirmed by findings from the present study in which correlations between the second FFQ and the FR 
were slightly higher than those obtained from the first FFQ (results not shown).  
Correlations coefficients, between FFQ1 and 2, observed in the current study were very similar to those 
reported in a  short-term repeatability study by Barrat et al (Barrat et al., 2012) and slightly higher than 
those reported by Jia et al (Jia et al., 2008), Barrett et al (Barrett and Gibson, 2010), Alissa (Alissa, 2005), 
Fernandez-Ballart et al (Fernandez-Ballart et al., 2010) and Lee et al (Lee et al., 2006). It should be noted 
that the time periods between the two FFQs in the latter studies were longer (from 3 months up to 1 year 
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compared with 1 month in the present study), which increased the likelihood of real changes in dietary 
habits and thus reduced correlation coefficients (Barrat et al., 2012).   
3.4.3- Effects of age and sex on intakes of zinc and zinc absorption modifiers in Saudi adults: 
The mean daily zinc intake assessed by the FFQ (10.6 mg) is very similar to the mean values (10.50 mg) 
obtained by Samman et al (Samman et al., 2010) in Australia and Alissa (Alissa, 2005) (10.23 mg) in 
Saudi Arabia but substantially lower than that reported by Barrett et al (Barrett and Gibson, 2010) 
(15.3mg) for Australian participants using the FFQ method. The mean phytic acid intake of Saudi adults 
(521 mg) was lower than intake of British (917 mg) (Amirabdollahian and Ash, 2010) and New Zealand 
adults (1498 mg) (Heath et al., 2000) using the 4-7 days weighed intake method and FFQ, respectively. 
The mean daily intake of protein was 76.4 g which is comparable with the result of another Saudi study 
(72.53 g) (Alissa, 2005) and lower than those reported in Taiwanese  (87 g) (Lee et al., 2006), Spanish 
(103.1 g) (Fernandez-Ballart et al., 2010) and Australian (105.9 g) (Barrett and Gibson, 2010) studies 
when using FFQ method.  
Several studies found that mean zinc and protein intake were lower in older adults than young adults 
when estimated by various dietary methods (e.g. FFQ and 24-h recall), in agreement with our findings 
irrespective of the method of measurement (Alissa, 2005, Adamson et al., 2009). Lower intake of phytic 
acid, zinc and protein in women than in men, as observed in our study, has been reported previously by 
Mcdaid et al (McDaid et al., 2007), Amirabdollahian and Ash (Amirabdollahian and Ash, 2010), 
Coulibaly et al (Coulibaly et al., 2009), and  Adamson et al (Adamson et al., 2009).  
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Chapter 4. Dietary Intakes of Zinc and Its Absorption Modifiers in 
Young and Older Saudi Adults
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4.1- Introduction: 
The first cases of dietary zinc deficiency in humans were described in the 1960s in male dwarfs from the 
Middle East (Gibson, 2005). The major factor associated with the development of zinc deficiency at the 
population level is inadequate dietary zinc intake. High physiological requirements for zinc (such as 
during infancy, adolescence, pregnancy and lactation), decreased dietary zinc absorption efficiency and 
treatment with certain drugs (e.g. penicillamine, thiazide and glucagon) are additional influencing factors 
(Gibson et al., 2008). 
Assessment of dietary intake is one of the three indicators which are recommended by 
WHO/UNICEF/IAEA/IZiNCG to assess zinc status at the population level. This indicator is important 
as it provides information on the dietary pattern that may be associated with zinc deficiency or 
inadequacy and it can aid in identifying populations or subpopulations at elevated risk for inadequate 
zinc intakes (de Benoist et al., 2007). In addition, dietary assessment may help to identify intervention 
targets to rectify zinc status. Three stages are involved in assessing the intake of absorbable zinc in the 
diet. First, calculation of total zinc and phytate intakes. Second, determination of the phytate-to-zinc 
molar ratio (PZR). Third, selection of the appropriate Estimated Average Requirements (EAR) and their 
use to determine the prevalence of inadequate zinc intakes. When the prevalence of inadequate zinc 
intakes is greater than 25%, the risk of zinc deficiency is considered to be high (de Benoist et al., 2007, 
IZiNCG, 2007b). Detailed information on food contributions to zinc intake and to its absorption 
modifiers (phytic acid and protein) is of similar importance as these data are useful for the development 
of food-based dietary guidelines and to make culturally appropriate recommendations to improve dietary 
quality (Sharma et al., 2013). Another important point to be considered when assessing zinc intake is the 
effect of non-nutritional factors such as age, sex, BMI, smoking and socioeconomic status. Differences 
in all of these factors were reported to cause differences in dietary zinc intake or in zinc absorption 
modifiers in several countries (Alissa, 2005, Adamson et al., 2009, Madej et al., 2013, McDaid et al., 
2007, Coulibaly et al., 2009, Kim and Choi, 2013, Alsufiani et al., 2014, Jitnarin et al., 2006, Hur et al., 
2011, van Rossum et al., 2000). 
Zinc is one of several micronutrient deficiencies which are highly prevalent in the Arab region. 
Nevertheless, the magnitude of these deficiency problems differs from country to country (Madani and 
Kumosani, 2001). In Saudi Arabia, there have been few studies of zinc intake and of its absorption 
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modifiers. Thus, the aim of this study is to assess intake of zinc and its absorption modifiers and the 
factors affecting them in young and older Saudi adults of both sexes. 
Objectives: 
1. To quantify the intakes of zinc and of its absorption modifiers in younger and older Saudi adults 
of both sexes.  
2. To estimate the prevalence of inadequate intakes of dietary zinc in different age and sex groups. 
3. To assess the impact of phytate intake on the predicted bioavailability of zinc in different age and 
sex groups by assessing the phytate to zinc molar ratio. 
4. To investigate associations between other factors such as BMI, smoking, household annual 
income and education and intakes of zinc and of its absorption modifiers. 
5. To identify food items that most contribute to intakes of zinc and of its absorption modifiers in 
Saudi adults. 
4.2- Materials and Method: 
4.2.1-Participants: 
Two hundreds and two male and female participants aged 20-30 years (younger adults) and 55-75 years 
(older adults) were recruited from King AbdulAziz university students, King AbdulAziz university 
hospital, King Fahad hospital, via advertisements in social media and via personal contact. Due to 
difficulties in recruiting older adults who were aged from 60 to 70 years, the eligible age range was 
expanded to be from 55 to 75 years. Exclusion criteria were presence of cancer, liver or kidney diseases, 
non-Saudis and other age groups. An overview of the recruitment strategy is shown in Figure 4.1. 
Participants were divided into four groups according to sex and age (53 young males, 51 young females, 
49 older males and 49 older females). The study was approved by the Ethical Committee, Faculty of 
Medicine, King AbdulAziz University and the Health Affairs of Jeddah city and all participants gave 
written informed consent. 
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Figure 4.1 Recruitment strategy 
Advertisements via social 
media, personal contact, 
email messages and by 
telephone.
Young adults were 
recruited from king 
abdulaziz university 
students, staff and their 
families and from public
Participants visited the expermintal 
biochemistry unit at king fahad 
medical research center to fill out 
the questionnaire, donate blood 
samples and take anthropometric 
measurments
Blood samples were 
processed within 3 hours 
from blood collection
Exclusion criteria: 
presence of cancer, liver or 
kidney dieases and non-
Saudies 
Older adults were recriuted 
from king abdulaziz university 
hospital and king fahad 
hospital
Patients in waiting areas of the hospital 
were invited to participate in the study. 
Subjects who accepted to participate in 
the study, filled out the questionnaire in 
the waiting area and were then taken to 
phlebotomy section for blood collection 
and anthropometric measurments
Blood samples tranfered in a 
box containing dry ice to king 
fahad medical research 
center and processed within 3 
to 4 hours
Exclusion criteria:
presence of cancer, liver or 
kidney dieases and non-
Saudies 
Inclusion criteria: 
-saudi nationaly and
- age range (20-30 years) or 
(55-57 years).
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4.2.2- Dietary and anthropometric assessment: 
All participants completed a questionnaire that has been designed to collect demographic information, 
medical history, smoking habits and socioeconomic status. In addition, all participants completed a FFQ 
which had been validated previously to be used in Saudi young and older adults (see Chapter 3). Intake 
of zinc, phytate and protein were calculated from the FFQ as described previously (see section 2.1.5). 
Total intakes of zinc and protein were also calculated by summing the intake from diet and from dietary 
supplements. The UK lower reference nutrient intake (LRNI) cutoff points were used to assess the 
adequacy of the zinc intakes by young and older adults of both sexes. The prevalence of inadequate 
intake was determined by calculating the % participants whose zinc intake was below 5.5 mg/d for young 
and older males or below 4 mg/d for young and older females. The phytate-to-zinc molar ratio (PZR) 
was calculated according to the following equation:  
 
Phytate − to − zinc molar ratio =
Phytate (mg)/660
Zinc(mg)/65.4
 
PZR in the diet has been used to estimate the absorption of zinc, whereby PZR <5 is associated with 
relatively high absorption pf zinc, PZR 5-15 with moderate absorption and PZR> 15 with low absorption 
(Hotz et al., 2003a, IZiNCG, 2007b). The % contributions of each food item to intake of all food 
components were calculated by dividing the mean intake of each food item by the total intake of the 
same food component ×100. Body weight, height, waist and hip circumference were measured as 
described previously in section 2.1.1.  
4.2.3- Statistical analysis: 
To test the differences in dietary component intake between age and sex groups, two way ANOVA was 
used. One way ANOVA was used to assess the differences in dietary components between different BMI, 
smoking, education and household annual income groups. All statistical analyses were performed using 
the statistical software package IBM SPSS version 19. Statistical significance was taken as P <0.05
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4.3- Results: 
4.3.1- Study participants: 
Two hundreds and two volunteers participated in this study. All completed the questionnaire and donated 
blood samples. The majority of the younger participants were healthy while half of the older adults had 
diabetes and high blood pressure. One third of older females had osteoporosis and arthritis (Table 4.1). 
The overlapping of these diseases was shown in (Figure 4.2). Overall mean body mass index (BMI) was 
28 kg/m2 and older participants had higher BMI compared with younger adults (mean BMI was 24.8, 26, 
32 and 29.6 for younger female, younger male, older female and older male adults, respectively). 
Approximately 60% of the participants were classified as overweight and obese. The prevalence of 
obesity and overweight was higher among older adults compared with younger adults. Additionally, 
more than half of the participants had an apple shaped fat-distribution pattern and this body shape was 
more prevalent in older adults than in young adults. Seventy percent of the participants were non-smokers 
while 13% were shisha/argela smokers (Table 4.1). Herbal teas were consumed by more than half the 
sample and the frequency of consumption of the different types of these herbs is summarized in Figure 
4.3(A). Thirty four percent of participants consumed dietary supplements including Vitamin D, calcium, 
multivitamins and minerals (Figure 4.3B). Only 19% of participants were on therapeutic diets currently 
or during the previous year. The prevalence of these therapeutic diets is summarized in Figure 4.3C.
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Table 4.1 Characteristics of study participants 
 Young 
Female 
(n=50) 
Young 
Male 
(n=53) 
Older 
Female 
(n=50) 
Older 
Male 
(n=49) 
All 
Participants 
(n=202) 
Mean age (years) 26.2 24.1 63.6 61.5  
Mean height (m) 158.2 172.8 156.6 167.6 164.1 
Mean body mass (Kg) 62.4 77.8 78.3 83.4 75.3 
Mean BMI (Kg/m2)§ 24.8 26.0 32.0 29.6 28.0 
BMI Classification N (%) 
 Under weight (<18.5) 2 (4) 4 (8) 0 (0) 0(0) 6 (3) 
 Normal (18.5 -24.99) 27 (55) 22 (41) 4 (9) 13 (28) 66 (34) 
 Overweight (25-29.99) 11 (22) 17 (32) 16 (36) 20 (44) 64 (33) 
 Obese (>30) 9 (18) 10 (19) 24 (55) 13 (28) 56 (29) 
Mean Waist Circumference (cm) 78.4 91.2 103 106 93.0 
Mean Hip Circumference (cm) 102 106 113 111 107 
Fat Distribution Pattern N (%)#  
 Apple Shape  
(WHR>0.9 for M and >0.8 for F) 
16 (31) 15 (28) 28 (57) 30 (61) (54) 
 Pear shape 
(WHR<0.9 for M and <0.8 for F) 
31 (61) 37 (70) 3 (6) 6 (12) (46) 
Health Status N (%) 
 cancer 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 high blood pressure 0 (0) 1 (2) 26 (53) 23 (47) 50 (25) 
 heart diseases 0 (0) 0 (0) 5 (10) 8 (16) 13 (6) 
 liver diseases 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 kidney diseases 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 osteoporosis 1 (2) 0 (0) 18 (37) 1 (2) 20 (10) 
 arthritis 1 (2) 0 (0) 18 (37) 6 (12) 25 (12) 
 diabetes 1 (2) 1 (2) 21 (43) 31(63) 54 (27) 
 lung diseases 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 allergy 13 (26) 7 (13) 7 (14) 6 (12) 34 (17) 
 hypothyroidism 2 (4) 0 (0) 8 (16) 1 (2) 11 (5) 
 Sickle cell anemia 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 Blood disorder 0(0) 0 (0) 2 (4) 0 (0) 2 (1) 
 gastrointestinal disorders 6 (12) 1 (2) 5 (10) 11 (22) 23 (11) 
Current intake of Herbs N (%) 
 Yes 25 (49) 29 (55) 31 (63) 28 (57) 113 (56) 
 No 26 (51) 24 (45) 18 (37) 21 (43) 89 (44) 
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 Young 
Female 
(n=50) 
Young 
Male 
(n=53) 
Older 
Female 
(n=50) 
Older 
Male 
(n=49) 
All 
Participants 
(n=202) 
Current intake of Dietary Supplements N (%) 
 Yes 11 (22) 10 (19) 34 (69) 13 (27) 68 (34) 
 No 40 (78) 43 (81) 15 (31) 36 (74) 134 (66) 
Dieting currently or during the past year N (%) 
 Yes 10 (20) 7 (13) 10 (20) 11 (22) 38 (19) 
 No 41 (80) 46 (87) 39 (80) 38 (78) 164 (81) 
Cigarettes smoking status N (%) 
 non smoker 37 (73) 30 (57) 47 (96) 26(53) 140 (69) 
 former smoker 1 (2) 3 (6) 0 (0) 17 (35) 21 (10) 
 passive smoker 8 (16) 6 (11) 0 (0) 1 (2) 15 (7) 
 smoker 5 (10) 14 (26) 2 (4) 5 (10) 26 (13) 
Shisha/argela smokers $ N(%) 6 (12) 16 (30) 1 (2) 4 (8) 27 (13) 
Highest grade in school 
 Illiterate (did not attend school) 0 (0) 0 (0) 20 (41) 4 (8) 24 (12) 
 primary 1 (2) 0 (0) 13 (27) 9 (18) 23 (11) 
 intermediate 1 (2) 0 (0) 3 (6) 4 (8) 8 (4) 
 high school 9 (18) 16 (30) 7 (14) 9 (18) 41 (20) 
 diploma 3 (6) 21 (40) 0 (0) 7 (14) 31 (15) 
 college 22 (43) 14 (26) 3 (6) 8 (16) 47 (23) 
 post graduate 15 (29) 2 (4) 3 (6) 8 (16) 28 (14) 
Household annual income N(%) 
 less than 50,000 SR 12 (24) 17 (32) 21 (46) 10 (21) 60 (31) 
 50,000 - < 100,000 SR 11 (22) 15 (28) 7 (15) 14 (29) 47 (24) 
 100,000 - < 150,000 SR 7 (14) 8 (15) 7 (15) 9 (19) 31 (16) 
 150,000 - < 200,000 SR 4 (8) 4 (8) 2 (4) 2 (4) 12 (6) 
 200,000 - < 250,000 SR 6 (12) 3 (6) 5 (11) 6 (13) 20 (10) 
 more than 250,000 SR 10 (20) 6 (11) 4 (9) 7 (15) 27 (14) 
Current Occupation N (%) 
 student 20 (39) 24 (45) 0 (0) 0 (0) 44 (22) 
 unemployed 6 (12) 3 (6) 30 (61) 2 (4) 41 (20) 
 employed 25 (49) 26 (49) 4 (8) 13 (27) 68 (34) 
 Self-employed 0 (0) 0 (0) 1 (2) 1 (2) 2 (1) 
 retired 0 (0) 0 (0) 14 (29) 33(67) 47 (23) 
 
§BMI, Body Mass Index, #WHR, Waist to Hip Ratio, $ shisha/argela, consists of tobacco, molasses or 
honey and dried fruits 
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Figure 4.2 Venn diagram showing the overlaps between prevalence of (A) diabetes, high blood pressure 
and heart disease and (B) osteoporosis and arthritis in older Saudi adults (n=98) 
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Figure 4.3 Types of (A) Herbal teas (B) Dietary Supplements and (C) therapeutic diets consumed by 
main study participants (n= 202) 
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4.3.2-Effects of age and sex on intakes of zinc and of zinc absorption modifiers in Saudi adults:   
The mean intakes of zinc and of its absorption modifiers by age and sex groups estimated using the FFQ 
and from dietary supplements are displayed in Table 4.2 There were no differences in intakes of zinc, 
phytic acid and protein between young and older adults from diet alone or from diet plus dietary 
supplements. Intake of zinc from the diet was ~3 mg higher in males than in females (P= 0.002). 
Similarly, males intake of protein was higher, by approximately ~ 20 g/d, than that of females (P= 0.004). 
Moreover, total intakes of zinc and protein (from diet and from dietary supplements) were higher in 
males compared with females (P= 0.01 and P= 0.003, respectively). In contrast, no difference in intake 
of phytic acid was observed between sex groups. The distribution of zinc intakes estimated using the 
FFQ are showed in Figure 4.4 (raw data for zinc intake are summarized in Appendix D).   
 
Table 4.2 Mean daily intake of zinc, phytic acid and protein estimated by FFQ and intake from dietary 
supplements by age and sex groups (n=202) 
 
All Male Female 
Pooled   
SEM 
Probability of effect 
  Young Older Young Older  Age Sex Age* 
Sex 
FFQ  
zinc (mg/day) 11.1 11.9 13.2 10.1 9.1 0.46 0.901 0.002 0.227 
phytic acid (mg/day) 508 562 544 507 419 25.2 0.278 0.074 0.465 
protein (g/day) 80.3 88.7 91.7 74.0 66.8 3.40 0.756 0.004 0.455 
FFQ + Dietary Supplements 
zinc (mg/day) 11.8 12.3 13.9 10.5 10.7 0.48 0.360 0.01 0.489 
protein (g/day) 81.4 92.0 91.7 75.2 66.8 3.44 0.526 0.003 0.554 
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Figure 4.4 The distribution of dietary zinc intake in young and older Saudi adults 
 
 
4.3.3- Prevalence of inadequate intake of dietary zinc in different age and sex groups: 
Figure 4.5 shows the percentages of participants with zinc intake (from diet alone and from diet plus 
dietary supplements) below the UK LRNI by age and sex. Twelve percent of all participants had 
inadequate intake of zinc either from diet or from diet and dietary supplements. When zinc estimated 
from diet only, young males showed the highest percentage of inadequate intake (15%) followed by 
young females (4%), older males (2%) and older females (2%) (Figure 4.5A). Intake of zinc from dietary 
supplements did not change the percentages of participants with inadequate intake from any group except 
young females who showed a small reduction in the prevalence of inadequate zinc intake (Figure 4.5B). 
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Figure 4.5 Percentage of participants with zinc intakes below the UK Lower Reference Nutrient Intake 
(LRNI) from (A) diet (B) diet and dietary supplements by age and sex 
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4.3.4- Effects of phytate intake on the estimated bioavailability of zinc in different age and sex 
groups: 
I examined the potential effect of phytic acid intake on the bioavailability of zinc by calculating the 
phytate to zinc molar ratio (PZR) in Saudi adults. Table 4.3 presents the mean, median, quartiles and the 
% of participants with 3 categories of phytate-to-zinc molar ratios. The median molar ratio of phytate-
to-zinc for all the participants was 4.40. Older adults had significantly lower phytate-to-zinc molar ratios 
compared with young adults (P<0.05). No significant differences between men and women were found. 
More than half the participants were classified as having PZR <5 and none of the participants had PZR 
> 15.  
 
Table 4.3 Mean, median, quartiles and % of participants with different phytate-to-zinc molar ratios 
(PZR) 
 
All Male Female 
Pooled   
SEM 
Probability of effect 
  
Young Older Young Older  Age Sex 
Age* 
Sex 
Mean 4.57 4.84 4.16 4.83 4.45 0.107 0.014 0.517 0.480 
Median 4.40 4.58 4.07 4.63 4.00     
Quartiles 
 (q25-q27) 
(3.41-5.6) (3.4-5.9) (3.2-5.2) (3.6-5.7) (3-5.5) 
    
PZR < 5 (%) 62 53 69 65 63     
PZR = 5-15 (%) 38 47 31 35 38     
PZR > 15 (%) 0 0 0 0 0     
 
PZR, Phytate-to-Zinc Molar Ratio 
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4.3.5- Associations between BMI, smoking, education and household annual income and intakes of 
zinc and of zinc absorption modifiers in Saudi adults: 
Intakes of zinc, phytic acid and protein by Saudi adults according to BMI category, smoking, education 
and household annual income are shown in Table 4.4. Intake of all three food components from diet and 
from the diet plus supplements appeared to be higher in underweight and obese participants but these 
differences were not statistically significant (P>0.05). Intakes of zinc, phytic acid and protein by smokers 
were substantially, and significantly, higher than for non-smokers, passive and former smokers. Non-
educated (illiterate) and highly educated (post graduate) participants had the lowest intakes of zinc and 
of its absorption modifiers (non-significant differences) while participants with middle household annual 
income (150,000 <200,000 SR) had the highest intakes but these differences were not statistically 
significant (P > 0.05).  
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Table 4.4 Mean daily intake of zinc, phytic acid and protein by BMI category, smoking, education and 
household annual income (n=202) 
 Dietary 
zinc  
(mg/d) 
 
Mean ±SD 
Total 
zinc# 
(mg/d) 
Mean ±SD 
Phytic 
acid 
(mg/d) 
Mean ±SD 
Dietary 
protein 
(g/d) 
 
Mean ±SD 
Total 
protein# 
(g/d) 
Mean ±SD 
BMI Classification  
 Under weight (<18.5) 13.9±9.8 13.9±9.8 609±330 108.7±75.3 108.7±75.3 
 Normal (18.5 -24.99) 10.7±6.2 11.3±6.3 504±354 76.7±43.9 78.0±44.0 
 Overweight (25-29.99) 10.4±5.1 11.4±6.1 466±287 77.1±43.8 79.5±46.0 
 Obese (>30) 12.5±8.5 13.1±8.5 583±444 89±58.4 89.0±58.4 
Cigarette smoking status  
 non smoker 10.4±5.5 11.2±5.8 470±281 75.0±39.9 76.78±41.2 
 former smoker 10.8±4.9 11.2±5.5 483±250 79.1±33.0 79.1±33.0 
 passive smoker 11.3±9.1 12.3±9.0 516±419 82.1±65.3 82.1±65.3 
 smoker 15.3±10.3* 15.7±10.6* 736±614* 109.4±77.6* 109.44±77.6* 
Highest grade in school 
 Illiterate (did not attend 
school) 
9.7±3.9 10.9±4.2 408±254 71.6±28.8 71.6±28.8 
 primary 10.9±7.1 12.0±6.8 499±317 79.5±45.8 79.5±45.8 
 intermediate 11.0±4.7 13.1±7.8 416±215 78.5±32.1 78.5±32.1 
 high school 12.2±8.3 12.9±8.4 536±417 88.9±65.8 88.9±65.8 
 diploma 11.1±6.9 11.3±7.1 561±413 77.7±44.0 77.7±44.0 
 college 12.0±7.5 12.4±7.7 580±414 88.8±55.9 92.1±56.7 
 post graduate 9.4±3.5 10.2±4.1 407±167 65.8±24.3 68.7±29.5 
Household annual income  
 less than 50,000 SR 10.9 ± 6.9 11.7±7.2 526±402 80.9±51.2 80.9±51.2 
 50,000 - < 100,000 SR 11.8 ± 6.8 12.4±6.8 521±322 83.9±45.0 83.9±45 
 100,000 - < 150,000 SR 11.0 ± 7.2 11.5±7.0 511±409 81.2±50.3 86.3±51.9 
 150,000 - < 200,000 SR 13.4±10.8 14.3±12.0 570±517 106.3±94.2 106.3±94.2 
 200,000 - < 250,000 SR 9.5 ± 4.3 10.3±4.7 448±252 67.8±30.9 68.4±31.5 
 more than 250,000 SR 11.1 ± 4.7 11.9±4.9 486±264 74.1±29.4 76.4±33.5 
#Total zinc and protein were calculated by summing intakes from diet and from dietary supplements, *P<0.05 
compared with non-smokers, former and passive smokers 
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4.3.6- Major food items contributing to intakes of zinc and of its absorption modifiers in Saudi 
adults: 
The percentage contributions by each food group to the daily intakes of zinc, phytate and protein are 
shown in Figure 4.6 (with details for individual food items summarized in Appendix E). The main source 
of zinc was the meat group which contributed more than two thirds of the average zinc intake. Within 
this group, the main contributors were chicken, lamb and diced meat (kebab or hamburger). Cereals 
(mainly white rice, rice with tomato sauce, brown pitta bread and white pasta) contributed 19% of the 
mean zinc intake. Dairy products, miscellaneous and vegetables contributed a further 16 %, 13% and 9% 
to the average zinc intake of Saudi adults, respectively (Figure 4.6A). Meats and cereals were also the 
top contributors to total daily zinc intake across all participating groups. Dairy products were the third 
top contributor for older adults while miscellaneous foods were for young adults. 
Almost half the intake of phytate (47%) came from the consumption of cereals. White rice, brown pitta 
and toast breads, whole grain corn flakes and crisp breads, and rice with tomato sauce were the main 
contributors within this group. A quarter of phytate intake was from vegetables. The top 4 contributors 
within this group were broad beans, chickpeas, potatoes and tabouleh. Miscellaneous foods (mainly 
falafel, chocolate, pizza, chips, corn chips and twisties) were the third largest contributor to phytate 
intake. Seeds and nuts and meats contributed a further 5% and 3% to the total daily intake of phytate, 
respectively (Figure 4.6B). Cereals were also the first contributor to total daily phytate intake across all 
participated groups. Vegetables were the second contributor for all groups except for young males for 
whom miscellaneous foods were the second contributor.  
Meats were the top contributors to the average daily intake of protein in Saudi adults. Chicken, lamb and 
diced meat (kebab or hamburger) were the highest contributors within this group. The second contributor 
to protein intake was vegetables and most protein came from broad beans, chickpeas, stuffed vegetables 
and potato. Cereals, dairy products and miscellaneous were the third, fourth and fifth major contributors 
to daily intake of protein, respectively (Figure 4.6C). Meats and cereals were the top contributors to total 
protein intake across all participating groups. Dairy products were the third top contributor for older 
adults while miscellaneous foods were for young adults.
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Figure 4.6 Percent food group contribution to intake of (A) Zinc (B) Phytic acid and (C) Protein in Saudi 
diet 
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4.4- Discussion: 
4.4.1- Effects of age and sex on intakes of zinc and zinc absorption modifiers in Saudi adults:   
The mean daily zinc intake assessed by the FFQ (11.1 mg) is similar to the mean values (10.50 mg) 
reported by Samman et al (Samman et al., 2010) in Australia and by Alissa (Alissa, 2005) (10.23 mg) 
and Alsufiani et al (10.6 mg)  (Alsufiani et al., 2015) (see Chapter 3) in Saudi Arabia but substantially 
lower than that reported by Barrett et al (Barrett and Gibson, 2010) (15.3mg) for Australian participants 
by using FFQ method. The mean phytic acid intake of Saudi adults (508 mg) was similar to results from 
a previous Saudi study by Alsufiani et al (Alsufiani et al., 2015) (521 mg) (see Chapter 3) and much 
lower than intakes of British (917 mg) (Amirabdollahian and Ash, 2010) and New Zealand adults (1498 
mg) (Heath et al., 2000) estimated using 4-7 days weighed intake method and FFQ, respectively. The 
mean daily intake of protein was 80.3 g which is comparable with the result of other Saudi studies (72.53 
g) (Alissa, 2005) and (76.4 g) (Alsufiani et al., 2014) and lower than those reported in Taiwanese  (87 g) 
(Lee et al., 2006), Spanish (103.1 g) (Fernandez-Ballart et al., 2010) and Australian (105.9 g) (Barrett 
and Gibson, 2010) studies when using either FFQ or 24h recall methods.  
In contrast with the findings from the present study, several studies have observed that mean zinc and 
protein intakes were lower in older adults than in young adults when estimated by FFQ, (Alissa, 2005, 
Adamson et al., 2009). This may due to the higher BMI of older males in the present study which was 
associated with higher zinc and protein intakes than for the older males in my previous study (see Chapter 
3). Higher intakes of zinc and protein in men than in women observed in the present study confirms the 
results that I reported in Chapter 3 and those of Madej et al (Madej et al., 2013), Mcdaid et al (McDaid 
et al., 2007), Coulibaly et al (Coulibaly et al., 2009) and Kim and Choi (Kim and Choi, 2013).  
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4.4.2- Prevalence of inadequate intake of dietary zinc in different age and sex groups: 
Dietary zinc deficiency in humans was first reported in male dwarfs from the Middle East in the 1960s 
(Sandstead et al., 1967). An estimated 17% of central Asia, North Africa and Middle East’s population 
is at risk of inadequate zinc intake (Wessells and Brown, 2012). In the Arab region, low zinc intake still 
persists in different age groups (Al-Daghri et al., 2013, al-Shawi, 1992, Naem et al., 2014, Baroudi et al., 
2010). In the present study, the prevalence of zinc intakes below the UK LRNI was calculated by using 
4 and 5.5 mg zinc/d as cut-off points for females and males, respectively. The LRNI is estimated to be 
adequate for only 2.5% of the population. For all participants in the current study, the percent of 
participants whose zinc intake (estimated by FFQ) below the UK LRNI was 12 %. The risk appeared to 
be greatest for young males (15%) followed by young females (4%) (Figure 4.5 A). Even when zinc 
from supplements was included, 15 % of respondents in the young males group had total zinc intakes 
below the UK LRNI (Figure 4.5 B).  
4.4.3- Effects of phytate intake on the predicted bioavailability of zinc in different age and sex groups: 
The median daily phytate-to-zinc molar ratio (PZR) in Saudi adults (4.40) observed in the present study 
is lower than those reported for Chinese (11.1) (Ma et al., 2007), South Korean (15.9) (Kwun and Kwon, 
2000), Iranian (10-13) (Abbaspour et al., 2013), young Indian women (26) (Herbst et al., 2014), British 
young adults (9.66) and British older adults (8.70) (Amirabdollahian and Ash, 2010). The higher PZR 
may be due to higher phytic acid intake in those populations compared with Saudi adults. 
Amirabdollahian and Ash (2010) found that young women (19-24 years) had a significantly lower PZR 
than older women in other age groups (25-34 years, 35-49 years and 50-64 years). Amirabdollahian and 
Ash (2010)  also reported that youngest age group had significantly lower phytate intake than the older 
age groups (Amirabdollahian and Ash, 2010). In contrast, our results showed that older adults had lower 
PZR compared with young adults and this may due to the lower phytic acid intake of older adults in 
comparison with young adults. In the present study, more than half the participants had PZR< 5 which 
indicates the potential for relatively high absorption of zinc and the remaining participants had potentially 
moderate absorption of zinc (PZR 5 - 15) (Hotz et al., 2003a). 
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4.4.4- Associations between BMI, smoking, education and household annual income and intakes of 
zinc and of zinc absorption modifiers in Saudi adults: 
Although the differences in food components intake between different BMI categories were non- 
significant, under- weight and obese participants appeared to have higher intakes of zinc, protein and 
phytate (Table 4.4). This may due to higher food intake of obese individuals than who is normal weight 
or over weight. In contrast, it is possible that underweight individuals were over-reporting their intakes. 
These potential explanations were supported by plasma zinc status measurements reported in Chapter 5 
(see section 5.3.5).  A similar difference in total protein intake was also reported by Shay et al (2012) 
who found higher intakes of protein across higher BMI categories in middle-aged US men (Shay et al., 
2012).  
Dietary differences in intake between smokers and non-smokers were previously reviewed by 
Dallongeville et al (1998). Their results showed that, in general, smokers have less healthy patterns of 
nutrient intake and with higher intakes of energy, total fat, cholesterol, saturated fats and alcohol while 
intakes of protein and carbohydrates did not differ between smokers and nonsmokers (Dallongeville et 
al., 1998). In present study, smokers had higher intakes of zinc and its absorption modifiers when 
compared with other smoking groups. These results are consistent with Jitnarin et al (2006) who reported 
that adult smokers living in the central region of Thailand had higher intakes of total protein and zinc in 
comparison with non-smokers (Jitnarin et al., 2006). In another study with Italian women, the authors 
found that dietary pattern of current smokers were characterized by higher intakes of macro and 
micronutrients from animal sources (D'Avanzo et al., 1997). These differences could be due to the 
smoking-related changes in taste which lead smokers to prefer certain foods. Moreover, nicotine intake 
from smoking may increase metabolic rate and lead to greater energy intakes (Dallongeville et al., 1998, 
Jitnarin et al., 2006).  
Socioeconomic status, including education and income, is associated with differences in food and 
nutrients intakes in several countries (Hur et al., 2011, van Rossum et al., 2000, D'Avanzo et al., 1997).  
In this study, non-educated (illiterate) and highly educated (post graduate) participants tended to have 
the lowest intake of zinc and its absorption modifiers while participants with middle household annual 
income (150,000 <200,000 SR) had the highest intake, these differences were not statistically significant 
(P > 0.05). These results are consistent with another Saudi study conducted by Al-Numair (2006) on 
adults living in Riyadh city who  found no significant associations between zinc intake and 
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socioeconomic status of the participants (Al-Numair, 2006). D’Avanzo et al (1997) also reported no 
meaningful differences in protein intake due to variation in education level (D'Avanzo et al., 1997). On 
the other hand, less educated Dutch elderly showed lower protein intake as proportion of energy (van 
Rossum et al., 2000) lower-income Korean men and women had lower intakes of protein compared to 
high income participants (Hur et al., 2011). 
4.4.5- Food items which contributed most to intake of zinc and its absorption modifiers in Saudi 
adults: 
Meats were the main sources of zinc for the Saudi adults and the majority came from lamb, chicken and 
diced meats. Zinc intake from these foods is high as they contain a high amount of zinc (e.g. 100 g of 
lamb contains 5.8 mg zinc) and they are frequently consumed in the Saudi diet. The second largest source 
of zinc was from cereals mainly white rice, rice with tomato sauce, brown pitta bread and white pasta. 
The zinc contents of these food items are not particularly high, but their frequency of consumption meant 
that they contributed substantially to zinc intake. These findings are comparable with the findings of 
Kwun and Kwon (2000) who reported that, among south Koreans meat, poultry and their products were 
the biggest contributors to zinc intake followed by cereals and grain products (Kwun and Kwon, 2000). 
In contrast, the major food group contributing to zinc intake in Japanese, Chinese and American people 
was cereals (Ma et al., 2007, Sarukura et al., 2011, Sharma et al., 2013).  
The top contributor to daily intake of phytate was cereals especially white rice, brown pitta and toast 
breads, whole grain corn flakes and crisp breads, and rice with tomato sauce. Whole grain corn flakes 
and crisp breads contains very high amount of phytate (e.g. 30 gm of whole grain corn flakes contains 
447.6 mg of phytate) but are less frequently consumed in Saudi Arabia. On the other hand, white rice, 
rice with tomato sauce and brown breads contains lesser amounts of phytate but are more frequently 
consumed in this population. Similarly, cereals were found to be the major contributor to phytate intake 
by South Korean and British adults (Amirabdollahian and Ash, 2010, Kwun and Kwon, 2000). 
Amirabdollahian and Ash (2010) reported that vegetables, potatoes and savory snacks were the second 
contributor to phytate intake in the UK population, in agreement of our findings (Amirabdollahian and 
Ash, 2010).  
In this study, protein intake came mainly from meats followed by vegetables and cereals. Meats 
contributed mostly to protein intake as they contain high amounts of protein (compared to other food 
groups) and they are frequently consumed in the Saudi diet. Whilst food items from vegetables and 
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cereals groups contain lower concentrations of protein, they were frequently consumed in relatively large 
amounts.  In Taiwanese elderly, the main food sources of protein were cereals/roots, meat and seafood 
for both sexs (Wu et al., 2005).  
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Chapter 5. Plasma Zinc Status in Young and Older Saudi Adults and its 
Relationship with Diet and other Variables 
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5.1- Introduction: 
Zinc absorbed from the intestine into the portal blood is transported loosely bound to proteins, 
predominantly albumin (Mahan and Escoot-Stump, 2004). Up to 60% of zinc is transported by albumin 
while transferrin, α-macroglobulin and immunoglobulin G (IgG) transport between 15 and 40% of zinc 
in the blood (Gropper et al., 2005). Circulating concentrations of metallothionein (MT), a metal storage 
protein, in plasma respond to changes in zinc intake, decreasing with low intakes. However, MT 
concentration also increases in response to stress and infection (King, 1990, Gibson et al., 2008).  
Measurement of serum or plasma zinc concentration is the best available biomarker for assessing zinc 
status and the risk of zinc deficiency in populations. Several advisory bodies including WHO / UNICEF 
/ IAEA and IZiNCG recommend the use of this measurement as a biomarker of zinc status because it 
reflects dietary zinc intake, responds consistently to zinc supplementation and reference data are 
available for most age and sex groups (de Benoist et al., 2007, Gibson et al., 2008). IZiNCG recommends 
that if more than 20% of a population (or population sub-group) has a serum zinc concentration below 
the relevant cutoff point, the whole population (or sub-group) should be considered to be at risk of zinc 
deficiency (IZiNCG, 2012a). When assessing zinc status based on plasma zinc concentration, it is 
important to appreciate that, in addition to nutritional factors, several non-nutritional factors including 
age, sex, BMI and smoking can affect zinc requirements and circulating zinc concentrations. Differences 
in these factors were reported to be associated with differences in plasma/serum zinc status in several 
countries including Tunis, Thailand, Nigeria and Mexico (Boonsiri et al., 2006, Sfar et al., 2009, Garcia 
et al., 2012, Northrop-Clewes and Thurnham, 2007, Ugwuja et al., 2011).  
Although plasma zinc concentrations are a reasonable biomarker of zinc status at the population level, it 
has limitations at the individual level. This is because plasma zinc is mobilized as a result of metabolic 
redistribution as well as poor zinc nutrition. Plasma zinc readily decreases with metabolic redistribution 
induced by infection, carcinoma, steroid use, endotoxemia and after a meal. This decline represents a 
redistribution of zinc from the small, vulnerable pool to the tissues, not a change in zinc nutrition. 
Metallothionein may be the key to diagnose metabolic zinc redistribution due to infection, trauma or 
stress. This is because hepatic metallothionein concentrations rise with inflammation or stress, which 
also causes a rise in plasma metallothionein.  Thus, high plasma metallothionein in association with low 
plasma zinc could be indicative of redistribution of tissue zinc in response to infection and stress and not 
to suboptimal zinc status. In contrast, low concentrations of both plasma zinc and metallothionein would 
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indicate a reduction in the size of the exchangeable zinc pool as a result of a decrease in zinc intake. 
Thus, measurement of both zinc and metallothionein in the plasma may allow plasma zinc concentrations 
to be better interpreted (King, 1990, King, 2011). 
Thus, the aim of this study was to measure plasma zinc and metallothionein concentration, and the 
nutritional and non-nutritional factors that may affect these measurements in young and older Saudi 
adults of both sexes. 
Objectives: 
1. To measure plasma zinc and metallothionein concentrations in younger and older Saudi men and 
women. 
2. To estimate the prevalence of zinc deficiency in men and women in these different age groups. 
3. To investigate the effect of zinc intake and of its absorption modifiers, dietary supplements and 
herbal tea intake on plasma zinc and metallothionein concentration.  
4. To investigate associations between non-nutritional factors, including BMI, fat distribution 
pattern, smoking, household annual income and education, and plasma zinc and metallothionein 
concentration. 
5.2- Materials and Methods: 
5.2.1- Participant recruitment: 
Two hundred and two male and female participants aged 20-30 years (younger adults) and 55-75 years 
(older adults) were recruited from King AbdulAziz University students, King AbdulAziz University 
Hospital and King Fahad Hospital via advertisement in social media and through personal contact. 
Participants were divided into four groups according to sex and age (53 young males, 51 young females, 
49 older males and 49 older females). Further details of recruitment are provided in section 4.2.1. Power 
analysis (using G power 3.1.9.2 software) indicated a 92% chance of detecting a medium effect size 
(calculated using the mean and SD from a previous Saudi study) between the young and older groups at 
the 5% level (two tailed).  
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5.2.2- Plasma zinc concentration, clinical chemistry and anthropometric measurements: 
All participants donated blood samples and completed a questionnaire. Blood samples were collected in 
trace-element free, plain and EDTA anticoagulant blood collection tubes.  Plasma samples separated 
from the trace-element free tubes were stored at -80°c for later measurement of the concentration of zinc 
and other metals by inductively coupled plasma atomic emission spectroscopy (see section 2.4). 
Hemolyzed samples (n=5) were excluded from the analysis. The prevalence of zinc deficiency was 
determined by calculating the percentage of participants whose plasma zinc concentration was below 
10.70 or 10.09 µmol/l for morning fasting and morning non-fasting females or below 11.31 or 10.70 
µmol/l  for morning fasting and morning non-fasting males, respectively (IZiNCG, 2012a). Serum 
samples separated from the plain tubes were stored at -80°C for later clinical chemistry measurements 
including glucose, albumin, creatinine, ALT and CRP using Elitech clinical systems. The EDTA tube 
was used for a CBC test using a Beckman coulter and then for separation of plasma. This plasma was 
stored at -80°C for later determination of metallothionein 1 using an ELISA kit (see section 2.5). 
Hemolyzed samples (n=10) were excluded from the analysis. The questionnaire (see Appendix A) had 
been designed to collect general demographic information, medical history, smoking habits and 
socioeconomic status. In addition, all participants completed an FFQ (previously validated to be used in 
young and older Saudi adults (see chapter 3)) and data from this FFQ were used to estimate intakes of 
zinc, phytate and protein as described previously (see section 2.1.5). Body weight, height, waist and hip 
circumference were measured as described in section 2.1.1. 
5.2.3- Statistical analyses: 
Two-way ANOVA was used to determine differences in plasma zinc and MT1 concentrations between 
subjects grouped according to age and sex. The same approach was used to determine relationships 
between BMI, fat distribution pattern, smoking, education, household annual income, dietary 
supplements and herbal tea intake and plasma zinc and MT1 concentrations. Because the data were not 
distributed normally, correlations between intake of food components and plasma zinc and MT1 
concentration were determined using Spearman’s correlation test. Spearman’s correlation test was also 
used to determine relationships between concentrations of plasma zinc and MT1 and other metals. All 
statistical analyses were performed using the statistical software package IBM SPSS version 19. 
Statistical significance was taken as P <0.05. 
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5.3- Results: 
5.3.1- Characteristics of study participants: 
Two hundred and two volunteers participated in this study. All completed the questionnaire and donated 
blood samples. Mean (SD) of biochemical parameters (haemoglobin, albumin, ALT, creatinine, glucose 
and CRP) by age and sex are shown in Table 5.1. Except for glucose concentrations, which were high 
among older adults, all parameters were in the normal range intervals (according to the WHO and FDA 
normal values) for all groups.  
Table 5.1 Mean (SD) of biochemical parameters of study participants 
 Young 
Female 
(n=51) 
Young 
Male 
(n=53) 
Older 
Female 
(n=49) 
Older 
Male 
(n=49) 
All 
Participants 
(n=202) 
Normal 
Ranges $ 
Hemoglobin (g/dl) 
12.1 (2.0) 15.0 (1.4) 12.4 (3.0) 13.2 (2.2) 13.2 (2.5) 
Male >13 
Female >12 # 
Albumin (g/dl) 4.6 (0.3) 4.7 (0.3) 4.3 (0.3) 4.3 (0.3) 4.5 (0.3) 3.5 – 5.5 
ALT (U/l) 16.0 (7.3) 33.0 (20.2) 24.8 (12.8) 33.5 (15) 26.8 (16.2) 0.0 – 30 
Creatinine (mg/dl) 0.64 (0.3) 0.80 (0.2) 0.57 (0.2) 0.77 (0.2) 0.70 (0.2) 1.0 – 2.0 
Glucose (mg/dl) 85.2 (15) 93.0 (16.2) 122.0(61.2) 153.2(90) 113.5 (61.2) 80 – 120 
CRP (mg/dl) < 1.0 < 1.0 < 1.0 < 1.0 < 1.0 < 1.0 
$ FDA blood serum chemistry normal values, # WHO cutoff points 
5.3.2- Associations between plasma zinc and plasma metallothionein 1 concentrations: 
The relationship between plasma zinc and plasma MT1 for all subjects was determined by Spearman’s 
correlation coefficient test. There was no statistically significant association between concentrations of 
zinc and MT1 in plasma (p=0.377). 
5.3.3- Effects of age and sex on plasma zinc and other metal ions concentration in Saudi adults:   
Figure 5.1 shows the mean plasma zinc concentration in young and older Saudi adults of both sexes 
measured by inductively coupled plasma atomic emission spectrometry. For all participants, mean 
plasma zinc (± SD) was 21.4 ± 13.1 µmol/l. In young males and females, mean plasma zinc 
concentrations were 15.1 and 13.4 µmol/l, respectively. However, concentrations were significantly 
higher in older males and females, where plasma zinc concentrations were 30.3 and 27.2 µmol/l, 
respectively, compared with the younger group of the same sex (P<0.001). For both age groups, mean 
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plasma zinc concentration was lower in females than males but did not differ significantly (P=0.126). 
Figure 5.2 shows the distribution of plasma zinc concentration in young and older adults. 
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Figure 5.1 Mean plasma zinc concentrations in subjects grouped according to age and sex (n=197). Error 
bars show SD. *** P<0.001 compared with the corresponding younger group of the same sex 
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Figure 5.2 Distribution of plasma zinc concentration in young and older adults (n=197) 
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Concentrations of Fe, Cu, Mg, Mn and Ca were significantly higher in older adults while lead 
concentration was higher in younger adults (Table 5.2). 
Table 5.2 Mean (± SD) concentrations of Cu, Se, Mg, Pb, Mn, As, Ca and Ni in plasma in young and 
older Saudi adults   
Minerals Young adults Older adults P 
Fe (µmol/l) 73.69 ± 73.6 101.52 ± 75.9 0.010 
Cu (µmol/l) 44.27 ± 34.2 97.31 ± 37.3 <0.001 
Se (µmol/l) 16.9 ± 14.6 14.1 ± 12.8 0.147 
Mg (mmol/l) 1.98 ± 0.9 2.7 ± 0.8 <0.001 
Mn (µmol/l) 4.92 ± 8.0 11.21 ± 17.2 0.349 
Pb (µmol/l) 0.83 ± 1.1 0.69 ± 0.9 0.001 
As (µmol/l) 3.80 ± 8.3 4.97 ± 7.1 0.296 
Ca (mmol/l) 3.99 ± 2.1 6.71 ± 2.0 <0.001 
Ni (µmol/l) 1.19 ± 0.9 1.10 ± 1.4 0.585 
 
5.3.4- The prevalence of zinc deficiency in young and older male and female Saudi adults: 
Figure 5.3 shows the percentages of participants with plasma zinc status below the IZiNCG  (IZiNCG, 
2012a) cut-off values by age and sex. Almost one third of all participants had plasma zinc below the 
relevant cut-off values (28%). Young males showed the highest percentage of zinc deficiency (51%) 
followed by young females (46%) whilst deficiency was much less common in older males (6%) and 
older females (6%) (Figure 5.3). 
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Figure 5.3 Percentage of participants with plasma zinc status below the IZiNCG (IZiNCG, 2012a) cut-
off values by age and sex (n =197) 
5.3.5- Relationships between dietary zinc, zinc absorption modifiers, dietary supplements and herbal 
tea intake on plasma zinc concentration: 
The relationships between dietary zinc, zinc absorption modifiers and plasma zinc concentration were 
determined by calculating the correlation coefficients between intake of food components and plasma 
zinc concentration (Table 5.3). Significant positive correlation coefficients were found between plasma 
zinc concentration and intake of dietary zinc, total zinc (including supplementary) and dietary protein. 
In contrast, there were no significant correlations between plasma zinc concentration and intake of total 
protein (including supplementary), phytic acid or phytate-to-zinc molar ratio. The sequential Bonferroni 
test indicates that these tests are non-significant at the “table-wide” 0.05 level. 
Table 5.3 Spearman correlation coefficients between intake of food components and plasma zinc 
concentration 
Food components intake r p 
Dietary zinc  0.153 0.032 
Total zinc 0.174 0.015 
Phytic acid 0.048 0.502 
Phytate-to-zinc ratio -0.116 0.106 
Dietary protein 0.154 0.031 
Total protein 0.136 0.058 
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Two-way ANOVA was used to investigate the effect of dietary supplements and herbal tea consumption 
on plasma zinc concentration in young and older adults. There was no significant difference between 
plasma zinc concentration and intake of herbal tea or dietary supplements (Figure 5.4). Table 5.4 shows 
the mean plasma zinc concentrations in consumers and non-consumers of several types of herbal tea. 
There were no statistically significant differences between consumers and non-consumers of any of the 
herbal tea. The mean plasma zinc concentration in consumers and non-consumers of dietary supplements 
are shown in Table 5.5. There were no statistically significant differences in plasma zinc concentration 
between consumers and non-consumers of any of the dietary supplements. 
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Figure 5.4 Mean plasma zinc concentration in subjects grouped according to consumption of herbal tea 
or dietary supplements (n= 197). Error bars show SD 
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Table 5.4 Mean plasma zinc concentration in consumers and non-consumers of herbal tea (n=197) 
Herbal tea Consumers Non-consumers 
Pooled   
SEM 
Probability of effect 
 
Young Older Young Older  Age 
Herbal tea 
consumption 
Age* Herbal 
tea 
consumption 
Mint 15.9  26.4 12.5 30.3 0.78 <0.001 0.887 0.020 
Green tea 20.3 27.9 14.0 28.9 1.58 <0.001 0.404 0.249 
Anise 13.9 27.6 14.3 28.8 1.40 <0.001 0.774 0.873 
Caraway - 23.5 14.2 28.8 2.64 <0.001 0.495 - 
Fennel - 22.4 14.2 28.9 2.17 <0.001 0.309 - 
Chaff Coffee - 27.3 14.2 28.8 1.91 <0.001 0.804 - 
Algal leaves tea - 28.7 14.2 28.7 2.64 <0.001 0.995 - 
Basil 6.2 31.9 14.4 28.5 2.23 <0.001 0.592 0.195 
Cinnamon 14.0 26.9 14.3 29.0 1.04 <0.001 0.576 0.663 
Ginger 12.8 26.7 14.4 29.0 1.34 <0.001 0.480 0.898 
Cumin 17.1 26.6 14.1 28.9 1.66 <0.001 0.918 0.431 
Chamomile 3.73 30.0 14.4 28.7 3.10 <0.001 0.455 0.336 
 
Table 5.5 Mean plasma zinc concentration in consumers and non-consumers of dietary supplements 
(n=197) 
Dietary 
Supplements 
Consumers Non-consumers 
Pooled   
SEM 
Probability of effect 
 
Young Older Young Older  Age 
Dietary 
supplement 
consumption 
Age* Dietary 
supplement 
consumption 
Calcium 5.54 26.4 14.3 29.7 2.83 0.002 0.284 0.631 
Vitamin D 9.65 27.5 14.5 29.1 1.42 <0.001 0.255 0.568 
Vitamin B 10.5 35.8 14.4 28.0 2.68 <0.001 0.617 0.133 
Vitamin C - 23.5 14.2 28.8 2.64 0.079 0.495 - 
Multivitamins 
and minerals 
17.2 31.6 14.0 28.5 1.45 <0.001 0.275 0.981 
Omega-3 19.5 33.7 14.1 28.6 2.55 0.006 0.305 0.974 
Iron 18.2 31.2 14.2 28.6 3.41 0.045 0.630 0.919 
Whey Protein 10.4 - 14.5 28.8 1.72 <0.001 0.421 - 
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5.3.6- Associations between BMI, fat distribution pattern, smoking, education and household annual 
income and plasma zinc concentration in Saudi adults: 
Mean plasma zinc concentrations in Saudi adults according to BMI category and fat distribution pattern 
are shown in Figure 5.5. For all participants, plasma zinc concentration tended to increase with increasing 
BMI but this effect was not statistically significant (P= 0.759). This trend was evident in young adults 
but not in older adults. Young and older adults together who had an apple-shaped fat distribution pattern 
had significantly higher plasma zinc concentration than participants who had a pear-shaped fat 
distribution pattern (P= 0.005). 
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Figure 5.5 Mean plasma zinc concentration by (A) BMI category and (B) fat distribution pattern 
(n=197). Error bars shows SD. **P<0.01 when compared with pear shaped fat distribution pattern 
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Figure 5.6 and Figure 5.7 shows the mean plasma zinc concentrations in Saudi adults by smoking and 
socioeconomic status, respectively. There were no significant differences in plasma zinc concentration 
between cigarette smoking categories (P=0.810) or between shisha smokers and non-smokers (P= 0.604). 
Education was not related to plasma zinc concentration (P=0.682). In both young and older adults, there 
appeared to be a U-shaped relationship between plasma zinc concentration and household annual income 
but there were no statistically significant differences (P=0.245). 
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Figure 5.6 Mean plasma zinc by (A) cigarette and (B) shisha smoking (n=197). Error bars show SD 
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Figure 5.7 Mean plasma zinc concentration by (A) education and (B) household annual income 
(n=197). Error bars show SD 
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5.3.7- Plasma metallothionein 1 (MT1) concentrations in young and older male and female Saudi 
adults: 
The mean plasma metallothionein 1 (MT1) concentrations in young and older male and female Saudi 
adults are shown in Figure 5.8. Mean (±SD) plasma MT1 in Saudi adults was 0.35 ± 0.2 ng/ml. Older 
adults had higher mean MT1 concentration than young adults but there was no statistically significant 
difference (P=0.081). Also, male participants had higher mean plasma MT1 concentration than female 
participants but again there was no statistically significant difference (P= 0.280).  
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Figure 5.8 Mean Plasma metallothionein 1 concentration in subjects grouped according to sex and age 
(n=192). Error bars show SD 
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5.3.8- Relationships between dietary zinc, zinc absorption modifiers, dietary supplements and herbal 
tea intake on plasma MT1 concentration: 
The relationships between dietary zinc, zinc absorption modifiers and plasma MT1 concentration were 
determined by calculating the correlation coefficients between intake of food components and plasma 
MT1 concentration (Table 5.6). There were no significant correlations between plasma MT1 
concentration and intake of zinc, total zinc (including supplementary), protein, total protein (including 
supplementary), phytic acid or phytate-to-zinc molar ratio.  
 
Table 5.6 Spearman correlation coefficients (r) between intake of food components and plasma MT1 
concentration 
Food components intake r p 
Dietary zinc  0.077 0.289 
Total zinc 0.113 0.119 
Phytic acid 0.109 0.134 
Phytate-to-zinc ratio 0.100 0.168 
Dietary protein 0.095 0.192 
Total protein 0.094 0.198 
 
Two way ANOVA was used to investigate the effect of dietary supplements and herbal tea consumption 
on plasma MT1 concentration in young and older adults (Figure 5.9).  Participants who consumed herbal 
tea had significantly lower mean plasma MT1 concentration compared with non-consumers. In contrast, 
participants who consumed dietary supplements had higher mean plasma MT1 concentration compared 
with non-consumers but these values did not differ significantly. Table 5.7 shows the mean plasma MT1 
concentrations in consumers and non-consumers of several types of herbal tea. Green tea consumers had 
significantly lower plasma MT1 concentrations than non-consumers. In contrast, there were no 
statistically significant differences between consumers and non-consumers of other herbal tea. The mean 
plasma MT1 concentration in consumers and non-consumers of dietary supplements are shown in Table 
5.8. There were no statistically significant differences in plasma MT1 concentration between consumers 
and non-consumers of any of the dietary supplements. 
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Figure 5.9 Mean plasma MT1 concentration in subjects grouped according to consumption of herbal 
tea or dietary supplements (n= 192). Error bars show SD.* P<0.05 compared with non-consumers 
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Table 5.7 Mean plasma MT1 concentrations in consumers and non-consumers of herbal teas (n=192) 
Herbal tea Consumers Non-consumers 
Pooled   
SEM 
Probability of effect 
 
Young Older Young Older  Age 
Herbal tea 
consumption 
Age* Herbal 
tea 
consumption 
Mint 0.31 0.37 0.35 0.37 0.01 0.092 0.352 0.446 
Green tea 0.23 0.27 0.33 0.39 0.03 0.340 0.025 0.766 
Anise 0.39 0.38 0.32 0.37 0.02 0.598 0.360 0.549 
Caraway - 0.25 0.33 0.37 0.04 0.068 0.319 - 
Fennel - 0.40 0.33 0.37 0.04 0.093 0.748 - 
Chaff Coffee - 0.29 0.33 0.38 0.03 0.063 0.316 - 
Algal leaves tea - 0.31 0.33 0.37 0.04 0.076 0.593 - 
Basil 0.31 0.26 0.33 0.38 0.04 0.985 0.323 0.493 
Cinnamon 0.33 0.32 0.33 0.38 0.02 0.490 0.425 0.425 
Ginger 0.38 0.33 0.32 0.38 0.02 0.985 0.831 0.213 
Cumin 0.34 0.38 0.33 0.37 0.03 0.437 0.840 0.980 
Chamomile 0.59 0.42 0.32 0.37 0.05 0.525 0.102 0.276 
 
Table 5.8 Mean plasma MT1 concentrations in consumers and non-consumers of dietary supplement 
(n=192) 
Dietary 
Supplements 
Consumers Non-consumers 
Pooled   
SEM 
Probability of effect 
 
Young Older Young Older  Age 
Dietary 
supplement 
consumption 
Age* Dietary 
supplement 
consumption 
Calcium 0.78 0.39 0.32 0.36 0.05 0.057 0.070 0.081 
Vitamin D 0.38 0.40 0.32 0.36 0.02 0.460 0.324 0.901 
Vitamin B 0.18 0.41 0.33 0.37 0.05 0.066 0.449 0.212 
Vitamin C 0.49 0.34 0.32 0.37 0.06 0.657 0.544 0.363 
Multivitamins 
and minerals 
0.45 0.42 0.32 0.37 0.03 0.843 0.091 0.409 
Omega-3 0.51 0.32 0.32 0.38 0.05 0.450 0.459 0.182 
Iron 0.58 0.95 0.32 0.37  0.050 0.000 0.127 
Whey Protein 0.47 - 0.32 0.37 0.04 0.048 0.163 - 
106 
 
5.3.9- Associations between BMI, fat distribution pattern, smoking, education and household annual 
income and plasma MT1 concentration in Saudi adults: 
Mean plasma MT1 concentrations in Saudi adults according to BMI category and fat distribution pattern 
are shown in Figure 5.10. There was no difference in plasma MT1 concentration between subjects in 
different BMI categories (P=0.386). Participants who had an apple-shaped fat distribution pattern had 
significantly higher plasma MT1 concentration than participants who had a pear-shaped fat distribution 
pattern but this difference was not statistically significant (P=0.239). 
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Figure 5.10 Mean plasma MT1 concentration by (A) BMI category and (B) fat distribution pattern 
(n=192). Error bars show SD 
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Figure 5.11 and Figure 5.12 shows the mean plasma MT1 concentrations in Saudi adults by smoking and 
socioeconomic status, respectively. There were no significant differences in plasma MT1 concentration 
between cigarette smoking categories (P=0.235) or between shisha smokers and non-smokers (P=0.239). 
Education and household annual income were not related to plasma MT1 concentration (P=0.070, 
P=0.736, respectively).  
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Figure 5.11 Mean plasma MT1 by (A) cigarette and (B) shisha smoking (n=192). Error bars show SD 
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Figure 5.12 Mean plasma MT1 concentration by (A) education and (B) household annual income 
(n=192). Error bars show SD 
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5.4- Discussion:  
5.4.1- Relationships between age and sex and plasma zinc and MT1 concentrations in Saudi adults: 
The mean plasma zinc concentration of young and older Saudi adults of both sexes (21.4 µmol/l) was 
slightly higher than the mean values (18.2 µmol/l) reported in northeast Thailand (Boonsiri et al., 2006) 
and substantially higher than those reported in Lebanese adults (15.3 µmol/l) (Obeid et al., 2008), 
Kuwaiti males (17 µmol/l), Kuwaiti females (15.5 µmol/l) (Abiaka et al., 2003), Greek (11.3µmol/l), 
French (14.2 µmol/l), German (12.2 µmol/l), Polish (12.6 µmol/l) (Marcellini et al., 2006) and other 
European populations including Italian, Belgium and English (13 µmol/l) (Arnaud et al., 2012). The 
mean plasma zinc concentration of young females was 13.4 µmol/l, which is comparable with the results 
for premenopausal Australian women (12.6 µmol/l) (Lim et al., 2015) . On the other hand, the mean 
plasma zinc in older females (27.2 µmol/l) was much higher than the mean plasma zinc concentration in 
postmenopausal Turkish women (19.5 µmol/l) (Arikan et al., 2011). 
In contrast with the findings from the present study, several studies have observed that the mean plasma 
or serum zinc concentration was lower in older adults than in young adults (Sfar et al., 2009, Al-Timimi 
et al., 2005, Boonsiri et al., 2006). A possible variable that could explain the higher plasma zinc 
concentration observed in older adults in the current study is the distribution of body fat. Participants 
who had an apple-shaped fat distribution pattern had significantly higher mean plasma zinc concentration 
than participants who had a pear-shaped fat distribution pattern. More than half of the older adults had 
apple-shaped fat distribution pattern while more than half the young adults had a pear-shaped distribution 
(see section 5.4.4). Another possible explanation for the higher plasma zinc concentration observed in 
older adults is dehydration (as indicated by significantly higher mean plasma magnesium concentrations 
in older adults compared with young adults (see Table 5.2)) (Strand et al., 2004). With aging, the 
proportion of water in the human body declines and, as a result, the water reservoir is reduced and the 
safety margin for staying hydrated become smaller (Brown et al., 2005). In Saudi Arabia, there is little 
information about the fluids intake by older Saudis. However, Hosa (2003) found that only 36% of 
females living in Riyadh drank more than 5 cups of water daily (Hosa, 2003). Moreover, fasting is 
another contributor to dehydration (Leiper et al., 2003). Most older Saudis fast two days per week 
(Monday and Thursday) and on the three middle days (13th, 14th and 15th) of each month which may lead 
to hypo hydration of older adults. High blood glucose causes further dehydration in older adults as the 
kidneys attempt to unload glucose and ketones by producing large amounts of urine. Almost half the 
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older adults in the current study had diabetes and high blood glucose levels as shown in Table 5.1. In 
addition to the distribution of body fat and dehydration, sarcopenia could be another variable. As more 
than 80% of total body zinc is in muscle, bone, hair and skin, sarcopenia (age-related decline in muscle 
mass) could lead to the release of zinc from muscle to the blood stream (Cruz-Jentoft et al., 2010). 
There is a lack of concordance in the literature concerning differences in plasma zinc concentration 
between men and women. Al Tamimi et al and Boonsiri el al found no differences in plasma zinc 
concentration between males and females while Sfar et al and Lam et al reported higher plasma zinc 
concentrations in males compared with females (Sfar et al., 2009, Al-Timimi et al., 2005, Boonsiri et al., 
2006, Lam et al., 2008). In the present study, males had slightly higher mean plasma zinc concentration 
compared with females but there were no statistically significant difference. 
Metallothionein is a low molecular weight cysteine-rich protein with two major isoforms comprising 
isoform 1 (MT1) and isoform 2 (MT2) (Milnerowicz and Bizon, 2010). In healthy Japanese subjects, the 
mean serum concentration of total MT was 23±4.6 ng/ml while in young Polish adults total serum MT 
concentrations were 0.81 and 0.76 ng/ml for females and males, respectively (Nakajima et al., 2010, 
Kowalska et al., 2015). In this study, the mean plasma MT1 concentration in young and older Saudi 
adults of both sexes combined was half the serum concentration of total MT in young Polish adults (0.35 
± 0.2 ng/ml). These differences in MT concentrations between our study and other studies may due to 
analytical differences in e.g. sources of the kits, antibody and type of ELISA used. There were no 
statistically significant differences between men and women and these results are in contrast with the 
findings of Kowalska et al (2015) who reported higher serum MT in females compared with males 
(Kowalska et al., 2015). Furthermore, the authors reported higher serum MT in prime-age adult men 
(mean age 36) compared to younger men (mean age 23). In current study, older adults had slightly higher 
mean plasma MT1 concentration compared with young adults but there was no statistically significant 
difference.  
5.4.2- The prevalence of zinc deficiency in young and older male and female Saudi adults: 
In young and older Saudi adults of both sexes, the prevalence of zinc deficiency was 28%, which is 
similar to the prevalence reported in Lebanese subjects (27.6%) but much higher than was observed in 
Kuwaiti adults (0.53%) (Obeid et al., 2008, Abiaka et al., 2003). Fifty one and forty six percent of young 
males and females, respectively, had low plasma zinc concentration, which indicated elevated risk of 
113 
 
zinc deficiency in those subpopulations (IZiNCG, 2012a). When using the same cutoff points, studies 
conducted in Australia and Mexico reported lower prevalence of zinc deficiency in young women 
compared with the findings from this study. For example, 17% of Australian women and 18% of Mexican 
women had zinc deficiency whereas 42% of Mexican men were zinc deficient (Garcia et al., 2012, Mejía-
Rodríguez et al., 2013, Lim et al., 2015), which is less than that observed for young Saudi Arabian men 
(51%) in the present study. On the other hand, older Saudis of both sexes had lower prevalence of zinc 
deficiency (6%). Andriollo et al reported a similar prevalence (5%) of zinc deficiency in European older 
adults whereas Sfar et al reported higher prevalence (44%) in Tunisian older adults (Andriollo-Sanchez 
et al., 2005, Sfar et al., 2009).  
5.4.3- Relationships between dietary zinc, zinc absorption modifiers and herbal teas intake on 
plasma zinc and MT1 concentration: 
Inadequate zinc intake and/or decreased dietary absorption efficiency contribute to reduced zinc status 
and the development of zinc deficiency at the population level (Gibson, 2005, Coneyworth et al., 2009). 
The efficiency of absorption can be affected by the presence of dietary enhancers and inhibitors (Seal 
and Mathers, 1989). The amount of protein in a meal has a positive effect on zinc absorption (Sandstrom 
et al., 1980) while phytic acid represses it through the formation of insoluble complexes with zinc in the 
gastrointestinal tract (Couzy et al., 1998, Kim et al., 2007, Hunt and Beiseigel, 2009). In the present 
study, there were significant positive correlation coefficients between plasma zinc concentrations and 
intakes of dietary zinc, total zinc and dietary protein. These positive correlations agree with the findings 
of other studies (Andriollo-Sanchez et al., 2005, Al-Numair, 2006, Winokan et al., 2010).  
Herbal teas are widely consumed by the Saudi population. In this study, green tea consumers had 
significantly lower mean plasma MT1 concentration than non-consumers. To date, the effect of green 
tea on plasma MT1 concentration has not been studied in any detail and merits further investigation. On 
the other hand, there was no statistically significant difference in plasma zinc concentration between 
green tea consumers and non-consumers. The few studies conducted in rats and humans showed that 
green tea consumption increased plasma zinc concentration (Suliburska et al., 2012, Meki et al., 2009, 
Hamdaoui et al., 2005). This effect could be due to the polyphenols in green tea, which stimulates zinc 
uptake and metallothionein expression as observed in Caco2 cells (Sreenivasulu et al., 2010).  
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5.4.4- Associations between BMI, fat distribution pattern, smoking, education and household annual 
income and plasma zinc and MT1 concentration in Saudi adults: 
Reported changes in plasma zinc concentrations associated with obesity are not consistent. For example, 
obese hypertensive patients in Poland had similar serum zinc concentrations compared with normal 
weight healthy adults (Suliburska et al., 2011). Moreover, no differences were observed in the plasma 
concentrations of zinc in Mexican women according to their BMI (Garcia et al., 2012). Conversely, other 
studies showed either increased or decreased in plasma zinc concentrations in obese compared with lean 
subjects (Yakinci et al., 1997, Chen et al., 1997). In the present study, there were no significant 
differences in plasma zinc concentration between participants in the different BMI categories. However, 
there appeared to be a non-significant trend towards higher plasma zinc concentration with increasing 
BMI in younger adults. A similar observation was reported by Al-Timimi et al (2005) and Yakinci et al 
(1997), who found that obese children and adults had higher serum zinc concentrations than control 
groups (Yakinci et al., 1997, Al-Timimi et al., 2005). In contrast, we observed in the current study a non-
significant trend in obese older adults towards lower plasma zinc concentration compared with 
participants from the same age group with BMIs in the normal range.  Broadly consistent with this 
observations are the findings of  Chen et al (1997), Marreiro et al (2002) and Yerlikaya et al (2013), who 
reported lower plasma zinc concentration in obese children and adults compared with lean controls (Chen 
et al., 1997, Marreiro et al., 2002, Yerlikaya et al., 2013). Alterations in zinc transporter expression could 
explain the differences observed in the current study in plasma zinc concentration between subjects with 
pear and apple-shaped fat distribution patterns. In the present study, ZnT1, ZnT5 and ZIP4 expression in 
participants with an apple-shaped fat distribution pattern was significantly higher than in participants 
with a pear-shaped fat distribution pattern, which may explain the higher plasma zinc concentration 
observed in the former (see section 6.3.4). Plasma MT1 concentration in participants with an apple-
shaped fat distribution pattern was higher than in participants with a pear-shaped fat distribution pattern 
but these differences were not significant.  
Smoking is a further factor that may affect plasma zinc concentration. Effects of smoking on biochemical 
markers of mineral status were reviewed by Northrop-Clewes and Thurnham (2007). Inflammation is a 
major contributory mechanism through which smoking affects mineral status, and effects were greater 
in heavy or long term smokers. Serum zinc concentration was depressed only in heavy smokers 
(Northrop-Clewes and Thurnham, 2007). In the present study, cigarette smoking was not associated with 
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any difference in plasma zinc concentration, which may be due to the higher zinc intake of smokers 
compared with non-smokers and the fact that smoking was only moderate (mean of 13 cigarettes /day). 
Similarly, there were no significant difference in plasma zinc concentration between smokers and non-
smokers of shisha, although there was suggestion of a non-significant trend towards lower concentration 
in smokers, which may reflect a higher level of toxic exposure. An hour-long shisha/argela smoking 
session involves 200 puffs, while smoking an average cigarette involves 20 puffs (CDC, 2015). Shisha 
smoking was also associated with a non-significant trend towards higher plasma MT1 concentration. MT 
plays important roles in free radical scavenging and detoxification of metals such as cadmium in cigarette 
smoke (Kowalska et al., 2015, Milnerowicz and Bizon, 2010).   
Difference in socioeconomic status have also been shown to be related to plasma zinc concentration 
(Aydemir et al., 2003). In the present study, plasma zinc concentration was not related to house hold 
annual income or education level. A similar result was reported by Al-Numair (Al-Numair, 2006).  
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Chapter 6. Associations between Zinc Intake, Zinc Status and Body Fat 
and Expression of ZnT1, ZnT5 and ZIP4  
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6.1- Introduction: 
Ageing is accompanied by changes in many physiological systems including the gastrointestinal tract 
(Brown et al., 2005), where one effect is a decrease in dietary zinc absorption (Aamodt and Rumble, 
1983). When young men (22-30 years old) and older men (65-74 years old) consumed the same purified 
formula diet containing 15 mg of zinc per day, mean zinc absorbance was 31% in the young men and 
fell significantly to 17% in the older men (Turnlund et al., 1986). August et al (1989), reported that zinc 
absorption from a zinc adequate diet in elderly subjects was 21% compared with 39% in young subjects 
(August et al., 1989). Absorption of dietary zinc in humans is predominantly in the proximal small 
intestine, either the distal duodenum or proximal jejunum (Lee et al., 1989, Krebs, 2000). Several studies 
on rat intestine and human intestinal Caco-2 cell monolayers have revealed that zinc uptake in the 
intestine is concentration-dependent and both carrier mediated (saturable) and non-mediated (non-
saturable) pathways are involved (Yasuno et al., 2012, Steel and Cousins, 1985). A variety of zinc 
transporters are expressed in the enterocyte and they belong to two families – the ZnT and Zip families. 
The ZnT (solute-linked carrier 30 (SLC30A)) proteins decrease intracellular zinc concentration by 
mediating zinc efflux from cells or influx into intracellular compartments (e.g. endosomes, Golgi 
apparatus) whereas the Zip (Zrt- and Irt-like (SLC39A)) proteins increase cytosolic zinc concentrations 
(Eide, 2004, Palmiter and Huang, 2004a, Wang and Zhou, 2010). Of the zinc transporters cloned to date 
and expressed in the intestine, localization and transport function of ZnT1, ZnT5 and ZIP4 are consistent 
with a role in dietary zinc absorption (Cragg et al., 2005). Abnormalities in expression of zinc transporters 
in the intestinal mucosa may be associated with age-related changes in zinc absorption (Coneyworth et 
al., 2009). To our knowledge, the relative expression of genes involved in zinc absorption in young and 
older adults has not been studied in detail.  
A large body of research shows that ageing is associated with extensive and widespread changes in gene 
expression in multiple tissues (Gonzalez et al., 2015, Jung et al., 2015, Gupta et al., 2015, Marthandan 
et al., 2015, Su et al., 2015). For example, ageing was associated with reduction in expression of genes 
in the ATP synthase, NADH dehydrogenase, cytochrome C reductase and oxidase complexes, as well as 
in glucose and pyruvate processing in human skeletal muscle tissues (Su et al., 2015). In cultured 
cerebellar granule neurons (CGNs), expression of neuropeptide Y and Slit homolog 2 (Drosophila) were 
reported to be increased during ageing (Gupta et al., 2015). Zinc has also a regulatory roles in gene 
expression. Theoretically, four fundamental mechanisms based on the binding of protein regulatory 
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factors to gene promoter regions may underlie transcriptional regulation by zinc, differentiated by 
whether the protein factor when bound exerts a positive or negative influence on transcription and 
whether the protein factor shows increased or reduced binding to the promoter region under conditions 
of increased zinc availability (Jackson et al., 2008). Based on these profound effects of ageing and zinc 
on gene expression, it is likely that zinc transporters expression is affected by aging and that dietary zinc 
intake is a modifying factor. A further variable to consider in this context is adiposity, since it has been 
shown in human subjects that obesity was associated with changes in zinc transporters expression (Noh 
et al., 2014a, Smidt et al., 2007). 
Collection of peripheral blood is relatively simple in a clinical setting and blood can be a surrogate tissue 
to observe the status of other tissues or organs. In addition, it has been suggested that immune cells may 
be the first to respond to a change in zinc status, even before plasma zinc falls below the normal range. 
Therefore, peripheral blood mononuclear cells (PBMCs) may provide a practical and responsive 
measurement of zinc transporter gene expression and cellular zinc homeostasis in humans (Bogale et al., 
2015, Foster et al., 2011). PBMC consist of several cellular subtypes including lymphocytes (T cells, B 
cells and natural killer cells) and monocytes. During aging, the cellular composition of blood has been 
seen to change. In particular a decrease in lymphocyte counts has been observed in older individuals 
(Forsey, 2009). A study by Teschendorff et al showed that these changes in cell composition during 
ageing could potentially explain the DNA hypomethylation observed with increasing age. However, this 
was not the case for age-related DNA hypermethylation. Specifically, the age-associated DNA 
hypomethylation signature observed in blood correlated with changes in blood cell-type composition in 
a set of cancer-related genes, while there was no relationship between the age-related DNA 
hypermethylation signature and the cellular composition of blood (Teschendorff et al., 2009). Therefore, 
it is important to ascertain whether changes in the proportions of different cell types of PBMC during 
aging are reflected in changes in the expression of zinc transporters genes.  
The aim of the work presented in this chapter was to investigate the effect of aging on the expression of 
zinc transporters involved in absorption of zinc from the gut and their relationship with zinc intake, Zinc 
status, body fat and cellular composition of the blood.  
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Objectives: 
1. To measure mRNAs corresponding to the zinc transporters ZnT1, ZnT5 and ZIP4 in young and 
older Saudi adults of both sexes. 
2. To investigate associations between zinc intake and plasma zinc concentration and these mRNAs. 
3. To investigate associations between BMI and fat distribution pattern and these mRNAs. 
4. To determine the leucocyte composition of blood in younger and older Saudi adults of both 
sexes and its possible association with zinc transporter mRNAs and plasma zinc concentration.  
6.2- Materials and Methods: 
6.2.1-Participant recruitment: 
Two hundred and two male and female participants aged 20-30 years (younger adults) and 55-75 years 
(older adults) were recruited from King Abdulaziz University students, King Abdulaziz University 
Hospital, King Fahad Hospital, via advertisement in social media and via personal contact. Participants 
were divided into four groups according to sex and age (53 young males, 51 young females, 49 older 
males and 49 older females). Further details of recruitment are given in section 4.2.1. 
6.2.2- Measurement of plasma zinc concentration, anthropometric parameters and dietary zinc 
intake: 
All participants donated blood samples and completed a questionnaire. Blood samples were collected in 
trace-element free (one sample) and EDTA (2 samples) anticoagulant blood collection tubes.  Plasma 
samples separated from the trace-element free tubes were stored at -80°c for later measurement of zinc 
concentration by inductively coupled plasma atomic emission spectroscopy (see section 2.4). Hemolyzed 
samples (n=5) were excluded from the analysis.  The two EDTA tubes (each containing 3 ml) were used 
for the separation of buffy coat for RNA extraction and analysis of cells by flow cytometery (see sections 
2.6 and 2.11, respectively). All buffy coat samples were stored immediately at -80°c for later use. RNA 
was converted to cDNA by reverse transcription then ZnT1, ZnT5 and ZIP4 were measured by qPCR 
(see sections 2.9 and 2.10). Percentages of T cells, B cells, natural killer cells and monocytes were 
measured by flow cytometery (see section 2.11). In addition, all participants completed an FFQ 
(previously validated to be used in Saudi young and older adults (see chapter 3)) and data from this FFQ 
were used to estimate intakes of zinc as described previously (see section 2.1.5). Body weight, height, 
waist and hip circumference were measured as described in section 2.1.1. 
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6.2.3- Statistical analysis: 
Two-way ANOVA was used to determine differences between subjects grouped according to age and 
sex in mRNA for ZnT1, ZnT5 and ZIP4 relative to GAPDH. The same approach was used to determine 
differences between older and younger subjects grouped according to BMI and fat distribution pattern in 
the same mRNAs. An independent t-test was used to determine differences between subject groups with 
respect to the percentage of T cells, B cells, natural killer cells and monocytes. Correlations between 
dietary zinc intake, total zinc intake, plasma zinc concentration, plasma MT1 concentration and 
proportions of leucocyte subtypes and the zinc transporter mRNAs measured were investigated using 
Pearson and/or Spearman correlation (r). All statistical analyses were performed using the statistical 
software package IBM SPSS version 19. Statistical significance was taken as P<0.05.  
6.3- Results: 
6.3.1- Relative mRNA level of the zinc transporters ZnT1, ZnT5 and ZIP4 in young and older male 
and female Saudi adults: 
Figure 6.1 shows ZnT1, ZnT5 and ZIP4 mRNAs relative to GAPDH measured by qPCR (detailed CT 
values are summarized in Appendix F). For all participants, relative to GAPDH mean ZIP4 mRNA was 
higher than ZnT1 and ZnT5. Older males had significantly higher  ZIP4 mRNA compared with young 
male adults (p= 0.042). Older males had higher mean ZnT1 and ZnT5 mRNAs than young males but 
there were no significant differences (P= 0.270 and P= 0.224, respectively). There were no differences 
in expression of any of the mRNAs measured between males and females (P >0.05). 
 
 
 
 
 
 
 
121 
 
a l
l
y o
u n
g  
m
a l
e
y o
u n
g  
fe
m
a l
e
o l
d e
r  
m
a l
e
o l
d e
r  
fe
m
a l
e
0
2 0 0
4 0 0
6 0 0
8 0 0
Z n T 1
m
R
N
A
 r
e
la
ti
v
e
 t
o
 G
A
P
D
H
A
a l
l
y o
u n
g  
m
a l
e
y o
u n
g  
fe
m
a l
e
o l
d e
r  
m
a l
e
o l
d e
r  
fe
m
a l
e
0
5 0 0
1 0 0 0
1 5 0 0
Z n T 5
m
R
N
A
 r
e
la
ti
v
e
 t
o
 G
A
P
D
H
B
a l
l
y o
u n
g  
m
a l
e
y o
u n
g  
fe
m
a l
e
o l
d e
r  
m
a l
e
o l
d e
r  
fe
m
a l
e
0
2 0 0 0
4 0 0 0
6 0 0 0
Z IP 4
m
R
N
A
 r
e
la
ti
v
e
 t
o
 G
A
P
D
H
*
C
 
 Figure 6.1 Zinc transporter mRNAs (A) ZnT1 (B) ZnT5 (C) ZIP4 for subjects grouped by age and sex 
(n=201). Data are means ± SEM relative to GAPDH mRNA. * P< 0.05 older males compared with young 
males 
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6.3.2- Associations between zinc intake and plasma zinc and MT1 concentrations and zinc transporter 
mRNAs: 
Analysis of the relationship between dietary zinc intake, total zinc intake (including supplementary), 
plasma zinc concentration and plasma MT1 concentration and the zinc transporter mRNAs measured are 
shown in Table 6.1. A strong and significant correlation was found between ZIP4, ZnT1 and ZnT5 
mRNAs in all participants and also when subjects were grouped according to age and sex. Sequential 
Bonferroni test also indicates a significant correlation at the “table-wide” 0.05 level. In young males, 
there was a significant inverse correlation between dietary zinc intake and ZnT5 mRNA. There was also 
a significant inverse correlation between plasma zinc concentration and MT1 in this group. There was a 
positive relationship between plasma MT1 concentration and ZnT1 and ZnT5 mRNAs in young females 
and an inverse relationship between MT1 and dietary zinc intake in the same group. In addition, plasma 
zinc concentration was correlated inversely with ZnT5 mRNA in this group. In older males but not older 
females, plasma zinc concentration was significantly correlated with ZIP4 mRNA. Sequential Bonferroni 
test indicates that these tests are non-significant at the “table-wide” 0.05 level. 
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Table 6.1 Pearson and/or Spearman correlation coefficients (r) between dietary zinc intake, total zinc 
intake, plasma zinc and MT1 concentrations and zinc transporters mRNAs  
 ZnT5 ZIP4 Dietary 
zinc 
intake 
Total 
zinc 
intake 
Plasma 
Zinc 
Conc. 
Sqrt 
Plasma 
Zinc Conc. 
Plasma 
MT1 
ZnT1        
all 0.811** 0.655** -0.044 -0.044 0.006 0.047 0.031 
Young male 0.786** 0.568** -0.266 -0.243 -0.012 -0.012 0.001 
Young female 0.824** 0.612** 0.050 0.114 -0.119 0.124 0.430* 
Older male 0.802** 0.775** -0.107 -0.143 0.090 0.030 -0.019 
Older female 0.834** 0.619** -0.002 0.017 -0.002 -0.014 -0.238 
ZnT5        
all  0.716** -0.068 -0.067 -0.006 0.041 0.050 
Young male  0.690** -0.284* -0.267 -0.077 -0.077 0.066 
Young female  0.714** 0.027 0.093 -0.292* -0.064 0.442* 
Older male  0.834** -0.122 -0.168 -0.187 0.116 -0.057 
Older female  0.655** -0.121 -0.098 0.003 -0.038 -0.269 
ZIP4        
All   0.049 0.032 0.086 0.143* 0.074 
Young male   -0.113 -0.099 -0.156 -0.156 0.018 
Young female   0.010 0.030 -0.257 0.014 0.268 
Older male   -0.046 -0.074 0.305* 0.195 -0.050 
Older female   0.102 0.020 -0.014 -0.058 -0.005 
Dietary zinc intake        
all       0.054 
Young male       0.107 
Young female       -0.298* 
Older male       0.199 
Older female       0.065 
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 ZNT5 ZIP4 Dietary 
zinc 
intake 
Total 
zinc 
intake 
Plasma 
Zinc 
Conc. 
Sqrt 
Plasma 
Zinc Conc. 
Plasma 
MT1 
Total zinc intake        
all       0.104 
Young male       0.124 
Young female       -0.094 
Older male       0.204 
Older female       0.035 
Plasma zinc conc.        
all       -0.034 
Young male       -0.377** 
Young female       -0.178 
Older male       -0.042 
Older female       0.137 
 
Significance of the correlation: * P <0.05, ** P <0.01. All the data are log-transformed. Sqrt, square root; 
MT1, metallothionein 1 
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6.3.3- Associations between BMI, fat distribution pattern and the zinc transporters mRNAs: 
Measurement of ZnT1, ZnT5 and ZIP4 mRNAs according to BMI category and fat distribution pattern 
are shown in Figure 6.2 and Figure 6.3, respectively. In young adults, there was a non-significant 
apparent trend towards higher ZnT1, ZnT5 and ZIP4 mRNAs with increasing BMI. In contrast, there 
appeared to be a non-significant trend towards lower levels of these mRNAs with increasing BMI in 
older adults. Young and older adults who had an apple-shaped fat distribution pattern had significantly 
higher ZnT1, ZnT5 and ZIP4 mRNAs compared with participants who had a pear-shaped fat distribution 
pattern (P=0.016, P=0.02 and P=0.027, respectively).  
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Figure 6.2 Zinc transporter mRNAs (A) ZnT1 (B) ZnT5 (C) ZIP4 in subjects grouped according to 
BMI category (n=201). Data are expressed as means ± SEM relative to GAPDH mRNA 
127 
 
a
ll 
y
o
u
n
g
 a
d
u
lt
s
o
ld
e
r  
a
d
u
lt
s
0
2 0 0
4 0 0
6 0 0
8 0 0
Z n T 1
m
R
N
A
 r
e
la
ti
v
e
 t
o
 G
A
P
D
H p e a r s h a p e d
a p p le  sh a p e d
* *
*
A
a
ll 
y
o
u
n
g
 a
d
u
lt
s
o
ld
e
r  
a
d
u
lt
s
0
5 0 0
1 0 0 0
1 5 0 0
Z n T 5
m
R
N
A
 r
e
la
ti
v
e
 t
o
 G
A
P
D
H p e a r s h a p e d
a p p le  sh a p e d
B
* *
*
a
ll
y
o
u
n
g
 a
d
u
lt
s
o
ld
e
r  
a
d
u
lt
s
0
2 0 0 0
4 0 0 0
6 0 0 0
Z IP 4
m
R
N
A
 r
e
la
ti
v
e
 t
o
 G
A
P
D
H p e a r s h a p e d
a p p le  sh a p e d*
*
*
C
    
Figure 6.3 Zinc transporters mRNAs in subjects grouped according to fat distribution pattern (n=201) 
(A) ZnT1 (B) ZnT5 (C) ZIP4. Data are expressed as means ± SEM relative to GAPDH mRNA. * Apple 
shaped compared with pear shaped fat distribution pattern (P<0.05) 
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6.3.4- The leucocytes composition of blood in young and older adults and its possible association 
with zinc transporters mRNAs and plasma zinc concentration: 
Figure 6.4 shows the proportions of T cells, B cells, natural killer cells and monocytes in young and older 
Saudi adults measured by flow cytometry. Mean (±SD) percentage of T cells for all participants was 52.4 
± 11.5 %. Older adults had a significantly lower proportion of T cells compared with young adults (P < 
0.001). Proportions of B cells, natural killer cells and monocytes were 11%, 13% and 6%, respectively. 
There were no significant differences in the proportions of these cell subtypes between young and older 
adults (P> 0.05). Spearman correlation coefficients between the proportion of cell subtypes and zinc 
transporter mRNAs and plasma zinc concentration are shown in Table 6.2. There was a significant 
positive correlation between plasma zinc concentration and proportion of monocytes and an inverse 
correlation between plasma zinc concentration and proportion of T cells. There were no significant 
correlations between proportions of cell subtypes and any of the zinc transporters mRNAs measured.  
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Figure 6.4  The percentage of (A) T cells (B) B cells (C) natural killer cells and (D) monocytes in young 
and older Saudi adults (n=166). Data are shown as mean ± SD. *** P<0.001 compared with young adults 
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Table 6.2 Spearman correlation coefficients (r) between the proportion of cell subtype and zinc 
transporters mRNAs and plasma zinc concentration 
 ZnT1 ZnT5 ZIP4 
Plasma zinc 
concentration 
CD3+ 0.100 0.142 0.071 -0.239** 
CD19+ 0.008 -0.024 -0.002 -0.049 
CD14+ -0.040 -0.080 -0.138 0.204** 
CD56+ -0.076 -0.033 0.036 0.004 
** P<0.01 
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6.4- Discussion: 
6.4.1- Relationships between ZnT1, ZnT5 and ZIP4 mRNAs and zinc intake, plasma zinc 
concentration and plasma MT1 concentration in young and older male and female Saudi adults: 
Several studies in animals and humans report regulatory effects of zinc on ZIP4 expression in the 
intestine and PBMCs. For example, Cragg et al (2005) found a reduction in ZIP4 protein in ileal mucosa 
of human subjects after zinc supplementation (Cragg et al., 2005). Similarly, Weaver et al (2007) found 
that administration of oral zinc caused degradation of ZIP4 in enterocytes while zinc deficiency increased 
ZIP4 protein level (Weaver et al., 2007). In young women, PBMC ZIP4 expression was decreased 
following zinc supplementation (Bogale et al., 2015). At the mechanistic level, ubiquitination and 
degradation of ZIP4 was observed in response to high zinc concentration (10-20µM) in tissue culture 
(Mao et al., 2007) and Kruppel-like factor (KLF4) was found to bind to the mouse ZIP4 promoter under 
zinc-limiting conditions to increase expression (Liuzzi et al., 2009). The positive association between 
ZIP4 expression and dietary zinc intake observed in older males in the current study appears discordant 
with these published findings. In a recent study conducted on Australian elderly subjects, ZIP1 
expression was increased significantly in blood lymphocytes in a zinc supplemented group compared 
with a placebo group (Sharif et al., 2015) which concurs with this positive relationship between a zinc 
transporter of the ZIP family and zinc intake in older adults.  
The strong positive association between expression of ZIP4, ZnT1 and ZnT5 shown in this study 
indicates that the expression of these 3 zinc transporters is highly coordinated and may indicate an 
interrelationship between zinc importers and exporters to maintain cellular zinc homeostasis. Such a 
model is consistent with a non-significant trend toward higher expression of ZnT1 and ZnT5 in older 
adults than young adults which could be a consequence of increased ZIP4 expression. In addition, a 
molecular mechanism involving the activity of metal responsive transcription factor (MTF-1) could be 
responsible for the induction of ZnT1 and ZnT5 transporters as a result of high zinc intake. MTF-1 is a 
transcription factor that enhances the transcription of target genes by binding to metal responsive 
elements (MRE) located in the promoter regions. In previous studies, several MREs were identified in 
the promoter regions of both ZnT1 and ZnT5 genes (Langmade et al., 2000; Cragg et al., 2002). However, 
deletion of an MRE from an SLC30A5 (ZnT5) promoter-reporter construct did not affect the response to 
zinc (Jackson et al., 2007); hence it cannot be assumed that these MREs are active and that MTF-1 
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regulates this gene. Higher expression of the zinc transporter genes we measured could explain the higher 
plasma zinc concentration observed in the older group.  
Unlike older male adults, older female adults did not show a differences in ZIP4 expression according to 
zinc intake. A possible reason is the lower zinc intake of older females compared with older males (see 
section 4.3.2) and/or the hormonal differences between sexes. To date, the regulation of zinc transporters 
by hormones has not been studied in any detail and merits further investigations.  
An inverse correlation between dietary zinc intake and expression of ZnT5 was observed in young males. 
ZnT5B is a bidirectional zinc transporter and mediates zinc uptake, as well as zinc efflux. Thus, 
inadequate zinc intake observed in this age group (see section 4.3.3) may result in a homeostatic response 
of ZnT5 to increased zinc uptake. Somewhat discordant with these results, Ryu et al (2011) reported a 
significant decrease in ZnT5 expression with dietary zinc depletion for 10 days in male subjects (Ryu et 
al., 2011). In the present study, zinc intake was assessed over the year previous to recruitment, which 
possibly reflects that short-term and long-term effects of inadequate zinc intake result in different 
responses of ZnT5. The strong positive correlation between expression of ZnT5, ZnT1 and ZIP4 may 
possibly reflect an increase in ZIP4 and ZnT1 expression with decreased zinc intake. A similar 
observation was reported by Burke et al (2014), who report an increase in ZnT1 expression during a 
depletion phase in healthy men (Burke et al., 2014).  
In young females, several correlations between plasma MT1 protein, zinc transporter mRNAs and dietary 
zinc intake were observed. For example, plasma MT1 was correlated significantly with expression of 
ZnT1 and ZnT5 and correlated inversely with dietary zinc intake.  Previous studies have investigated the 
relationship between zinc intake and/or plasma zinc concentration with either MT1 or MT2 expression 
in PBMC. For instance, Chu et al (2015) showed that changes in MT2A expression were correlated with 
changes in the expression of zinc transporters genes, especially ZIP1, in response to zinc supplementation 
but no significant changes in plasma zinc concentration were observed (Chu et al., 2015). On the other 
hand, expression of MT1 did not change significantly following zinc supplementation (Bogale et al., 
2015). 
6.4.2- Associations between BMI, fat distribution pattern and zinc transporters mRNA: 
Previous published work has revealed a relationship between obesity and expression of zinc transporters 
associated with alterations in zinc metabolism (Noh et al., 2014b). In the present study, there was a trend 
133 
 
towards higher ZnT1, ZNnT5 and ZIP4 mRNAs in younger adults with higher BMI but there were no 
statistically significant relationships. On the other hand, zinc transporters mRNAs tended to decrease 
with increasing BMI in older adults, but again there were no statistically significant relationship.  
Both age groups showed a significant increase in expression of all zinc transporter mRNAs measured 
with abdominal fatness. Higher levels of inflammatory markers such as hs-CRP and IL-6 were observed 
in abdominally obese individuals (Faam et al., 2014) and these inflammatory markers were reported to 
be related to changes in expression of several zinc transporters in obese women (Noh et al., 2014a). In 
the present study, CRP measurements were normal for all participants. Thus, differences in inflammation 
are unlikely to be an explanation for the differences in zinc transporter mRNAs observed in our study. 
Expression of zinc transporter genes may also change between different types of adipose tissue. When 
comparing expression of zinc transporters in subcutaneous fat tissue with expression in visceral fat from 
lean and obese subjects, Smidt et al (2007) observed that ZnT6 and ZnT8 were more highly expressed 
in subcutaneous fat from lean subjects compared to subcutaneous fat from obese subjects and also that 
expression was higher in visceral compared with abdominal fat tissue from both lean and obese subject.  
However, ZnT1 and ZnT5 were expressed at similar levels irrespective of leanness/obesity and the type 
of adipose tissue (Smidt et al., 2007).  Interpretation of our own data in the context of these published 
findings is complicated by the fact we measured the zinc transporter mRNAs in leukocytes, not in adipose 
tissue.   
6.4.3- The leucocytes composition of blood in young and older adults and its possible relationship 
with zinc transporter mRNAs and plasma zinc concentration: 
The mean percentages of CD3+ cells (Tcells) in young and older Saudi adults measured in the current 
study (52%) was lower than the mean values (72%) reported in Saudi male adults living in Riyadh city 
(Al Qouzi et al., 2002), Chinese young adults (69%), Chinese older adults (64%) (Jiao et al., 2009), 
Brazilian young adults (75%), and Brazilian older adults (67%) (Tavares et al., 2014). The mean 
proportions of CD19+ (B cell) (11%) and  CD56+ (natural killer cells) (13%) is comparable with the 
findings of these other studies (Tavares et al., 2014, Jiao et al., 2009, Al Qouzi et al., 2002). Consistent 
with findings of the present study, Tavares et al (2014) found a statistically significant reduction in the 
number of T cell in older compared with young adults (Tavares et al., 2014). In an investigation of T cell 
subsets, Stervbo et al. found a significant decrease in γδTCR+T cells in elderly compared with younger 
subjects (Stervbo et al., 2015).  A possible cause of an age-related decrease in Tcell counts is thymic 
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involution (a prominent feature of immunosenescence) which leads to a decrease in the generation of 
new T cells, finally resulting in a lower number of naϊve (CD45RA+) and a higher number of memory 
(CD45R0+) T cells. Zinc deficiency can also cause thymic involution and thus decrease T cell counts 
(Haase and Rink, 2009, Mitchell et al., 2006), but no such effect is indicated by the findings of the current 
study because plasma zinc concentration and proportion of T cells correlated inversely. Consistent with 
this inverse correlation, Ibs and Rink (2003) reported a decrease in T cells function (measured by 
suppression of alloreactivity) with high zinc dosage (> 30µmol/l) in the mixed lymphocyte culture (Ibs 
and Rink, 2003). 
We predicted an age-related relationship between leucocytes subtype proportion and zinc transporter 
gene expression on the basis of the reported correlation between the age-associated changes in blood cell-type 
composition and DNA hypomethylation in blood (Teschendorff et al., 2009). However, we observed no 
relationship between the proportion of T cells, B cells, natural killer cells or monocytes with any of the 
mRNAs measured. Therefore, age-related changes in the leucocytes composition of blood are unlikely to 
underlie the differences between the groups we observed with respect to zinc transporter mRNAs. 
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7.1- Introduction and Hypothesis: 
Around the world, the number of people aged 60 years and over is on the rise (World Health 
Organization, 2011). For example, there were 784 million older people in 2011 which represents 11% of 
the total population. This is expected to reach 30% in 2100 (World Health Organization, 2011, United 
Nations, 2011). In Saudi Arabia, the number of older people (>60 years) in 2009 was 907,529 which 
represents 5.2 % of the Saudi population (Ministry of Economy and Planning, 2009a). Ageing is 
accompanied by changes in all physiological systems including the gastrointestinal tract (Brown et al., 
2005), where one effect is a decrease in dietary zinc absorption (Aamodt and Rumble, 1983). Several 
zinc transporters belonging to the ZnT and Zip families are expressed in the enterocyte. Of the zinc 
transporters cloned to date and expressed in the intestine, localization and transport function of ZnT1, 
ZnT5 and ZIP4 are consistent with a role in dietary zinc absorption (Cragg et al., 2005). Aberrant 
expression of zinc transporters in the intestinal mucosa may associated with age-related changes in zinc 
absorption (Coneyworth et al., 2009).  
Dietary zinc intake may also change with age. NHANES III data showed that 60.7% of U.S adults aged 
19-50 years had adequate zinc intake but this fell to 42.5 % in people aged 71 and older (Briefel et al., 
2000). Inadequate zinc intake and/or decreased dietary absorption efficiency are contributing factors to 
age-related decline in zinc status (Gibson et al., 2008, Coneyworth et al., 2009). In Saudi Arabia, the 
mean serum zinc concentration of healthy older adults (> 50 years old) was approximately 40% lower 
than that in young adults (18-22 years old) (6.1 and 10.2 µmol/L, respectively) (Kumosani et al., 1997). 
In another study conducted on healthy northeast Thais aged between 23 and 75 years old, serum zinc 
concentrations declined as age increased (Boonsiri et al., 2006). A decline in zinc status may contribute 
to the development of frailty in older people because of its role in impaired immune response (Haase et 
al., 2006) and to other age-related degenerative diseases (Coneyworth et al., 2009). The limited number 
of studies of zinc intake and zinc status in the Saudi population, especially in the light of recent changes 
in patterns of eating in Saudi Arabia, motivated me to do this research. In addition, studying the effect 
of aging on expression of zinc transporters involved in absorption of zinc from the gut and their 
relationship with zinc status may help to reveal the mechanisms underlying age-related changes in zinc 
status. Based on this my hypothesis were: 
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1) Zinc intake and zinc status in Saudi elderly are lower than in young Saudi adults. 
2) Ageing changes the expression of zinc transporter genes including SLC30A1, SLC30A5 and SLC39A4. 
3) Age-related changes in expression of these zinc transporter genes may be associated with changes in 
zinc intake and zinc status in older people. 
7.2- Summary of main findings: 
7.2.1 Zinc intake and zinc status in young and older Saudi adults: 
To assess zinc status and estimate the risk of zinc deficiency in young and older Saudi adults, I measured 
dietary intake and plasma zinc concentration (de Benoist et al., 2007). Since there was no suitable tool 
designed specifically for quantifying intakes of zinc and its absorption modifiers by adults of all ages 
and both genders in the Saudi population, this project started by developing and validating a food 
frequency questionnaire (FFQ) suitable for quantifying intakes of zinc and of zinc absorption modifiers. 
Following piloting, this instrument was then tested in young and older Saudi adults of both genders living 
in Jeddah city, the western region of Saudi Arabia. The FFQ demonstrated reasonable relative validity 
and high repeatability in estimating and ranking intakes of zinc, phytic acid and protein. Moreover, its 
use demonstrated clear gender and age-related differences in intakes of these food components. Then, 
the FFQ was used to estimate the intake of zinc and its absorption modifiers in two hundreds and two 
male and female participants aged 20-30 years (younger adults) and 55-75 years (older adults). In 
addition, all participants donated blood samples which were used to estimate plasma zinc concentration 
by inductively coupled plasma atomic emission spectroscopy. The findings of the study showed that 
there were no difference in intakes of zinc and its absorption modifiers between young and older adults 
either from diet alone or from diet plus dietary supplements. On the other hand, plasma zinc 
concentrations were significantly higher in older males and females compared with younger groups from 
both genders. These results are discordant with previous published findings (Alsufiani et al., 2015, Sfar 
et al., 2009). The current study demonstrated that males had significantly higher intakes of zinc and 
protein than females. Plasma zinc concentration was also higher in males compared with females but 
these differences were not significant. These observations agree with findings from other studies (Madej 
et al., 2013), Mcdaid et al (McDaid et al., 2007), Coulibaly et al (Coulibaly et al., 2009) and Kim and 
Choi (Kim and Choi, 2013) and Boonsiri et al (Boonsiri et al., 2006).  
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Human zinc deficiency was first described in the Middle East (Sandstead et al., 1967) and in the Arab 
region, low zinc intake still persists in different age groups. Twelve percent of the Saudi adults who 
participated in this study had inadequate intake of zinc (below UK LRNI) either from diet alone or from 
diet plus dietary supplements. These results indicates elevated risk of zinc deficiency among Saudi adults 
and the risk was appeared to be greatest for young males followed by young females. Similarly, young 
males and young females had low plasma zinc concentrations (less than the age/sex/time of day-specific 
cutoffs shown in Table 1.10) which indicated greater risk of zinc deficiency in younger compared with 
older adults.  
The findings of this study did not agree with my hypothesis that older adults in Saudi Arabia have lower 
zinc intake and lower plasma zinc concentrations than their younger counter-parts. This motivated me to 
further investigate changes in expression of zinc transporters involved in absorption of zinc from the gut 
and their relationship with zinc intake and zinc status in young and older Saudi adults. 
7.2.2- Age-related changes in expression of zinc transporters and relationships with zinc intake and 
zinc status: 
I used qPCR to quantify expression of the zinc transporters ZnT1, ZnT5 and ZIP4 at the mRNA level in 
buffy coat. The results of current study demonstrated for the first time differences in expression of zinc 
transporters between young and older Saudi adults of both sexes. Older males had significantly higher 
mean ZIP4 mRNA compared with young males. Older adults had also a non-significant trend toward 
higher ZnT1 and ZnT5 mRNAs than in young males. Strong and significant correlations were found 
between ZnT1, ZnT5 and ZIP4 mRNA abundance in all participants and also when subjects were 
grouped according to age and sex. Moreover, several age and sex-specific correlations between zinc 
intake, plasma zinc concentration and expression of zinc transporters were found. For instance, in older 
males but not females, plasma zinc concentration was correlated significantly with ZIP4 mRNA. The 
positive relationship between ZIP4 expression and dietary zinc intake observed in older males appears 
discordant with published findings (Cragg et al., 2005, Bogale et al., 2015) but is in line with findings 
from a recent study conducted on Australian elderly subjects in which ZIP1 expression in PBMCs was 
increased with zinc supplementation (Sharif et al., 2015). The strong positive associations between 
expressions of each of the 3 zinc transporters investigated in this study suggests that regulation of 
expression of the corresponding genes is coordinated.  Increased expression of these zinc transporters 
could then explain the increased plasma zinc concentration in this age group and also explain the positive 
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relationship between ZIP4 expression and plasma zinc concentration. However, in young males, there 
was an inverse correlation between dietary zinc intake and expression of ZnT5. Inadequate zinc intake 
observed in this age group may result in a homeostatic response of ZnT5 to increased zinc uptake because 
ZnT5B is a bidirectional zinc transporter and mediates zinc uptake, as well as zinc efflux. In young 
females, several relationships between dietary zinc intakes, zinc transporter mRNAs and plasma MT1 
concentrations were observed. For example, plasma MT1 was correlated significantly with expression 
of ZnT1 and ZnT5 and correlated inversely with dietary zinc intake. All these results supports my 
hypotheses. 
This is the first study, to my knowledge, to examine the potential influence of body fat distribution 
(dichotomised as apple-shaped or pear-shaped fat distribution patterns) on the plasma zinc concentration 
and expression of zinc transporters. Young and older adults who had an apple-shaped fat distribution 
pattern, had significantly higher expression of ZnT1, ZnT5 and ZIP4 and also higher plasma zinc 
concentration compared with participants who had a pear-shaped fat distribution pattern. Higher levels 
of inflammatory markers such as hs-CRP and IL-6 were observed in abdominally obese individuals 
(Faam et al., 2014) and these inflammatory markers were reported to be related to changes in expression 
of several zinc transporters in obese women (Noh et al., 2014a). In the present study, CRP measurements 
were normal for all participants. Thus, differences in inflammation are unlikely to explain the differences 
in zinc transporter mRNAs observed in our study. 
7.3- Strengths and Limitations of the Study: 
One of the strengths of the current study is the use of an FFQ which was designed and validated 
specifically for assessing intakes of zinc and of zinc absorption modifiers by Saudi adults. The use of a 
FFQ rather than e.g. a food diary reduces the burden associated with dietary intake estimation for both 
study participants and researchers. Such an approach may be particularly useful in some cultural settings 
because it lowers the cognitive complexity and difficulty for participants not involved in cooking. Since 
including too few items has been shown to lead to underestimation of intake using an FFQ (Cade et al., 
2002) the present study used a relatively large number of food items (64) to assess intake of zinc and its 
absorption modifiers. Additionally, we used a relatively large number of frequency categories to reduce 
participants’ frustration if unable to find the correct response (Cade et al., 2002). However, in common 
with all conventional approaches to estimating dietary intake, FFQs have potential limitations due to 
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subjectivity in intake recording (Penn et al., 2010). Newer developments, including the use of 
metabolomics approaches, may provide more objective estimates of dietary exposure (Fave et al., 2011).  
Another strength of this study is the success in recruiting the full number (200) of participants to the 
main study. In addition these were divided equally between younger and older participants and with 
similar numbers of females and males within each age group. The younger and older cohorts were well 
separated in age (20-30 and 55-75 years for younger and older groups, respectively). These participant 
features strengthened my ability to detect effects of age and gender and also possible age*gender 
interactions. My recruits were also highly compliant in completing the dietary and health questionnaires 
(100% compliance) and in providing blood samples (100% compliance).  
Further, the use of qPCR is a robust method for quantifying mRNAs corresponding to the zinc 
transporters ZnT1, ZnT5 and ZIP4. qPCR provides a highly sensitive and reproducible method for 
measuring changes in expression of specific genes through transcript sequence detection. Analytical 
sensitivity of qPCR rests with the fluorometric basis of this technology, which markedly reduces sample 
size requirements (Aydemir et al., 2006). Zinc transporters were not determined at the protein level so I 
cannot be confident that changes in zinc transporter expression observed at the mRNA level resulted in 
changes in the abundance of the transporter proteins and, therefore, in capacity to transport zinc. It is 
possible that there are difference in post-transcriptional and translational regulation of these zinc 
transporters in response to age and other factors and this should be investigated in future studies.  In 
addition, my measurements were made in buffy coat and not in small bowel epithelial cells (enterocytes) 
which are the key cells regulating zinc absorption from the gut into the body. Finally, because of its 
cross-sectional nature, this study cannot reveal casual relationships and longitudinal studies would be 
helpful in clarifying the direction of causality for effects of age.  Evidence of causality for effects of zinc 
intake on expression of zinc transporters would require intervention studies. 
7.4- Implications for Public Health in Saudi Arabia: 
The present study provides useful information about the dietary intake of zinc and its absorption 
modifiers by young and older Saudi adults of both sexes. This includes intakes from the diet per se and 
also from supplements. Given the rapid changes in socioeconomic circumstances within Saudi Arabia 
coupled with changes in eating patterns, contemporary information on nutrient intakes and the food 
sources of those nutrients is important in understanding links between diet and health. This is especially 
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important for older Saudi adults since life expectancy is increasing steadily in Saudi Arabia as it is in 
most other countries worldwide. Despite growing prosperity, the traditionally high prevalence of zinc 
deficiency (assessed by comparison of dietary intakes with the UK LRNI for zinc), appears to continue 
in young Saudi adults of both genders. Importantly, in this population, intakes of phytate were relatively 
low leading to low PZR which suggests that any inhibitory effect of phytate on zinc absorption in these 
Saudi adults will be relatively modest. In addition, the prevalence of low plasma zinc concentrations was 
greater in younger than in older Saudi adults. Since younger Saudi adults are more likely to have adopted 
Western-style eating patterns, this observation suggests that secular changes in eating patterns are not 
advantageous, at least from the perspective of zinc nutrition. These data could help in the planning and 
development of a nutrition education programs oriented specifically for young adults of both sexes to 
improve their zinc intake and, therefore, zinc status as assessed by plasma zinc concentration. The 
detailed information on food contribution to zinc intake provided by this study will be useful for the 
development of food-based dietary guidelines and to make culturally appropriate recommendations to 
improve dietary quality.  
7.5- Future Work: 
In the short term, further research aimed to examine the effect of ageing on the methylation status of the 
promoter regions of the zinc transporters ZnT1, ZnT5 and ZIP4 would be of interest. This would help to 
determine whether the observed changes in expression of these zinc transporter genes occurred via 
epigenetic mechanisms. I have collected DNA samples from participants in the current study and, in 
future work, I intend to determine the association between DNA methylation and expression of these 
zinc transporters.  In addition, this work could be extended to examine the effects of other epigenetic 
mechanisms including the roles of histone modifications and microRNA (Mathers et al., 2010). 
In the longer term, it will be important to extend these investigations of DNA methylation and expression 
of zinc transporters in a more relevant cell type such as enterocyte using animal models or intestinal 
mucosal biopsies from humans. The latter studies could be conducted using participants with ileostomies 
as used by (Cragg et al., 2005). In addition, investigating the regulation of zinc transporters by hormones 
is of similar importance. For example, determination of sex hormones such as testosterone and estrogen 
in young and older adults from both sexes could help in explaining the sex-specific changes in gene 
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expression during ageing. Further studies are required to investigate the mechanisms through which fat 
distribution pattern appear to affect plasma zinc concentration and expression of zinc transporters genes.  
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QUESTIONNAIRE 
 
Time of blood draw  
Time of last meal  
 
 
1.1 ) Gender:          Male                       Female 
1.2) Age:………………. 
1.3) Weight:………....Kg 
1.4) Height:……………cm=……………………m 
1.5) BMI=……………..Kg/m2 
1.6) Waist circumference:……………… 
1.7) Hip circumference:……………… 
      1.8) waist-to-hip ratio:……………… 
 
 
 
 
 
 
• Demographic data
section 1:
Serial number 
168 
 
 
       2.1) Have you ever been diagnosed by a medical doctor or have any of the                   
              Following conditions: (please mark with a check) and if you currently   
              Taking any medications, please specify? 
                           
 
• Medical history
section 2:
 Disease Mark medication 
2.1.1- Cancer   
2.1.2- High blood pressure   
2.1.3- Heart disease   
2.1.4- Liver disease   
2.1.5- Kidney disease   
2.1.6- Arthritis   
2.1.7- Osteoporosis   
2.1.8- Diabetes   
2.1.9- Lung disease   
2.1.10- Allergies   
2.1.11- Thyroid disease   
2.1.12- Sickle cell anemia   
2.1.13- Blood disorders   
2.1.14- Depression   
2.1.15- 
Any gastrointestinal 
disorders 
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2.2) are you currently taking any herbs? 
                            Yes                 no 
2.3) if yes, please specify? 
……………………………………………… 
2.4) are you currently taking dietary supplements? 
                            Yes                 no 
2.5) if yes, please specify the amount and the duration? 
……………………………………………………… 
2.7) are you currently (or during the past year) on a diet? 
                            Yes                 no 
2.8) if yes, please specify the type of the diet? 
…………………………………………………….. 
 
 
3.1) Are you currently 
Smoker (go to question 3.2) 
Passive smoker ( go to section 4) 
Former smoker (go to section 4) 
Non-smoker (go to section 4) 
3.2) How many cigarettes do you usually smoke per day?     …………… 
 
3.3) Do you smoke shisha/argella? 
                        Yes                 no 
 
3.4) If yes, how many shisha/ argella do you usually smoke? ............  
• Smoking habits
section 3:
170 
 
 
 
4.1) What is the highest grade you completed in school? 
Illiterate 
      Primary school or less 
      Intermediary school 
      High school graduate 
Diploma degree 
College graduate 
Post graduate 
4.2) What is your household annual income? 
Less than 50,000 Saudi riyals 
                50,000 -  < 100,000 Saudi riyals 
                100,000 -  < 150,000 Saudi riyals 
                 150,000 -  < 200,000 Saudi riyals 
                  200,000 - < 250,000 Saudi riyals 
                  More than 250,000 Saudi riyals  
 
4.3) What is your current occupation? 
Student 
Unemployed  
                Employee 
                 Businessman/ businesswoman  
                  Retired 
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How often on average you had consumed each food item over the past year and please specify if the 
usual serving size differed from the standard serve: 
 
    Average  
Food item  Quantity S M L never 
Less 
than 
1/month 
1-3 
times/ 
month 
Once / 
week 
2-4 
times/ 
week 
5-6 
times/ 
week 
Once/ 
day 
2 or 
more/ 
day 
1-Eggs: 
1egg                   
1.1-Eggs  
2-Meat: 
120 gm                   
2.1-Beef  
2.2-Lamb  
2 chops, 
100 gm 
                  
2.3-Veal  
1 chop, 
                  
90 gm 
2.4-Diced 
meat 
(kabab or 
hamburger)  
150 gm                   
2.5-Meat 
shawerma  
1 
medium 
sandwich 
                  
2.6-
Chicken 
shawerma  
1 
medium 
sandwich 
                  
2.7-
Chicken  
 1 breast 
or thigh,                   
110 gm 
2.8-Liver  
3/4 cup, 
150 gm 
                  
3-Seafood: whole; 1 
fillet, 
120 gm 
                    
3.1-Fish  
3.2-Oysters  
smoked; 
1; 5 gm 
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    Average  
Food item  quantity S M L never 
Less 
than 
1/month 
1-3 
times/ 
month 
Once / 
week 
2-4 
times/ 
week 
5-6 
times/ 
week 
Once/ 
day 
2 or 
more/ 
day 
3.3- Crab/ 
scallops  
1/2 cup, 
90 gm 
                  
3.4-Lobster/ 
1/2 cup, 
90 gm 
                  prawn/ 
squid  
4-Dairy: 1 slice, 
20 gm 
                  
4.1-Cheese  
4.2- Yogurt  
 1 
cartoon,                   
200 g) 
4.3- Cow’s 
Milk  
1 glass, 
200 ml 
                  
4.4- Cow’s 
Milk (with 
cereal) 
½ cup, 
125 ml 
                  
4.5- Cow’s 
Milk (in 
tea/coffee) 
2 tbsp, 
40 ml 
                  
4.6-
Fermented 
milk (laban) 
1 glass, 
200 ml 
                  
4.7- Ice 
cream  
2 
scoops, 
60 gm 
                  
5-
Vegetables: 
  
                  
5.1-Potato  
1 
medium, 
150 gm 
5.2- 
Broccoli  
1 cup, 
80 gm 
                  
 
 
 
 
 
173 
 
 
    Average  
Food item  quantity S M L never 
Less 
than 
1/month 
1-3 
times/ 
month 
Once 
/ 
week 
2-4 
times/ 
week 
5-6 
times/ 
week 
Once/ 
day 
2 or 
more/ 
day 
5.3-
Spinach, 
silver beet  
1/3 cup, 
60 gm 
                  
5.4- 
Tabouli   
1 cup, 
200 gm 
                  
5.5- Okra 
with 
tomato 
sauce  
1 cup                   
5.6-
Vegetables, 
stuffed  
1 piece                   
5.7- Peas  
1/3 cup, 
60 gm 
                  
5.8- 1/2 cup, 
100 gm 
                  
Chickpeas  
5.9-Broad 
bean  
1/2 cup, 
100 gm 
                  
6- fruits:   
                  Citrus 
fruits 
1 peace 
7-
Beverages: 
  
                  
Cocoa/    
7.1-
drinking 
chocolate  
1 
tbsp,9gm 
8-Seeds 
and nuts: 
  
                  
8.1-Sesame 
butter  
1 
teaspoon 
8.2-Nuts  15 gm                   
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    Average  
Food item  quantity S M L never 
Less 
than 
1/month 
1-3 
times/month 
Once 
/ 
week 
2-4 
times/ 
week 
5-6 
times/week 
Once/ 
day 
2 or 
more/ 
day 
9-Cereals: 
1 cup, 
30gm 
                  
9.1- 
Whole 
grain corn 
flakes  
9.2- Corn 
flakes  
1 cup, 
30 gm 
                  
9.3- brown 
Beta 
Bread  
1 slice, 
25 gm 
                  
9.4- white 
Beta 
Bread  
1 slice, 
25 gm 
                  
9.5- brown 
Loaf bread  
1 
medium 
size 
                  
9.6- White 
Loaf bread  
1 
medium 
size 
                  
9.7- brown 
Toast  
1 slice, 
25 g 
                  
9.8-
whiteToast  
1 slice, 
25 g 
                  
9.9- white 
Pasta  
1 cup, 
100gm 
                  
9.10- 
white Rice  
1 cup,75 
gm 
                  
9.11- Rice 
with milk 
(saleeq)  
1 cup                   
9.12- Rice 
with 
tomato 
sauce 
(kabsa)  
1 cup                   
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    Average  
Food item  quantity S M L never 
Less than 
1/month 
1-3 
times/ 
month 
Once / 
week 
2-4 times/ 
week 
5-6 times/ 
week 
Once/ 
day 
2 or 
more/ 
day 
9.13- Rice with 
lentil  
1 cup                   
9.14-  whole 
meal Crisp 
bread  
1; 5 gm                   
9.15- white 
Crisp bread  
 1; 5 gm                   
9.16- Rolled 
oats (boiled)  
1 cup, 230 
g 
                  
9.17- Fruit cake/ 
loaf 
1 slice, 75 
gm 
                  
9.18- Muffin  1; 55 g                   
9.19-Biscuits ( 
bran, whole 
meal)  
1; 20 gm                   
10-
Miscellaneous: 
  
                  
10.1- Meat pie 
(sambosak)   
1 piece 
10.2-Cheese pie 
(sambosak)  
1 piece                   
10.3- Meet pie 
(fatayer)  
160 gm                   
10.4-Cheese pie 
(fatayer)  
160 gm                   
10.5- Pizza  150 gm                   
10.6-Tameya  3 pieces                   
10.7- Pop corn  1 cup                   
10.8- Chips/ 
corn chips/ 
twisties  
50 gm                   
10.9-Chocolate  
1 bar,50 
gm 
                  
10.10-Custard  1/2 cup                   
10.11- Rice 
with milk and 
sugar 
(mohalabeya)  
1/2 cup                   
10.12-Cream 
caramel 
1/2 cup                   
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5.1) are there any other foods not mentioned above that you usually eat? 
                        Yes                 no 
5.2) if yes, what is it? And how often on average you had consumed it? 
…………………………………………………………………. 
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(Day 1- week day) 
Date: 
Day of the week: 
Meal 
Food type and description 
(give brand name if applicable) 
quantity 
Breakfast   
Snack   
Lunch   
Snack   
Diner   
snack   
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(Day 2- week day) 
Date: 
Day of the week: 
Meal 
Food type and description 
(give brand name if applicable) 
quantity 
Breakfast   
Snack   
Lunch   
Snack   
Diner   
snack   
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(Day 3- weekend day) 
Date: 
Day of the week: 
Meal Food type and description quantity 
Breakfast   
Snack   
Lunch   
Snack   
Diner   
snack   
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Example of dietary analysis  
 
participant 
ID 
zinc 
content/1 
serving of 
egg (A) 
size of egg  
consumed 
(B) 
frequency of 
egg 
consumption 
(C) 
amount 
of zinc 
consume
d from 
egg 
(A*B*C) 
zinc 
content/1 
serving of 
beef (A) 
size of beef  
consumed 
(B) 
frequency of 
beef 
consumption  
( C ) 
amount of 
zinc 
consumed 
from beef 
(A*B*C) 
… ….. 
total 
zinc 
intake 
from all 
food 
items 
(mg/d) 
1 0.462 1.5 0.0667 0.046 5.826 1 0.1429 0.83   10.80 
2 0.462 1.5 0.4286 0.297 5.826 0 0 0   30.259 
3 0.462 0.5 0.1429 0.033 5.826 0.5 0.0667 0.194   9.096 
4 0.462 0.5 0.4286 0.099 5.826 0 0 0   16.238 
5 0.462 0.5 1 0.231 5.826 0.5 0.0167 0.048   6.594 
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Raw data for intake of zinc, phytic acid and protein for participants of validation study 
participant 
ID 
zinc intake 
(mg/d) 
phytic acid intake 
(mg/d) 
protein 
intake (g/d) 
1 9.25864821 524.0480533 65.6837537 
2 11.42890631 503.3335291 76.54543795 
3 5.72516596 261.0743761 43.30056171 
4 8.56373091 421.7385172 61.6120977 
5 14.12612917 617.9800984 94.4832198 
6 9.43956872 1073.383721 59.66802206 
7 6.69800706 431.220008 43.94686865 
8 10.3870993 643.0866585 92.03641646 
9 9.85950215 617.1965855 73.26523428 
10 7.40459957 353.6541104 48.32384582 
11 17.96186722 1216.465104 124.5798296 
12 8.04954921 557.593961 69.72522793 
13 8.48711767 490.4663948 64.1846757 
14 6.2982817 295.6046549 41.40348078 
15 7.43273912 221.7488404 56.68901248 
16 14.55595367 441.0880422 98.90557641 
17 7.73922367 558.4070134 70.55494209 
18 5.89847651 323.7368581 45.67170137 
19 15.74631971 709.4125655 103.1477231 
20 17.39414696 401.0496301 122.9424064 
21 4.22407637 269.1067541 29.5527208 
22 8.33003056 643.9765086 61.05490924 
23 26.391 1312.73 194.4184 
24 12.20258277 607.8738236 80.17612557 
25 11.3275361 606.0223701 81.04179277 
26 14.18548237 740.9741693 105.9486937 
27 12.29983215 407.5859075 93.65469164 
28 5.96962581 472.376765 41.54915516 
29 9.39159936 409.1374672 60.28974647 
30 6.41362131 228.5585847 46.1623856 
31 7.93147828 366.3598712 63.06354011 
32 11.61747402 462.8995693 70.01424705 
33 9.0519732 575.5555967 65.16856595 
34 5.46835812 255.5150298 43.81290665 
35 9.29992742 553.0388488 55.48007978 
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36 9.6601506 489.5515351 75.78224728 
37 3.9832854 155.9438859 25.09845218 
38 14.47 685.4739 99.9275 
39 4.2903868 132.6983283 31.23645533 
40 4.409121 133.9633375 24.00339723 
41 6.3094675 319.126054 59.09385586 
42 8.55318026 413.4792021 64.82602106 
43 9.47463636 452.9870293 84.86946803 
44 7.40804117 346.8431862 55.03055937 
45 11.15531886 756.1812448 99.45003073 
46 19.22069521 1137.033772 140.6537971 
47 13.61293628 552.0007621 99.04647304 
48 13.14441202 678.9908091 98.77169196 
49 8.40770096 415.2190393 57.99735332 
50 15.25489836 668.6601615 116.2046283 
51 12.94641942 522.781052 90.09180166 
52 10.00893942 444.5891179 69.71911805 
53 8.98639782 354.842259 61.78089128 
54 8.54371552 407.606724 74.71563336 
55 19.8303423 1117.107492 149.5247001 
56 7.8927437 385.249731 57.95591663 
57 11.58090512 604.6198428 96.89727921 
58 10.8965025 423.7031509 99.04816246 
59 12.86312696 640.9616951 94.05489011 
60 5.5539003 251.5214756 50.42079606 
61 13.44328011 393.1801181 83.68011902 
62 12.28567835 443.6224261 80.69904261 
63 14.27682 758.9512 91.5549 
64 8.13643625 224.4291993 51.66945179 
65 17.24400667 363.5002774 103.8783211 
66 18.0560083 388.3026812 106.6905229 
67 17.70757775 1291.653792 133.2709228 
68 13.44851532 362.5450936 88.85671703 
69 8.99347912 445.7832505 50.11659994 
70 10.28484235 555.3207381 77.75686143 
71 7.91617545 397.5149293 62.51030786 
72 11.86270676 766.1542199 87.07074623 
73 14.23282163 636.2020606 110.1397319 
74 5.18116823 354.7527527 33.46700318 
75 10.70228694 385.1149496 74.38885941 
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76 7.54852587 370.5185734 61.14191365 
77 13.52756772 400.0056381 88.46412571 
78 13.50618099 817.2955003 90.84864994 
79 7.46166863 423.0604098 59.05549025 
80 9.20620045 562.1675946 68.2606347 
81 14.61884738 863.8769677 104.8390999 
82 9.63864325 525.9677437 64.6185024 
83 7.71907972 441.4528549 55.9453729 
84 5.73095395 349.2057349 45.26927738 
85 11.77948739 573.0805713 103.3503504 
86 8.9691429 506.6951143 69.7311385 
87 14.04003514 789.436863 101.8797578 
88 10.9812854 751.9635524 73.04690678 
89 16.09628156 891.8174448 117.0006241 
90 21.34618074 685.8230768 132.9052193 
91 9.37268391 713.9797556 65.53322704 
92 6.61417857 315.9937145 46.50632368 
93 10.6829985 479.9399932 70.36785495 
94 16.82871577 965.2812698 126.4616956 
95 7.9788354 327.8255676 84.29212203 
96 4.56909687 264.5654711 33.52182113 
97 11.97647964 472.6640161 81.4442452 
98 8.61046886 345.3999396 66.71442896 
99 5.21345907 292.4645685 35.064079 
100 4.78397693 170.4568158 33.6929127 
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Raw data for zinc intake of participants of the main study 
participant ID zinc intake (mg/d) 
1 10.80298 
2 30.25996 
3 9.096576 
4 16.23887 
5 6.594625 
6 6.45074 
7 7.773274 
8 7.566641 
9 3.847592 
10 25.33129 
11 16.89895 
12 8.48454 
13 11.64969 
15 4.649884 
16 4.102952 
17 11.15229 
18 16.97242 
19 4.874043 
20 6.908182 
21 14.2806 
23 25.28748 
24 39.77378 
25 3.567685 
26 9.859602 
27 7.202284 
28 17.21102 
29 9.904947 
30 9.284128 
31 9.556275 
32 6.272592 
33 12.12372 
34 4.224291 
35 11.50598 
36 6.955037 
37 6.254953 
38 3.301857 
39 7.443996 
40 7.697296 
41 9.163277 
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42 2.42842 
43 8.040598 
44 32.30861 
45 8.307898 
46 10.40254 
47 5.772159 
48 19.4406 
49 34.35042 
50 9.733813 
51 10.04801 
52 16.87125 
53 7.195335 
54 10.15215 
55 12.0032 
56 19.15833 
57 4.428718 
58 9.77238 
59 3.30553 
60 13.7074 
61 13.10154 
62 7.200376 
63 7.405242 
64 6.190081 
65 6.598013 
66 6.873601 
67 7.400145 
68 7.86702 
69 3.09983 
70 6.683962 
71 22.4795 
72 10.56144 
73 13.54657 
74 14.09758 
75 4.456412 
76 9.703492 
77 3.929793 
78 14.28881 
79 11.70587 
80 18.06818 
81 18.67103 
82 11.82378 
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83 5.728675 
84 8.331228 
85 5.65616 
86 7.606377 
87 6.612202 
88 7.634465 
89 19.66739 
90 24.31117 
91 5.799805 
92 10.87504 
93 9.152188 
94 6.073008 
95 6.905123 
96 4.799942 
97 7.336238 
98 12.80155 
99 14.19721 
100 4.683997 
101 7.33562 
102 20.48949 
103 35.36006 
104 7.995299 
105 7.238709 
106 6.813947 
107 11.10644 
108 10.6373 
109 11.73492 
110 13.03866 
111 9.787564 
112 6.380718 
113 4.905188 
114 10.35702 
115 5.290186 
116 5.984145 
117 11.38142 
118 7.595044 
119 13.8753 
120 20.11827 
121 7.480049 
122 8.227486 
124 6.500306 
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125 15.91242 
126 10.48426 
127 4.772961 
128 5.269564 
129 11.61615 
130 6.944205 
131 4.821005 
132 19.34347 
133 7.996156 
134 8.987689 
135 8.491692 
136 5.447627 
137 10.12384 
138 6.587354 
139 10.91655 
140 7.664847 
141 13.85371 
142 9.727458 
143 5.871782 
144 12.24471 
145 11.8933 
146 6.658255 
147 10.10051 
148 5.931104 
149 6.629374 
150 11.73738 
151 11.43126 
152 27.87895 
153 36.58801 
154 13.00869 
155 37.5872 
156 20.60777 
157 14.66097 
158 5.011547 
159 19.27911 
160 8.938238 
161 7.066104 
162 13.49623 
163 13.26847 
164 8.478604 
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165 20.20768 
166 11.75054 
167 9.231413 
168 11.37443 
169 23.86972 
170 9.89127 
171 6.011448 
172 11.03012 
173 4.081334 
174 14.05431 
175 9.510537 
176 6.74149 
177 14.82102 
178 10.16138 
179 9.606388 
180 3.207858 
181 8.471256 
182 11.44424 
183 11.2147 
184 14.55491 
185 8.367536 
186 14.0082 
187 8.783955 
188 9.37234 
189 8.763071 
190 8.937041 
191 12.17081 
192 17.23748 
193 13.74477 
194 17.52057 
195 8.943402 
196 9.486558 
197 24.56024 
198 8.393264 
199 9.851438 
200 10.72525 
201 7.216202 
202 7.673033 
203 6.267477 
204 10.60237 
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Percent contribution of food items and food groups to intake of zinc and its absorption modifiers in Saudi adults 
Food item Zinc 
Phytic 
acid 
Protein Food item Zinc 
Phytic 
acid 
Protein Food item Zinc 
Phytic 
acid 
Protein 
Eggs 1.5 0 2.5 Vegetables 8.8 25.8 23 white toast  0.3 0.4 0.4 
Eggs 1.5 0 2.5 potato 2 6.6 1.7 white pasta  1.8 3.1 1.5 
Meat 36.9 3.1 35.5 broccoli 0.1 0.1 0.1 white rice  4.2 9.5 3.1 
Beef 3.8 0 2.9 spinach, silver beet  0.3 0.1 0.1 rice with milk (saleeq)  1 1.3 1 
lamb  10.6 0 6.3 tabouli  0.5 3.2 0.4 
rice with tomato sauce 
(kabsa) 
1.9 3.8 1.5 
veal  0.8 0 0.9 
okra with tomato 
sauce  
0.5 0.3 0.4 rice with lentil  0.6 2.1 0.5 
diced meat 5.5 0.2 3.2 vegetables, stuffed  2.4 0.7 1.6 whole meal crisp bread  0.7 3.8 0.4 
meat shawerma  0.6 0.5 0.1 chickpeas  1.7 6.8 1.2 rolled oats (boiled)  0.7 1.1 0.5 
chicken shawerma  0.9 1.2 0.7 broad bean  1.8 8 2 fruit cake/loaf  0.3 0.5 0.3 
chicken  10.5 1.2 18.4 Fruits 0.4 0.4 0.7 muffin  0.1 0.2 0.1 
liver  3.8 0 3 citrus fruits  0.4 0.4 0.7 
biscuits (bran, whole 
meal ) 
0.4 2.3 0.4 
Seafood 1.6 0.2 7.4 Beverages: Cocoa 0.1 0.2 0.03 Miscellaneous 13.1 17.6 12.6 
Fish 0.1 0.1 6.2 drinking chocolate  0.1 0.2 0.03 meat pie (sambosak)  0.8 0.2 0.7 
oysters  0.3 0 0 Seeds and nuts 1.2 4.7 0.7 cheese pie (sambosak)  0.2 0.3 0.5 
crab/scallops  0.3 0 0.2 sesame butter  0.3 2.2 0.1 meat pie (fatayer)  1 0.3 0.8 
lobster/prawn/squid  0.9 0.1 1 nuts  0.9 2.5 0.6 cheese pie (fatayer)  0.6 0.9 1.4 
Dairy  15.8 0 15.5 Cereals 18.9 46.5 17 pizza  1.9 1.2 2.5 
Cheese 4.5 0 4.5 
whole grain corn 
flakes  
0.6 3.8 0.2 
Beans and vegetables 
patty (tameya, flafel)  
3.8 7.1 3.6 
yogurt  4.4 0 3.5 corn flakes  0.03 0.01 0.2 popcorn  0.2 0.6 0.1 
cow's milk  2.8 0 3.2 brown pita bread  2.5 5.8 2.2 
chips/ corn chips/ 
twisties  
0.5 2.3 0.6 
cow's milk (with 
cereal)  
0 0 0.5 white pita bread  1 2.9 1.5 chocolate  3.5 4.2 1.6 
cow's milk (in 
tea/coffee) 
0.6 0 0.7 brown loaf bread  0.7 2.9 0.7 custard  0.2 0 0.3 
fermented milk 
(laban)  
2.6 0 2.8 white loaf bread  1.2 0.6 1.7 
rice with milk and sugar 
(mohalabeya)  
0.2 0.1 0.2 
ice cream  0.4 0 0.3 brown toast  0.8 3.2 0.8 cream caramel  0.2 0.4 0.3 
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Raw Ct values 
Sample Number Gender 
Age 
Group 
average 
GAPDH CT 
values 
average 
ZnT1 CT 
values 
average 
ZnT5 CT 
values 
average 
ZIP4 CT 
values 
sample1 female young 18.649 26.1669 27.88335 30.1727 
sample 2 female young 20.0326 28.098 29.6682 31.2217 
sample 3 female young 20.23095 28.3245 31.79085 34.9044 
sample 4 female young 19.15395 26.7374 28.57955 30.23075 
sample 5 female young 19.22195 26.8598 27.242 28.4573 
sample 6 female older 19.55555 27.2377 27.40055 28.8871 
sample 7 female young 20.16365 27.2806 27.77115 28.212 
sample 8 female young 18.50905 27.34355 28.03305 29.9085 
sample 9 male young 19.57845 27.51155 27.9602 28.6219 
sample 10 male young 19.1167 25.9179 27.06555 29.6253 
sample 11 male young 19.2531 27.70025 28.67455 28.7274 
sample 12 female young 18.3021 26.6019 27.66485 28.9482 
sample 13 female young 17.90425 27.33335 28.10215 28.7738 
sample 15 female young 18.02415 27.44505 28.3546 29.29045 
sample 16 female young 18.2482 27.32975 28.1349 28.6775 
sample 17 male young 16.0368 27.3752 28.3134 29.761 
sample 18 male young 15.3224 26.59435 27.77995 29.14515 
sample 19 female young 15.78205 26.29595 26.9878 28.528 
sample 20 male young 17.927 27.3869 27.66905 28.7971 
sample 21 male young 17.3494 26.18915 26.865 27.90665 
sample 23 female young 17.2738 27.28015 27.85455 28.9634 
sample 24 female young 17.85775 27.6021 27.46855 29.3454 
sample 25 female young 18.1638 26.9614 27.6162 29.2222 
sample 26 female young 18.863 27.3989 27.76335 29.2963 
sample 27 female young 18.20305 26.7441 27.98995 29.2944 
sample 28 male young 19.7692 26.5698 26.96695 28.42015 
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sample 29 male young 19.2699 26.36895 26.8764 29.0076 
sample 30 male young 19.9738 26.997 27.03595 29.33905 
sample 31 male young 17.57245 27.1207 27.2113 28.63415 
sample 32 male young 16.7731 26.30445 27.03385 28.5112 
sample 33 female young 18.03075 28.5253 29.0546 30.64045 
sample 34 female young 17.21175 26.74685 27.512 28.6899 
sample 35 male young 18.1587 25.5477 29.2977 30.49655 
sample 36 male young 17.35235 24.4066 27.83065 29.80025 
sample 37 male young 17.88355 25.02045 27.9063 29.12665 
sample 38 male young 18.15765 27.30755 27.8101 29.95455 
sample 39 male young 17.67745 26.58295 27.17435 28.8196 
sample 40 male young 18.2488 26.97275 27.4521 29.53805 
sample 41 female young 17.79525 26.454 27.001 28.41755 
sample 42 male young 17.9228 26.8915 27.2892 28.96855 
sample 43 female older 18.111 26.91295 27.63655 29.2851 
sample 44 male young 16.9678 25.97395 27.1946 28.68135 
sample 45 male young 17.6801 26.96675 27.7954 28.9037 
sample 46 male young 17.5852 26.8323 27.4136 28.9052 
sample 47 male young 20.63675 29.3629 30.3201 31.47135 
sample 48 male young 19.3855 27.10775 27.8239 28.98925 
sample 49 male young 19.95885 27.6284 28.80665 27.88185 
sample 50 male young 20.48355 27.5519 29.0989 29.32835 
sample 51 male young 19.74815 26.3551 27.5299 28.2911 
sample 52 male young 19.9169 26.7378 28.0045 28.23955 
sample 53 female young 20.3418 27.1112 27.74835 28.925 
sample 54 female young 18.7644 26.98305 27.84825 28.8479 
sample 55 male young 18.7611 26.84365 27.885 29.3799 
sample 56 male young 18.62615 27.06915 27.6017 28.70665 
sample 57 male young 17.97365 26.6155 27.65815 25.4041 
sample 58 male young 18.12585 26.73275 26.95345 25.30355 
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sample 59 male young 18.0839 27.6572 28.5447 25.78465 
sample 60 female young 18.78445 27.3159 28.62565 26.63205 
sample 61 female young 18.9918 26.72895 27.06535 28.2821 
sample 63 female young 18.2832 27.01625 27.71475 28.4999 
sample 64 female young 18.32395 27.11075 27.2982 28.3297 
sample 65 female young 18.2685 27.30945 27.56345 28.2819 
sample 66 female young 19.34085 27.2049 28.0253 29.3323 
sample 67 female young 19.3865 26.7087 27.78425 28.7612 
sample 68 male young 19.3216 27.83945 27.8934 30.18575 
sample 69 female young 17.92525 27.10045 27.84625 28.91925 
sample 70 female young 18.13115 26.74265 27.4158 28.56905 
sample 71 male young 17.39275 26.5395 26.9635 28.1618 
sample 72 male young 17.54535 26.0706 26.8527 29.00115 
sample 73 female young 19.1823 26.64475 28.0811 28.2231 
sample 74 male young 18.6731 26.3078 27.0026 29.2644 
sample 75 male young 19.1052 27.0013 28.122 29.5731 
sample 76 male young 18.7795 26.89335 27.6347 28.79935 
sample 77 male young 17.22205 26.484 27.1775 28.7155 
sample 78 male young 18.3788 27.03875 27.76925 29.42985 
sample 79 female young 18.1022 27.03925 27.2912 28.82155 
sample 80 male young 19.82695 26.9567 25.22935 29.47365 
sample 81 female young 20.43045 27.2297 25.2573 28.9683 
sample 82 male young 19.9685 26.78045 25.5027 29.18145 
sample 83 male young 20.1616 26.34785 25.3192 28.8346 
sample 84 male young 19.9827 26.89365 27.55465 28.20505 
sample 85 female young 19.8631 27.13605 26.7441 28.94625 
sample 86 female young 20.2025 26.1339 26.63855 28.6847 
sample 87 female young 19.6538 26.8072 27.55255 28.897 
sample 88 female young 21.023 27.79615 28.72335 29.494 
sample 89 male young 19.96065 26.80085 27.37115 28.27475 
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sample 90 male young 20.3021 26.78165 27.47845 28.22595 
sample 91 female young 17.977 26.41015 27.1343 28.5834 
sample 92 female older 18.1226 27.79955 27.94135 28.91605 
sample 93 male young 18.2414 27.41005 28.08285 29.51555 
sample 94 female young 18.05145 27.5022 27.7542 28.54645 
sample 95 female young 20.78355 27.06385 27.89095 28.7199 
sample 96 female young 20.1448 26.84465 27.88085 28.33395 
sample 97 female young 20.29315 27.81325 27.99705 30.28495 
sample 98 male young 18.4087 27.3395 27.91685 29.454 
sample 99 male young 19.11825 27.89985 28.3395 28.7676 
sample 100 male young 18.46575 27.8401 28.248 28.3823 
sample 101 female young 18.03105 27.2729 27.6396 28.35375 
sample 102 male young 18.3151 27.47605 27.77915 30.2596 
sample 103 male older 18.29605 26.9778 27.60245 29.5706 
sample 104 male older 17.29615 26.39765 27.4746 29.0024 
sample 105 male older 19.7654 26.7898 27.62865 28.1684 
sample 106 female older 20.47115 27.7083 28.5491 30.52575 
sample 107 male older 18.78165 27.2792 27.6286 30.119 
sample 108 female older 18.9404 26.7121 27.6978 29.95755 
sample 109 male older 19.54215 27.67155 27.708 30.56275 
sample 110 female older 18.7238 26.723 26.93155 28.59915 
sample 111 male older 19.631 26.6834 27.75915 28.43795 
sample 112 female older 18.2956 27.8742 27.92385 29.6877 
sample 113 female older 17.71385 26.5703 27.3225 29.1302 
sample 114 female older 17.9188 26.9427 28.3988 29.328 
sample 115 female older 19.37145 27.04325 28.4834 29.1332 
sample 116 female older 19.76085 28.5861 29.81275 31.74915 
sample 117 female older 19.49695 27.0535 28.1282 28.3597 
sample 118 female older 19.2303 26.88785 27.5903 28.92135 
sample 119 male older 20.81625 28.0731 27.1187 28.6223 
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sample 120 male older 20.6622 27.92155 27.63775 30.2346 
sample 121 female older 19.6928 26.9748 28.416 28.8824 
sample 122 female older 19.6363 26.72755 27.60665 28.8956 
sample 123 female older 20.2921 26.8958 27.251 28.21155 
sample 124 female older 19.87635 26.39685 27.81175 29.66095 
sample 125 female older 18.14325 26.3509 26.80585 29.3449 
sample 126 female older 19.1789 27.19545 28.0286 31.19 
sample 127 female young 18.5413 27.5281 27.32665 29.15065 
sample 128 female young 18.1531 27.02355 27.6654 32.3045 
sample 129 female young 18.6121 27.5492 28.3494 26.0485 
sample 130 female older 17.7444 25.6964 26.8743 24.04855 
sample 131 female older 18.2357 26.82625 27.9147 26.4972 
sample 132 male older 17.7356 27.26915 28.25805 28.17145 
sample 133 female older 17.92675 27.0489 27.6495 28.59835 
sample 134 female older 17.9664 27.51535 28.0242 28.19995 
sample 135 female older 17.7462 26.46395 27.0263 29.93265 
sample 136 female older 19.86135 27.4598 28.58385 29.14055 
sample 137 female older 19.77665 27.70025 27.76395 29.29205 
sample 138 male older 19.07305 27.56925 27.6851 29.9336 
sample 139 male older 19.50755 27.6949 28.38155 29.6083 
sample 140 male older 18.83025 26.83745 27.8879 30.54105 
sample 141 male older 18.86875 27.65735 27.8424 27.63215 
sample 142 female young 19.195 27.8981 27.9561 27.8655 
sample 143 female older 19.095 26.98645 28.17035 28.54775 
sample 144 male older 18.7479 27.03435 27.39675 28.3662 
sample 145 male older 18.71895 26.9725 27.3144 28.70145 
sample 146 female older 17.71975 27.8523 28.75425 30.7473 
sample 147 female older 19.2054 26.9584 27.57675 29.9437 
sample 148 female older 18.9572 26.8727 27.451 28.2637 
sample 149 male older 19.09295 27.42875 27.514 29.4283 
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Sample 150 male older 18.09135 27.14685 27.40775 30.18385 
Sample 151 female older 18.13755 27.42685 28.10965 29.8179 
sample 152 male older 17.8844 26.3085 27.99655 28.95785 
Sample 153 female young 18.1445 27.5167 27.89515 29.2397 
Sample 154 female older 20.5608 27.43905 25.8706 29.77545 
Sample 155 male older 19.80245 26.6904 26.00275 29.47255 
Sample 156 male older 20.1966 27.26125 25.97205 30.84415 
Sample 157 female older 19.52485 26.7311 27.61385 28.9839 
Sample 158 female older 20.55605 27.74645 27.46855 30.30065 
Sample 159 female older 20.1663 26.92975 28.2811 29.71695 
Sample 160 female young 19.3281 26.7008 27.19985 27.8989 
Sample 161 male older 19.50185 27.0209 27.92685 28.97455 
Sample 162 female older 20.27985 27.73575 28.902 31.3651 
Sample 163 female older 19.5328 26.09005 26.31195 28.6405 
Sample 164 male older 20.46835 26.97995 27.1614 29.9061 
Sample 165 male older 19.3583 26.37695 27.0513 29.3073 
Sample 166 male older 17.4405 26.97595 27.455 29.6712 
Sample 167 female older 17.29075 26.59235 27.74545 29.75315 
Sample 168 male older 17.18245 26.0221 27.337 29.46155 
Sample 169 male older 17.7875 24.2699 27.3647 28.9189 
Sample 170 male older 17.77305 23.4355 26.7366 29.84685 
Sample 171 female older 17.76625 23.92135 27.41075 28.61125 
Sample 172 male older 19.6055 27.73635 32.5714 32.3818 
Sample 173 male older 17.2439 26.29435 26.9823 28.6559 
Sample 174 male older 17.8295 26.6388 27.05395 28.8107 
Sample 175 female older 17.33375 26.98245 27.5587 28.5379 
Sample 176 male older 17.38105 26.14735 26.92505 28.6039 
Sample 177 male older 17.73985 27.76605 28.7081 30.7247 
Sample 178 male older 18.87095 27.594 28.21335 29.825 
Sample 179 male older 17.16145 26.8944 27.8435 29.5682 
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Sample 180 female older 17.25105 27.0849 27.73095 29.55325 
Sample 181 male older 17.63755 27.10915 27.7796 29.64335 
Sample 182 female older 20.52645 29.9981 30.74685 31.0038 
Sample 183 female older 19.8143 27.19915 27.50995 27.89575 
Sample 184 male older 19.3178 26.6509 27.6136 29.2484 
Sample 185 female older 19.51645 26.61865 27.35585 28.4934 
Sample 186 male older 18.93065 26.23155 27.3849 29.26632 
Sample 187 male older 19.67085 27.0157 27.89955 29.4848 
Sample 188 male older 20.04685 27.91415 28.27275 30.82385 
Sample 189 male older 17.6749 27.08845 28.3532 30.8423 
Sample 190 male older 18.6408 28.4131 29.25515 30.91645 
Sample 191 male older 18.48165 27.5874 28.58915 31.7746 
Sample 192 female older 15.88255 27.9218 28.5501 30.61545 
Sample 193 male older 15.6954 27.57735 28.00915 30.6304 
Sample 194 male older 16.20545 27.31505 28.13335 31.23435 
Sample 195 male older 16.09155 28.1501 28.4258 30.82725 
Sample 196 male older 17.25645 28.0078 28.75825 31.43055 
Sample 197 male older 17.2288 27.44635 28.6097 30.24195 
Sample 198 male older 16.91605 27.4858 28.26855 29.8584 
Sample 199 female older 18.4232 26.54455 26.9785 29.13125 
Sample 200 male older 18.45905 26.76065 27.11195 29.6687 
Sample 201 female older 18.6189 26.30165 26.87965 28.68455 
Sample 202 female older 18.0768 25.756 26.73745 28.7652 
Sample 203 female older 18.08985 25.17715 27.17 28.7808 
Sample 204 female older 18.8004 25.2799 27.165 30.92155 
  
203 
 
 
